,Tumor type,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count,category,subcategory
HALLMARK_COAGULATION,discovery_tumor_BRCA,HALLMARK_COAGULATION,HALLMARK_COAGULATION,3/7,138/4383,0.00097419793488311,0.006819385544181771,0.006152829062419643,CPN1/KLKB1/PROZ,3.0,,
hsa04610,discovery_tumor_BRCA,hsa04610,Complement and coagulation cascades,2/7,88/8843,0.0019905089426428286,0.0278671251969996,0.01676218056962382,KLKB1/SERPINA5,2.0,Organismal Systems,Immune system
R-HSA-140837,discovery_tumor_BRCA,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,2/11,23/11009,0.00022703043681217158,0.008854187035674692,0.004779588143414139,KLKB1/SERPINA5,2.0,,
R-HSA-140877,discovery_tumor_BRCA,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),2/11,39/11009,0.0006591632381204337,0.012853683143348458,0.006938560401267723,KLKB1/SERPINA5,2.0,,
GO:0007596,discovery_tumor_BRCA,GO:0007596,blood coagulation,3/11,224/18870,0.0002538311050185486,0.019358327770289847,0.0112123278447914,FERMT3/KLKB1/PROZ,3.0,,
GO:0050817,discovery_tumor_BRCA,GO:0050817,coagulation,3/11,229/18870,0.00027085775498561585,0.019358327770289847,0.0112123278447914,FERMT3/KLKB1/PROZ,3.0,,
GO:0007599,discovery_tumor_BRCA,GO:0007599,hemostasis,3/11,231/18870,0.00027787073354483034,0.019358327770289847,0.0112123278447914,FERMT3/KLKB1/PROZ,3.0,,
hsa04610,discovery_tumor_CECA,hsa04610,Complement and coagulation cascades,3/12,88/8843,0.0001963482445446551,0.002436503186412415,0.0017098267974823963,F13A1/F13B/VTN,3.0,Organismal Systems,Immune system
hsa04512,discovery_tumor_CECA,hsa04512,ECM-receptor interaction,3/12,89/8843,0.0002030419322010346,0.002436503186412415,0.0017098267974823963,FN1/FREM2/VTN,3.0,Environmental Information Processing,Signaling molecules and interaction
R-HSA-6806834,discovery_tumor_CECA,R-HSA-6806834,Signaling by MET,3/17,79/11009,0.00022494805134624896,0.018417127073176356,0.011589725274882145,FN1/HGFAC/SH3KBP1,3.0,,
R-HSA-140875,discovery_tumor_CECA,R-HSA-140875,Common Pathway of Fibrin Clot Formation,2/17,22/11009,0.000509135292365981,0.018417127073176356,0.011589725274882145,F13A1/F13B,2.0,,
R-HSA-3000170,discovery_tumor_CECA,R-HSA-3000170,Syndecan interactions,2/17,27/11009,0.00077011686280869,0.018417127073176356,0.011589725274882145,FN1/VTN,2.0,,
R-HSA-1474244,discovery_tumor_CECA,R-HSA-1474244,Extracellular matrix organization,4/17,300/11009,0.000971440861959777,0.018417127073176356,0.011589725274882145,FN1/PRSS1/PRSS2/VTN,4.0,,
R-HSA-1592389,discovery_tumor_CECA,R-HSA-1592389,Activation of Matrix Metalloproteinases,2/17,33/11009,0.0011521738139107188,0.018417127073176356,0.011589725274882145,PRSS1/PRSS2,2.0,,
R-HSA-1474228,discovery_tumor_CECA,R-HSA-1474228,Degradation of the extracellular matrix,3/17,140/11009,0.0012011169830332406,0.018417127073176356,0.011589725274882145,FN1/PRSS1/PRSS2,3.0,,
R-HSA-2129379,discovery_tumor_CECA,R-HSA-2129379,Molecules associated with elastic fibres,2/17,37/11009,0.001448043868896705,0.018494191744840516,0.011638221349728013,FN1/VTN,2.0,,
R-HSA-140877,discovery_tumor_CECA,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),2/17,39/11009,0.001608190586507871,0.018494191744840516,0.011638221349728013,F13A1/F13B,2.0,,
R-HSA-1566948,discovery_tumor_CECA,R-HSA-1566948,Elastic fibre formation,2/17,44/11009,0.002043809038866739,0.02089227017508222,0.013147309606745103,FN1/VTN,2.0,,
R-HSA-977606,discovery_tumor_CECA,R-HSA-977606,Regulation of Complement cascade,2/17,47/11009,0.0023291262015399964,0.021427961054167964,0.013484414851021032,CFP/VTN,2.0,,
R-HSA-166658,discovery_tumor_CECA,R-HSA-166658,Complement cascade,2/17,58/11009,0.003526210033064404,0.027957492004960456,0.017593387417309213,CFP/VTN,2.0,,
R-HSA-3000171,discovery_tumor_CECA,R-HSA-3000171,Non-integrin membrane-ECM interactions,2/17,59/11009,0.003646629391951364,0.027957492004960456,0.017593387417309213,FN1/VTN,2.0,,
R-HSA-6798695,discovery_tumor_CECA,R-HSA-6798695,Neutrophil degranulation,4/17,480/11009,0.005398847201425765,0.038207226348551566,0.02404344907517547,CFP/COTL1/PRSS2/TXNDC5,4.0,,
R-HSA-3000178,discovery_tumor_CECA,R-HSA-3000178,ECM proteoglycans,2/17,76/11009,0.0059813116361175965,0.03930576218020135,0.0247347473674036,FN1/VTN,2.0,,
R-HSA-216083,discovery_tumor_CECA,R-HSA-216083,Integrin cell surface interactions,2/17,85/11009,0.007431564618749812,0.04558026299499885,0.028683231861841376,FN1/VTN,2.0,,
GO:0042060,discovery_tumor_CECA,GO:0042060,wound healing,5/21,423/18870,8.361811477471816e-05,0.011583673343351449,0.008616627188738622,F13A1/F13B/FN1/HGFAC/VTN,5.0,,
GO:0007596,discovery_tumor_CECA,GO:0007596,blood coagulation,4/21,224/18870,9.87210932069296e-05,0.011583673343351449,0.008616627188738622,F13A1/F13B/HGFAC/VTN,4.0,,
GO:0050817,discovery_tumor_CECA,GO:0050817,coagulation,4/21,229/18870,0.00010750927193689106,0.011583673343351449,0.008616627188738622,F13A1/F13B/HGFAC/VTN,4.0,,
GO:0007599,discovery_tumor_CECA,GO:0007599,hemostasis,4/21,231/18870,0.00011117911193701158,0.011583673343351449,0.008616627188738622,F13A1/F13B/HGFAC/VTN,4.0,,
GO:0072378,discovery_tumor_CECA,GO:0072378,"blood coagulation, fibrin clot formation",2/21,16/18870,0.00014022575443762414,0.011583673343351449,0.008616627188738622,F13A1/F13B,2.0,,
GO:0045785,discovery_tumor_CECA,GO:0045785,positive regulation of cell adhesion,5/21,482/18870,0.00015444897791135265,0.011583673343351449,0.008616627188738622,ABI3BP/CCDC88B/FN1/PRSS2/VTN,5.0,,
GO:0072376,discovery_tumor_CECA,GO:0072376,protein activation cascade,2/21,19/18870,0.00019941979856726564,0.012819844193609936,0.00953616480366774,F13A1/F13B,2.0,,
GO:0010811,discovery_tumor_CECA,GO:0010811,positive regulation of cell-substrate adhesion,3/21,123/18870,0.00032988661571461806,0.01638818623753127,0.012190510464409228,ABI3BP/FN1/VTN,3.0,,
GO:0030198,discovery_tumor_CECA,GO:0030198,extracellular matrix organization,4/21,321/18870,0.0003912905867888294,0.01638818623753127,0.012190510464409228,ABI3BP/PRSS1/PRSS2/VTN,4.0,,
GO:0043062,discovery_tumor_CECA,GO:0043062,extracellular structure organization,4/21,322/18870,0.00039592569633258186,0.01638818623753127,0.012190510464409228,ABI3BP/PRSS1/PRSS2/VTN,4.0,,
GO:0045229,discovery_tumor_CECA,GO:0045229,external encapsulating structure organization,4/21,323/18870,0.00040060010802854225,0.01638818623753127,0.012190510464409228,ABI3BP/PRSS1/PRSS2/VTN,4.0,,
GO:0018149,discovery_tumor_CECA,GO:0018149,peptide cross-linking,2/21,28/18870,0.0004381688878480576,0.016431333294302162,0.012222605818919503,F13A1/FN1,2.0,,
GO:0050878,discovery_tumor_CECA,GO:0050878,regulation of body fluid levels,4/21,365/18870,0.0006350329689152543,0.02198191046245111,0.016351456203647845,F13A1/F13B/HGFAC/VTN,4.0,,
GO:0048483,discovery_tumor_CECA,GO:0048483,autonomic nervous system development,2/21,46/18870,0.0011853549563511608,0.03810069502557303,0.02834156963305783,FN1/NRP2,2.0,,
GO:0035987,discovery_tumor_CECA,GO:0035987,endodermal cell differentiation,2/21,49/18870,0.0013441328512811212,0.04032398553843364,0.029995385733852388,FN1/VTN,2.0,,
GO:0010810,discovery_tumor_CECA,GO:0010810,regulation of cell-substrate adhesion,3/21,220/18870,0.0017803980572389726,0.04820881408663604,0.035860591531111714,ABI3BP/FN1/VTN,3.0,,
GO:0001706,discovery_tumor_CECA,GO:0001706,endoderm formation,2/21,58/18870,0.0018779708788844963,0.04820881408663604,0.035860591531111714,FN1/VTN,2.0,,
GO:0001755,discovery_tumor_CECA,GO:0001755,neural crest cell migration,2/21,59/18870,0.0019425628988148636,0.04820881408663604,0.035860591531111714,FN1/NRP2,2.0,,
GO:0090497,discovery_tumor_CECA,GO:0090497,mesenchymal cell migration,2/21,61/18870,0.0020748866225958366,0.04820881408663604,0.035860591531111714,FN1/NRP2,2.0,,
GO:0022617,discovery_tumor_CECA,GO:0022617,extracellular matrix disassembly,2/21,62/18870,0.002142613959406046,0.04820881408663604,0.035860591531111714,PRSS1/PRSS2,2.0,,
HALLMARK_COAGULATION,discovery_tumor_CHOL,HALLMARK_COAGULATION,HALLMARK_COAGULATION,7/26,138/4383,1.0500991907926097e-05,0.0002625247976981524,0.0002625247976981524,C1R/C8A/GSN/MASP2/PROS1/SERPING1/VWF,7.0,,
hsa04610,discovery_tumor_CHOL,hsa04610,Complement and coagulation cascades,6/28,88/8843,2.5835564516975845e-07,2.8677476613843187e-05,2.6107517827680857e-05,C1R/C8A/MASP2/PROS1/SERPING1/VWF,6.0,Organismal Systems,Immune system
hsa05203,discovery_tumor_CHOL,hsa05203,Viral carcinogenesis,5/28,205/8843,0.00040570489612384755,0.022516621734873538,0.020498773698889142,GSN/HLA-A/PKM/YWHAQ/YWHAZ,5.0,Human Diseases,Cancer: overview
R-HSA-166658,discovery_tumor_CHOL,R-HSA-166658,Complement cascade,6/32,58/11009,1.33665035445931e-08,2.9940967939888546e-06,2.1386405671348964e-06,C1R/C8A/CPN2/MASP2/PROS1/SERPING1,6.0,,
R-HSA-114608,discovery_tumor_CHOL,R-HSA-114608,Platelet degranulation,7/32,129/11009,6.79418577717093e-08,6.595540188221357e-06,4.711100134443826e-06,A1BG/ITIH3/ITIH4/PROS1/SERPING1/TMSB4X/VWF,7.0,,
R-HSA-76005,discovery_tumor_CHOL,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,7/32,134/11009,8.833312752082174e-08,6.595540188221357e-06,4.711100134443826e-06,A1BG/ITIH3/ITIH4/PROS1/SERPING1/TMSB4X/VWF,7.0,,
R-HSA-977606,discovery_tumor_CHOL,R-HSA-977606,Regulation of Complement cascade,5/32,47/11009,2.1052482985424946e-07,1.178939047183797e-05,8.42099319416998e-06,C1R/C8A/CPN2/PROS1/SERPING1,5.0,,
R-HSA-76002,discovery_tumor_CHOL,R-HSA-76002,"Platelet activation, signaling and aggregation",8/32,263/11009,6.102455089041573e-07,2.7338998798906244e-05,1.9527856284933033e-05,A1BG/ITIH3/ITIH4/PROS1/SERPING1/TMSB4X/VWF/YWHAZ,8.0,,
R-HSA-140837,discovery_tumor_CHOL,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,3/32,23/11009,3.797991848926222e-05,0.0014179169569324562,0.0010127978263803257,PROS1/SERPING1/VWF,3.0,,
R-HSA-140877,discovery_tumor_CHOL,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),3/32,39/11009,0.00018989411411404996,0.006076611651649599,0.004340436894035428,PROS1/SERPING1/VWF,3.0,,
R-HSA-9614399,discovery_tumor_CHOL,R-HSA-9614399,Regulation of localization of FOXO transcription factors,2/32,11/11009,0.00044290852483513124,0.011883779926063187,0.008488414232902277,YWHAQ/YWHAZ,2.0,,
R-HSA-430116,discovery_tumor_CHOL,R-HSA-430116,GP1b-IX-V activation signalling,2/32,12/11009,0.0005305258895563923,0.011883779926063187,0.008488414232902277,VWF/YWHAZ,2.0,,
R-HSA-9755779,discovery_tumor_CHOL,R-HSA-9755779,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,2/32,12/11009,0.0005305258895563923,0.011883779926063187,0.008488414232902277,YWHAQ/YWHAZ,2.0,,
R-HSA-75035,discovery_tumor_CHOL,R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,2/32,13/11009,0.0006258477183756316,0.012744535356012861,0.009103239540009187,YWHAQ/YWHAZ,2.0,,
R-HSA-166786,discovery_tumor_CHOL,R-HSA-166786,Creation of C4 and C2 activators,2/32,14/11009,0.0007288312978046145,0.013406591846900386,0.009576137033500276,C1R/MASP2,2.0,,
R-HSA-111447,discovery_tumor_CHOL,R-HSA-111447,Activation of BAD and translocation to mitochondria,2/32,15/11009,0.0008394340842330122,0.013406591846900386,0.009576137033500276,YWHAQ/YWHAZ,2.0,,
R-HSA-9735871,discovery_tumor_CHOL,R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,2/32,15/11009,0.0008394340842330122,0.013406591846900386,0.009576137033500276,YWHAQ/YWHAZ,2.0,,
R-HSA-9651496,discovery_tumor_CHOL,R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),2/32,16/11009,0.0009576137033500276,0.013406591846900386,0.009576137033500276,SERPING1/VWF,2.0,,
R-HSA-9671793,discovery_tumor_CHOL,R-HSA-9671793,Diseases of hemostasis,2/32,16/11009,0.0009576137033500276,0.013406591846900386,0.009576137033500276,SERPING1/VWF,2.0,,
R-HSA-1445148,discovery_tumor_CHOL,R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,3/32,72/11009,0.001161158496402161,0.015299970776122591,0.01092855055437328,ACTB/YWHAQ/YWHAZ,3.0,,
R-HSA-166663,discovery_tumor_CHOL,R-HSA-166663,Initial triggering of complement,2/32,23/11009,0.0019934981976723622,0.02480797757103384,0.017719983979309885,C1R/MASP2,2.0,,
R-HSA-6798695,discovery_tumor_CHOL,R-HSA-6798695,Neutrophil degranulation,6/32,480/11009,0.0022933679954381912,0.0270376016304292,0.019312572593163716,A1BG/CAMP/CHI3L1/GSN/LCN2/PKM,6.0,,
R-HSA-9705683,discovery_tumor_CHOL,R-HSA-9705683,SARS-CoV-2-host interactions,4/32,203/11009,0.002693263380334084,0.03016454985974174,0.021546107042672673,HLA-A/MASP2/YWHAQ/YWHAZ,4.0,,
R-HSA-114452,discovery_tumor_CHOL,R-HSA-114452,Activation of BH3-only proteins,2/32,30/11009,0.0033843642145717752,0.03609988495543227,0.025785632111023055,YWHAQ/YWHAZ,2.0,,
R-HSA-6802948,discovery_tumor_CHOL,R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,2/32,36/11009,0.004848559388128052,0.04936715013366744,0.03526225009547674,ACTB/VWF,2.0,,
GO:0006959,discovery_tumor_CHOL,GO:0006959,humoral immune response,8/41,258/18870,7.0874238766345e-08,7.470144765972763e-05,6.0653427491619466e-05,C1R/C8A/CAMP/GAPDH/HLA-A/MASP2/RNASE4/SERPING1,8.0,,
GO:0006958,discovery_tumor_CHOL,GO:0006958,"complement activation, classical pathway",4/41,42/18870,2.022023939224243e-06,0.0010656066159711762,0.0008652134013627947,C1R/C8A/MASP2/SERPING1,4.0,,
GO:0002455,discovery_tumor_CHOL,GO:0002455,humoral immune response mediated by circulating immunoglobulin,4/41,55/18870,6.036813759085091e-06,0.0013361444474177385,0.0010848750981230614,C1R/C8A/MASP2/SERPING1,4.0,,
GO:0006022,discovery_tumor_CHOL,GO:0006022,aminoglycan metabolic process,5/41,121/18870,6.215718553381058e-06,0.0013361444474177385,0.0010848750981230614,B4GALT5/CHI3L1/ITIH3/ITIH4/ITIH5,5.0,,
GO:0098974,discovery_tumor_CHOL,GO:0098974,postsynaptic actin cytoskeleton organization,3/41,17/18870,6.338446145245439e-06,0.0013361444474177385,0.0010848750981230614,ACTB/ACTBL2/POTEI,3.0,,
GO:0099188,discovery_tumor_CHOL,GO:0099188,postsynaptic cytoskeleton organization,3/41,20/18870,1.0578178544957325e-05,0.0018582333643975034,0.0015087823082544397,ACTB/ACTBL2/POTEI,3.0,,
GO:0006956,discovery_tumor_CHOL,GO:0006956,complement activation,4/41,67/18870,1.3314086294836028e-05,0.002004720993536739,0.0016277221289776982,C1R/C8A/MASP2/SERPING1,4.0,,
GO:0030212,discovery_tumor_CHOL,GO:0030212,hyaluronan metabolic process,3/41,34/18870,5.4364947953011155e-05,0.00716258189280922,0.005815618774447115,ITIH3/ITIH4/ITIH5,3.0,,
GO:0019730,discovery_tumor_CHOL,GO:0019730,antimicrobial humoral response,4/41,133/18870,0.00019513321377314941,0.0228522674796555,0.018554772257025787,CAMP/GAPDH/HLA-A/RNASE4,4.0,,
GO:0001867,discovery_tumor_CHOL,GO:0001867,"complement activation, lectin pathway",2/41,11/18870,0.00025020662682112565,0.023974344060860586,0.0194658361345048,MASP2/SERPING1,2.0,,
GO:0042989,discovery_tumor_CHOL,GO:0042989,sequestering of actin monomers,2/41,11/18870,0.00025020662682112565,0.023974344060860586,0.0194658361345048,GSN/TMSB4X,2.0,,
GO:0007409,discovery_tumor_CHOL,GO:0007409,axonogenesis,6/41,448/18870,0.0003849283926204225,0.03380954381849377,0.02745147221056171,ACTB/ACTBL2/B4GALT5/MEGF8/NOTCH3/POTEI,6.0,,
GO:0019731,discovery_tumor_CHOL,GO:0019731,antibacterial humoral response,3/41,70/18870,0.00047104854221440115,0.038191166422613755,0.031009106463182848,CAMP/HLA-A/RNASE4,3.0,,
hsa04610,discovery_tumor_CRCA,hsa04610,Complement and coagulation cascades,1/1,88/8843,0.009951373968110189,0.009951373968110189,-2147483648.0,CFHR3,1.0,Organismal Systems,Immune system
R-HSA-977606,discovery_tumor_CRCA,R-HSA-977606,Regulation of Complement cascade,1/1,47/11009,0.004269234262875954,0.005268416749931837,-2147483648.0,CFHR3,1.0,,
R-HSA-166658,discovery_tumor_CRCA,R-HSA-166658,Complement cascade,1/1,58/11009,0.005268416749931837,0.005268416749931837,-2147483648.0,CFHR3,1.0,,
GO:0006956,discovery_tumor_CRCA,GO:0006956,complement activation,1/1,67/18870,0.0035506094329622595,0.007101218865924519,-2147483648.0,CFHR3,1.0,,
GO:0006959,discovery_tumor_CRCA,GO:0006959,humoral immune response,1/1,258/18870,0.013672496025437075,0.013672496025437075,-2147483648.0,CFHR3,1.0,,
HALLMARK_KRAS_SIGNALING_DN,discovery_tumor_ESCA,HALLMARK_KRAS_SIGNALING_DN,HALLMARK_KRAS_SIGNALING_DN,1/1,200/4383,0.045630846452201834,0.045630846452201834,-2147483648.0,C5,1.0,,
hsa05133,discovery_tumor_ESCA,hsa05133,Pertussis,3/6,78/8843,1.295577224992071e-05,0.00012778648002107705,6.725604211635634e-05,C4A/C4B/C5,3.0,Human Diseases,Infectious disease: bacterial
hsa04610,discovery_tumor_ESCA,hsa04610,Complement and coagulation cascades,3/6,88/8843,1.864029324392941e-05,0.00012778648002107705,6.725604211635634e-05,C4A/C4B/C5,3.0,Organismal Systems,Immune system
hsa05150,discovery_tumor_ESCA,hsa05150,Staphylococcus aureus infection,3/6,100/8843,2.738281714737365e-05,0.00012778648002107705,6.725604211635634e-05,C4A/C4B/C5,3.0,Human Diseases,Infectious disease: bacterial
hsa05322,discovery_tumor_ESCA,hsa05322,Systemic lupus erythematosus,3/6,139/8843,7.343155510990856e-05,0.00022848345606801425,0.00012025445056211276,C4A/C4B/C5,3.0,Human Diseases,Immune disease
hsa04936,discovery_tumor_ESCA,hsa04936,Alcoholic liver disease,3/6,144/8843,8.16012343100051e-05,0.00022848345606801425,0.00012025445056211276,C4A/C4B/C5,3.0,Human Diseases,Endocrine and metabolic disease
hsa05171,discovery_tumor_ESCA,hsa05171,Coronavirus disease - COVID-19,3/6,238/8843,0.000362585421476107,0.0008460326501109164,0.0004452803421636402,C4A/C4B/C5,3.0,Human Diseases,Infectious disease: viral
R-HSA-977606,discovery_tumor_ESCA,R-HSA-977606,Regulation of Complement cascade,3/6,47/11009,1.4456429859817116e-06,3.430948321157754e-05,1.589070801378328e-05,C4A/C4B/C5,3.0,,
R-HSA-166658,discovery_tumor_ESCA,R-HSA-166658,Complement cascade,3/6,58/11009,2.7447586569262033e-06,3.430948321157754e-05,1.589070801378328e-05,C4A/C4B/C5,3.0,,
R-HSA-166663,discovery_tumor_ESCA,R-HSA-166663,Initial triggering of complement,2/6,23/11009,6.231245065338079e-05,0.0005192704221115066,0.00024050419550427675,C4A/C4B,2.0,,
R-HSA-8957275,discovery_tumor_ESCA,R-HSA-8957275,Post-translational protein phosphorylation,2/6,108/11009,0.00139401054648482,0.008712565915530126,0.0040352936871929,C4A/C4B,2.0,,
R-HSA-381426,discovery_tumor_ESCA,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),2/6,125/11009,0.0018620598041399258,0.009310299020699629,0.004312138493797722,C4A/C4B,2.0,,
GO:0006958,discovery_tumor_ESCA,GO:0006958,"complement activation, classical pathway",3/7,42/18870,3.5663133245588547e-07,4.025961622697077e-05,2.0341700830469444e-05,C4A/C4B/C5,3.0,,
GO:0043277,discovery_tumor_ESCA,GO:0043277,apoptotic cell clearance,3/7,48/18870,5.367948830262769e-07,4.025961622697077e-05,2.0341700830469444e-05,C4A/C4B/SPG11,3.0,,
GO:0002455,discovery_tumor_ESCA,GO:0002455,humoral immune response mediated by circulating immunoglobulin,3/7,55/18870,8.133165106733845e-07,4.066582553366923e-05,2.0546943427538138e-05,C4A/C4B/C5,3.0,,
GO:0006956,discovery_tumor_ESCA,GO:0006956,complement activation,3/7,67/18870,1.4822761041239136e-06,5.558535390464676e-05,2.8085231446558367e-05,C4A/C4B/C5,3.0,,
GO:2000425,discovery_tumor_ESCA,GO:2000425,regulation of apoptotic cell clearance,2/7,10/18870,5.300625566277129e-06,0.00015901876698831387,8.03463243730428e-05,C4A/C4B,2.0,,
GO:0016064,discovery_tumor_ESCA,GO:0016064,immunoglobulin mediated immune response,3/7,205/18870,4.282588077569922e-05,0.0009583228195175709,0.0004842052140720359,C4A/C4B/C5,3.0,,
GO:0019724,discovery_tumor_ESCA,GO:0019724,B cell mediated immunity,3/7,208/18870,4.472173157748665e-05,0.0009583228195175709,0.0004842052140720359,C4A/C4B/C5,3.0,,
GO:0006909,discovery_tumor_ESCA,GO:0006909,phagocytosis,3/7,237/18870,6.596736388503974e-05,0.001236888072844495,0.0006249539736477448,C4A/C4B/SPG11,3.0,,
GO:0006959,discovery_tumor_ESCA,GO:0006959,humoral immune response,3/7,258/18870,8.490477500699697e-05,0.0014150795834499497,0.0007149875790062902,C4A/C4B/C5,3.0,,
GO:0002449,discovery_tumor_ESCA,GO:0002449,lymphocyte mediated immunity,3/7,368/18870,0.00024291946812462164,0.0036411784644737196,0.0018397533294183005,C4A/C4B/C5,3.0,,
GO:0002460,discovery_tumor_ESCA,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3/7,380/18870,0.0002670197540614061,0.0036411784644737196,0.0018397533294183005,C4A/C4B/C5,3.0,,
GO:0050766,discovery_tumor_ESCA,GO:0050766,positive regulation of phagocytosis,2/7,72/18870,0.0002977932578697548,0.003722415723371935,0.001880799523387925,C4A/C4B,2.0,,
GO:0002443,discovery_tumor_ESCA,GO:0002443,leukocyte mediated immunity,3/7,466/18870,0.0004863697029016119,0.005611958110403215,0.0028355156768353085,C4A/C4B/C5,3.0,,
GO:0050764,discovery_tumor_ESCA,GO:0050764,regulation of phagocytosis,2/7,100/18870,0.0005738621257372672,0.006148522775756434,0.0031066220340664093,C4A/C4B,2.0,,
GO:0045807,discovery_tumor_ESCA,GO:0045807,positive regulation of endocytosis,2/7,155/18870,0.0013702356848832092,0.013702356848832092,0.006923296092041478,C4A/C4B,2.0,,
GO:0075522,discovery_tumor_ESCA,GO:0075522,IRES-dependent viral translational initiation,1/7,11/18870,0.004074068588381996,0.03819439301608121,0.019298219629177875,PCBP2,1.0,,
GO:0030100,discovery_tumor_ESCA,GO:0030100,regulation of endocytosis,2/7,291/18870,0.004728877943999466,0.03887029416825394,0.01963972757974936,C4A/C4B,2.0,,
GO:0032490,discovery_tumor_ESCA,GO:0032490,detection of molecule of bacterial origin,1/7,13/18870,0.004813277716220976,0.03887029416825394,0.01963972757974936,C4B,1.0,,
GO:0090385,discovery_tumor_ESCA,GO:0090385,phagosome-lysosome fusion,1/7,14/18870,0.005182705889100525,0.03887029416825394,0.01963972757974936,SPG11,1.0,,
GO:1905522,discovery_tumor_ESCA,GO:1905522,negative regulation of macrophage migration,1/7,14/18870,0.005182705889100525,0.03887029416825394,0.01963972757974936,C5,1.0,,
GO:2001256,discovery_tumor_ESCA,GO:2001256,regulation of store-operated calcium entry,1/7,16/18870,0.005921209608675815,0.042294354347684394,0.02136977903883001,SPG11,1.0,,
GO:0008228,discovery_tumor_ESCA,GO:0008228,opsonization,1/7,17/18870,0.006290285217710356,0.042888308302570614,0.02166988208971989,C4B,1.0,,
GO:0006957,discovery_tumor_ESCA,GO:0006957,"complement activation, alternative pathway",1/7,18/18870,0.006659243367791112,0.0434298480508116,0.021943502173041654,C5,1.0,,
GO:0001845,discovery_tumor_ESCA,GO:0001845,phagolysosome assembly,1/7,19/18870,0.007028084090071496,0.04392552556294685,0.022193949758120515,SPG11,1.0,,
GO:0019081,discovery_tumor_ESCA,GO:0019081,viral translation,1/7,21/18870,0.007765413375807939,0.04397727581384937,0.022220097253313368,PCBP2,1.0,,
GO:0097049,discovery_tumor_ESCA,GO:0097049,motor neuron apoptotic process,1/7,21/18870,0.007765413375807939,0.04397727581384937,0.022220097253313368,SPG11,1.0,,
GO:0002115,discovery_tumor_ESCA,GO:0002115,store-operated calcium entry,1/7,22/18870,0.008133902001537296,0.04397727581384937,0.022220097253313368,SPG11,1.0,,
GO:0002689,discovery_tumor_ESCA,GO:0002689,negative regulation of leukocyte chemotaxis,1/7,23/18870,0.008502273324010878,0.04397727581384937,0.022220097253313368,C5,1.0,,
GO:0061744,discovery_tumor_ESCA,GO:0061744,motor behavior,1/7,23/18870,0.008502273324010878,0.04397727581384937,0.022220097253313368,SPG11,1.0,,
GO:0098581,discovery_tumor_ESCA,GO:0098581,detection of external biotic stimulus,1/7,26/18870,0.009606683783067282,0.045194237703777194,0.022834983260855844,C4B,1.0,,
GO:0010758,discovery_tumor_ESCA,GO:0010758,regulation of macrophage chemotaxis,1/7,28/18870,0.010342371476517065,0.045194237703777194,0.022834983260855844,C5,1.0,,
GO:0006910,discovery_tumor_ESCA,GO:0006910,"phagocytosis, recognition",1/7,29/18870,0.010710039632745971,0.045194237703777194,0.022834983260855844,C4B,1.0,,
GO:0021952,discovery_tumor_ESCA,GO:0021952,central nervous system projection neuron axonogenesis,1/7,29/18870,0.010710039632745971,0.045194237703777194,0.022834983260855844,SPG11,1.0,,
GO:0010575,discovery_tumor_ESCA,GO:0010575,positive regulation of vascular endothelial growth factor production,1/7,30/18870,0.011077590703420181,0.045194237703777194,0.022834983260855844,C5,1.0,,
GO:0039694,discovery_tumor_ESCA,GO:0039694,viral RNA genome replication,1/7,30/18870,0.011077590703420181,0.045194237703777194,0.022834983260855844,PCBP2,1.0,,
GO:0090382,discovery_tumor_ESCA,GO:0090382,phagosome maturation,1/7,30/18870,0.011077590703420181,0.045194237703777194,0.022834983260855844,SPG11,1.0,,
GO:0006869,discovery_tumor_ESCA,GO:0006869,lipid transport,2/7,453/18870,0.011147911966931707,0.045194237703777194,0.022834983260855844,APOF/SPG11,2.0,,
GO:0032102,discovery_tumor_ESCA,GO:0032102,negative regulation of response to external stimulus,2/7,481/18870,0.012507700849805415,0.049372503354495056,0.024946106958060665,C5/PCBP2,2.0,,
GO:0090659,discovery_tumor_ESCA,GO:0090659,walking behavior,1/7,35/18870,0.012913590860816448,0.049667657156986345,0.025095237300372046,SPG11,1.0,,
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,discovery_tumor_HNCA,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,6/17,200/4383,6.797092862870337e-05,0.001835215072974991,0.00157406361034892,ACTA2/CD44/FSTL1/QSOX1/THBS1/TPM2,6.0,,
hsa04814,discovery_tumor_HNCA,hsa04814,Motor proteins,4/15,197/8843,0.0002689551011855508,0.011790918119341423,0.007922229419490319,ACTA2/ACTC1/MYH9/TPM2,4.0,Cellular Processes,Cell motility
hsa04820,discovery_tumor_HNCA,hsa04820,Cytoskeleton in muscle cells,4/15,232/8843,0.0005017411965677201,0.011790918119341423,0.007922229419490319,ACTC1/MYH9/THBS1/TPM2,4.0,,
R-HSA-114608,discovery_tumor_HNCA,R-HSA-114608,Platelet degranulation,6/22,129/11009,1.4736187708637054e-07,1.4136743929692711e-05,9.434221955144087e-06,ALDOA/F5/PPBP/QSOX1/SELENOP/THBS1,6.0,,
R-HSA-76005,discovery_tumor_HNCA,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,6/22,134/11009,1.8479403829663675e-07,1.4136743929692711e-05,9.434221955144087e-06,ALDOA/F5/PPBP/QSOX1/SELENOP/THBS1,6.0,,
R-HSA-76002,discovery_tumor_HNCA,R-HSA-76002,"Platelet activation, signaling and aggregation",6/22,263/11009,9.496397773097453e-06,0.00048431628642797014,0.00032321073122472036,ALDOA/F5/PPBP/QSOX1/SELENOP/THBS1,6.0,,
R-HSA-445355,discovery_tumor_HNCA,R-HSA-445355,Smooth Muscle Contraction,3/22,45/11009,9.309022651010541e-05,0.003560701164011532,0.0023762505188105855,ACTA2/ANXA6/TPM2,3.0,,
R-HSA-6798695,discovery_tumor_HNCA,R-HSA-6798695,Neutrophil degranulation,6/22,480/11009,0.0002734004582053309,0.008366054021083126,0.005583125146508863,ALDOA/CD44/CRISP3/GDI2/PPBP/QSOX1,6.0,,
R-HSA-397014,discovery_tumor_HNCA,R-HSA-397014,Muscle contraction,4/22,205/11009,0.0006564043467798738,0.01673831084288678,0.011170389760990834,ACTA2/ACTC1/ANXA6/TPM2,4.0,,
R-HSA-8957275,discovery_tumor_HNCA,R-HSA-8957275,Post-translational protein phosphorylation,3/22,108/11009,0.0012344572540130654,0.02698170855199986,0.018006368968310878,F5/FSTL1/QSOX1,3.0,,
R-HSA-381426,discovery_tumor_HNCA,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),3/22,125/11009,0.0018795411233203173,0.03526508386153433,0.023534318091288822,F5/FSTL1/QSOX1,3.0,,
R-HSA-70263,discovery_tumor_HNCA,R-HSA-70263,Gluconeogenesis,2/22,35/11009,0.0021794897726622165,0.03526508386153433,0.023534318091288822,ALDOA/PGK1,2.0,,
R-HSA-390522,discovery_tumor_HNCA,R-HSA-390522,Striated Muscle Contraction,2/22,36/11009,0.0023049074419303484,0.03526508386153433,0.023534318091288822,ACTC1/TPM2,2.0,,
R-HSA-140877,discovery_tumor_HNCA,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),2/22,39/11009,0.00270119933211842,0.03757122707401075,0.02507333351344371,F11/F5,2.0,,
GO:0042060,discovery_tumor_HNCA,GO:0042060,wound healing,7/26,423/18870,1.2316688246991941e-06,0.0010038100921298432,0.000729925840321733,ANXA6/APCS/CD44/F11/F5/MYH9/THBS1,7.0,,
GO:0031639,discovery_tumor_HNCA,GO:0031639,plasminogen activation,3/26,27/18870,6.644644654682228e-06,0.002707692696783008,0.00196891312662426,F11/PGK1/THBS1,3.0,,
GO:0031638,discovery_tumor_HNCA,GO:0031638,zymogen activation,3/26,59/18870,7.172109648908174e-05,0.019484231212867208,0.014168062218720356,F11/PGK1/THBS1,3.0,,
GO:0061045,discovery_tumor_HNCA,GO:0061045,negative regulation of wound healing,3/26,75/18870,0.00014681134559290133,0.02075615603836978,0.015092949111530108,APCS/F11/THBS1,3.0,,
GO:0090130,discovery_tumor_HNCA,GO:0090130,tissue migration,5/26,380/18870,0.00014971086248569788,0.02075615603836978,0.015092949111530108,ACTA2/ACTC1/FSTL1/MYH9/THBS1,5.0,,
GO:0010763,discovery_tumor_HNCA,GO:0010763,positive regulation of fibroblast migration,2/26,15/18870,0.00018958069372583265,0.02075615603836978,0.015092949111530108,ACTA2/THBS1,2.0,,
GO:0007596,discovery_tumor_HNCA,GO:0007596,blood coagulation,4/26,224/18870,0.00023538173893085916,0.02075615603836978,0.015092949111530108,F11/F5/MYH9/THBS1,4.0,,
GO:0050817,discovery_tumor_HNCA,GO:0050817,coagulation,4/26,229/18870,0.0002560653665088625,0.02075615603836978,0.015092949111530108,F11/F5/MYH9/THBS1,4.0,,
GO:0007599,discovery_tumor_HNCA,GO:0007599,hemostasis,4/26,231/18870,0.00026469454305979234,0.02075615603836978,0.015092949111530108,F11/F5/MYH9/THBS1,4.0,,
GO:0051917,discovery_tumor_HNCA,GO:0051917,regulation of fibrinolysis,2/26,18/18870,0.0002755446360600229,0.02075615603836978,0.015092949111530108,F11/THBS1,2.0,,
GO:0046827,discovery_tumor_HNCA,GO:0046827,positive regulation of protein export from nucleus,2/26,19/18870,0.00030770077997978426,0.02075615603836978,0.015092949111530108,ANP32B/YWHAE,2.0,,
GO:1903035,discovery_tumor_HNCA,GO:1903035,negative regulation of response to wounding,3/26,97/18870,0.0003141845437649567,0.02075615603836978,0.015092949111530108,APCS/F11/THBS1,3.0,,
GO:0016485,discovery_tumor_HNCA,GO:0016485,protein processing,4/26,245/18870,0.0003310797895690885,0.02075615603836978,0.015092949111530108,F11/MYH9/PGK1/THBS1,4.0,,
GO:0001667,discovery_tumor_HNCA,GO:0001667,ameboidal-type cell migration,5/26,497/18870,0.0005167929492058639,0.03008473240019851,0.021876272962624167,ACTA2/ANXA6/FSTL1/MYH9/THBS1,5.0,,
GO:0042730,discovery_tumor_HNCA,GO:0042730,fibrinolysis,2/26,27/18870,0.0006273301249070336,0.0339038945684096,0.024653397019069562,F11/THBS1,2.0,,
GO:0001778,discovery_tumor_HNCA,GO:0001778,plasma membrane repair,2/26,29/18870,0.0007244016698217013,0.0339038945684096,0.024653397019069562,ANXA6/MYH9,2.0,,
GO:0071621,discovery_tumor_HNCA,GO:0071621,granulocyte chemotaxis,3/26,130/18870,0.0007397423056178584,0.0339038945684096,0.024653397019069562,CCL14/PPBP/THBS1,3.0,,
GO:0030048,discovery_tumor_HNCA,GO:0030048,actin filament-based movement,3/26,133/18870,0.0007903975420856227,0.0339038945684096,0.024653397019069562,ACTA2/ACTC1/MYH9,3.0,,
GO:0061041,discovery_tumor_HNCA,GO:0061041,regulation of wound healing,3/26,133/18870,0.0007903975420856227,0.0339038945684096,0.024653397019069562,APCS/F11/THBS1,3.0,,
GO:0046825,discovery_tumor_HNCA,GO:0046825,regulation of protein export from nucleus,2/26,34/18870,0.0009967302994950565,0.04061675970442355,0.02953469255872194,ANP32B/YWHAE,2.0,,
GO:0030224,discovery_tumor_HNCA,GO:0030224,monocyte differentiation,2/26,35/18870,0.0010562436658138497,0.04099231369706131,0.02980777863925801,APCS/MYH9,2.0,,
GO:0097530,discovery_tumor_HNCA,GO:0097530,granulocyte migration,3/26,156/18870,0.0012531840153130413,0.04451858846009008,0.03237192806332673,CCL14/PPBP/THBS1,3.0,,
GO:0006936,discovery_tumor_HNCA,GO:0006936,muscle contraction,4/26,351/18870,0.001272703136436391,0.04451858846009008,0.03237192806332673,ACTA2/ALDOA/ANXA6/TPM2,4.0,,
GO:0010762,discovery_tumor_HNCA,GO:0010762,regulation of fibroblast migration,2/26,39/18870,0.0013109768380885423,0.04451858846009008,0.03237192806332673,ACTA2/THBS1,2.0,,
GO:0043281,discovery_tumor_HNCA,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,3/26,163/18870,0.0014216554645882608,0.046074471851420454,0.03350329693555017,ANP32B/CD44/THBS1,3.0,,
GO:0050878,discovery_tumor_HNCA,GO:0050878,regulation of body fluid levels,4/26,365/18870,0.0014698604517017569,0.046074471851420454,0.03350329693555017,F11/F5/MYH9/THBS1,4.0,,
HALLMARK_COAGULATION,discovery_tumor_LC,HALLMARK_COAGULATION,HALLMARK_COAGULATION,1/1,138/4383,0.031485284052019225,0.045630846452201834,-2147483648.0,ANG,1.0,,
HALLMARK_COMPLEMENT,discovery_tumor_LC,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,1/1,200/4383,0.045630846452201834,0.045630846452201834,-2147483648.0,ANG,1.0,,
HALLMARK_GLYCOLYSIS,discovery_tumor_LC,HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,1/1,200/4383,0.045630846452201834,0.045630846452201834,-2147483648.0,ANG,1.0,,
hsa05014,discovery_tumor_LC,hsa05014,Amyotrophic lateral sclerosis,1/1,371/8843,0.041954087979192645,0.041954087979192645,-2147483648.0,ANG,1.0,Human Diseases,Neurodegenerative disease
R-HSA-418990,discovery_tumor_LC,R-HSA-418990,Adherens junctions interactions,1/1,57/11009,0.0051775819783811405,0.013897720047234108,-2147483648.0,ANG,1.0,,
R-HSA-421270,discovery_tumor_LC,R-HSA-421270,Cell-cell junction organization,1/1,88/11009,0.007993459896448507,0.013897720047234108,-2147483648.0,ANG,1.0,,
R-HSA-446728,discovery_tumor_LC,R-HSA-446728,Cell junction organization,1/1,115/11009,0.01044599872831331,0.013897720047234108,-2147483648.0,ANG,1.0,,
R-HSA-211000,discovery_tumor_LC,R-HSA-211000,Gene Silencing by RNA,1/1,137/11009,0.01244436370242541,0.013897720047234108,-2147483648.0,ANG,1.0,,
R-HSA-1500931,discovery_tumor_LC,R-HSA-1500931,Cell-Cell communication,1/1,153/11009,0.013897720047234108,0.013897720047234108,-2147483648.0,ANG,1.0,,
GO:0032429,discovery_tumor_LC,GO:0032429,regulation of phospholipase A2 activity,1/3,10/18870,0.0015890669230512744,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0016078,discovery_tumor_LC,GO:0016078,tRNA catabolic process,1/3,16/18870,0.002541698548630622,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0032148,discovery_tumor_LC,GO:0032148,activation of protein kinase B activity,1/3,26/18870,0.0041280709967321805,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0046339,discovery_tumor_LC,GO:0046339,diacylglycerol metabolic process,1/3,27/18870,0.00428661566808719,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0007202,discovery_tumor_LC,GO:0007202,activation of phospholipase C activity,1/3,28/18870,0.004445143511477068,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0001556,discovery_tumor_LC,GO:0001556,oocyte maturation,1/3,33/18870,0.005237530340211571,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0009303,discovery_tumor_LC,GO:0009303,rRNA transcription,1/3,37/18870,0.005871136990928338,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0010863,discovery_tumor_LC,GO:0010863,positive regulation of phospholipase C activity,1/3,37/18870,0.005871136990928338,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:1900274,discovery_tumor_LC,GO:1900274,regulation of phospholipase C activity,1/3,39/18870,0.006187839398511197,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0010518,discovery_tumor_LC,GO:0010518,positive regulation of phospholipase activity,1/3,49/18870,0.007770342544468289,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0046460,discovery_tumor_LC,GO:0046460,neutral lipid biosynthetic process,1/3,51/18870,0.008086641445282039,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0046463,discovery_tumor_LC,GO:0046463,acylglycerol biosynthetic process,1/3,51/18870,0.008086641445282039,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0034661,discovery_tumor_LC,GO:0034661,ncRNA catabolic process,1/3,55/18870,0.008719037575691146,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0001541,discovery_tumor_LC,GO:0001541,ovarian follicle development,1/3,56/18870,0.008877094598666146,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0010517,discovery_tumor_LC,GO:0010517,regulation of phospholipase activity,1/3,59/18870,0.00935116485877463,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0060193,discovery_tumor_LC,GO:0060193,positive regulation of lipase activity,1/3,60/18870,0.009509154678849496,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0048599,discovery_tumor_LC,GO:0048599,oocyte development,1/3,61/18870,0.009667127700431877,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0009994,discovery_tumor_LC,GO:0009994,oocyte differentiation,1/3,65/18870,0.010298851819700472,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0019731,discovery_tumor_LC,GO:0019731,antibacterial humoral response,1/3,70/18870,0.011088129109882217,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0048662,discovery_tumor_LC,GO:0048662,negative regulation of smooth muscle cell proliferation,1/3,70/18870,0.011088129109882217,0.046015735806011204,0.011088129109882217,ANG,1.0,,
GO:0060191,discovery_tumor_LC,GO:0060191,regulation of lipase activity,1/3,78/18870,0.012350099763432376,0.04881229906499463,0.011761999774697503,ANG,1.0,,
GO:0061844,discovery_tumor_LC,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,1/3,83/18870,0.013138285964344187,0.049567169774571256,0.011943896331221988,ANG,1.0,,
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,discovery_tumor_LIHC,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,12/65,200/4383,2.790009396756369e-05,0.0011439038526701113,0.0009985296788391216,CADM1/CDH2/COMP/FBLN1/FLNA/FUCA1/ITGB1/LUM/PVR/SPP1/TGFBI/TIMP1,12.0,,
HALLMARK_ANGIOGENESIS,discovery_tumor_LIHC,HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,4/65,36/4383,0.0018174375941419352,0.03389116087219559,0.029584068540555845,LUM/NRP1/SPP1/TIMP1,4.0,,
HALLMARK_ADIPOGENESIS,discovery_tumor_LIHC,HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,9/65,200/4383,0.0024798410394289458,0.03389116087219559,0.029584068540555845,ADIPOQ/APOE/DDT/ENPP2/FAH/GPX3/TALDO1/TKT/YWHAG,9.0,,
hsa04514,discovery_tumor_LIHC,hsa04514,Cell adhesion molecules,14/81,157/8843,1.1285668413046207e-10,1.8282782829134856e-08,1.5681139268653676e-08,ALCAM/CADM1/CDH1/CDH2/CDH5/CNTN1/ICAM1/ICAM2/ICAM3/ICOSLG/ITGB1/NCAM1/PTPRF/PVR,14.0,Environmental Information Processing,Signaling molecules and interaction
hsa05150,discovery_tumor_LIHC,hsa05150,Staphylococcus aureus infection,7/81,100/8843,3.3579279256657334e-05,0.002719921619789244,0.002332876243094088,C1QA/C1QB/C1QC/FCGR2A/FCGR3A/ICAM1/KRT10,7.0,Human Diseases,Infectious disease: bacterial
hsa04145,discovery_tumor_LIHC,hsa04145,Phagosome,8/81,157/8843,8.858202919310933e-05,0.004783429576427904,0.0041027466152598,CALR/COLEC11/COMP/FCGR2A/FCGR3A/ITGB1/MARCO/TFRC,8.0,Cellular Processes,Transport and catabolism
hsa04512,discovery_tumor_LIHC,hsa04512,ECM-receptor interaction,6/81,89/8843,0.00015540950113937952,0.005517943779219615,0.004732739303814094,COMP/GP1BA/HSPG2/ITGB1/LAMB1/SPP1,6.0,Environmental Information Processing,Signaling molecules and interaction
hsa00030,discovery_tumor_LIHC,hsa00030,Pentose phosphate pathway,4/81,31/8843,0.0001703069067660375,0.005517943779219615,0.004732739303814094,ALDOB/H6PD/TALDO1/TKT,4.0,Metabolism,Carbohydrate metabolism
hsa00511,discovery_tumor_LIHC,hsa00511,Other glycan degradation,3/81,18/8843,0.0005471368002102835,0.013211017731201913,0.01133108733280476,AGA/FUCA1/FUCA2,3.0,Metabolism,Glycan biosynthesis and metabolism
hsa01230,discovery_tumor_LIHC,hsa01230,Biosynthesis of amino acids,5/81,75/8843,0.0005950667588049846,0.013211017731201913,0.01133108733280476,ALDOB/ENO1/GOT1/TALDO1/TKT,5.0,Metabolism,Global and overview maps
hsa01200,discovery_tumor_LIHC,hsa01200,Carbon metabolism,6/81,116/8843,0.0006523959373433044,0.013211017731201913,0.01133108733280476,ALDOB/ENO1/GOT1/H6PD/TALDO1/TKT,6.0,Metabolism,Global and overview maps
hsa04610,discovery_tumor_LIHC,hsa04610,Complement and coagulation cascades,5/81,88/8843,0.0012312296765826976,0.0207695168284036,0.017814010535083014,C1QA/C1QB/C1QC/C7/PROCR,5.0,Organismal Systems,Immune system
hsa04142,discovery_tumor_LIHC,hsa04142,Lysosome,6/81,132/8843,0.0012820689400249137,0.0207695168284036,0.017814010535083014,AGA/AP3M1/CTSD/FUCA1/FUCA2/GNPTG,6.0,Cellular Processes,Transport and catabolism
hsa05322,discovery_tumor_LIHC,hsa05322,Systemic lupus erythematosus,6/81,139/8843,0.0016715643259522133,0.024617583709478048,0.021114496748870063,C1QA/C1QB/C1QC/C7/FCGR2A/FCGR3A,6.0,Human Diseases,Immune disease
hsa05142,discovery_tumor_LIHC,hsa05142,Chagas disease,5/81,103/8843,0.002472992739556476,0.03338540198401243,0.028634652773811827,ACE/C1QA/C1QB/C1QC/CALR,5.0,Human Diseases,Infectious disease: parasitic
hsa04066,discovery_tumor_LIHC,hsa04066,HIF-1 signaling pathway,5/81,109/8843,0.003162734449722971,0.03941253698885549,0.0338041252925856,ALDOB/ENO1/LDHB/TFRC/TIMP1,5.0,Environmental Information Processing,Signal transduction
hsa00350,discovery_tumor_LIHC,hsa00350,Tyrosine metabolism,3/81,36/8843,0.0042525076837751224,0.04920758891225499,0.0422053394179185,AOC3/FAH/GOT1,3.0,Metabolism,Amino acid metabolism
R-HSA-8957275,discovery_tumor_LIHC,R-HSA-8957275,Post-translational protein phosphorylation,11/92,108/11009,1.3379783490009822e-09,5.940623869564361e-07,5.239241535035426e-07,APOE/CDH2/CHGB/CST3/FUCA2/GOLM1/IGFBP7/LAMB1/PRKCSH/SPP1/TIMP1,11.0,,
R-HSA-381426,discovery_tumor_LIHC,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),11/92,125/11009,6.406733024923617e-09,1.4222947315330429e-06,1.254370886985045e-06,APOE/CDH2/CHGB/CST3/FUCA2/GOLM1/IGFBP7/LAMB1/PRKCSH/SPP1/TIMP1,11.0,,
R-HSA-1474244,discovery_tumor_LIHC,R-HSA-1474244,Extracellular matrix organization,15/92,300/11009,2.3684385845343635e-08,3.505289105110858e-06,3.0914356261290637e-06,CDH1/COMP/CTSD/EFEMP1/FBLN1/HSPG2/ICAM1/ICAM2/ICAM3/ITGB1/LAMB1/LUM/NCAM1/SPP1/TIMP1,15.0,,
R-HSA-216083,discovery_tumor_LIHC,R-HSA-216083,Integrin cell surface interactions,9/92,85/11009,3.265586017421488e-08,3.6248004793378515e-06,3.1968368381073513e-06,CDH1/COMP/HSPG2/ICAM1/ICAM2/ICAM3/ITGB1/LUM/SPP1,9.0,,
R-HSA-3000480,discovery_tumor_LIHC,R-HSA-3000480,Scavenging by Class A Receptors,5/92,19/11009,3.872065625047884e-07,3.438394275042521e-05,3.0324387631953957e-05,APOE/CALR/COLEC11/FTL/MARCO,5.0,,
R-HSA-2173782,discovery_tumor_LIHC,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,6/92,42/11009,1.1895980437472883e-06,8.803025523729934e-05,7.763692496034935e-05,APOE/CALR/CD163/COLEC11/FTL/MARCO,6.0,,
R-HSA-166786,discovery_tumor_LIHC,R-HSA-166786,Creation of C4 and C2 activators,4/92,14/11009,4.288387086408083e-06,0.0002720062666235984,0.0002398917287434296,C1QA/C1QB/C1QC/COLEC11,4.0,,
R-HSA-446728,discovery_tumor_LIHC,R-HSA-446728,Cell junction organization,8/92,115/11009,4.978582917557183e-06,0.0002763113519244237,0.00024368853228043058,CADM1/CDH1/CDH13/CDH2/CDH5/FLNA/ITGB1/PVR,8.0,,
R-HSA-418990,discovery_tumor_LIHC,R-HSA-418990,Adherens junctions interactions,6/92,57/11009,7.44200948149852e-06,0.00036713913442059363,0.000323792693230111,CADM1/CDH1/CDH13/CDH2/CDH5/PVR,6.0,,
R-HSA-166663,discovery_tumor_LIHC,R-HSA-166663,Initial triggering of complement,4/92,23/11009,3.5812375395296156e-05,0.0014870811967318983,0.0013115083100622715,C1QA/C1QB/C1QC/COLEC11,4.0,,
R-HSA-3000178,discovery_tumor_LIHC,R-HSA-3000178,ECM proteoglycans,6/92,76/11009,3.947947424379936e-05,0.0014870811967318983,0.0013115083100622715,COMP/HSPG2/ITGB1/LAMB1/LUM/NCAM1,6.0,,
R-HSA-1500931,discovery_tumor_LIHC,R-HSA-1500931,Cell-Cell communication,8/92,153/11009,4.019138369545671e-05,0.0014870811967318983,0.0013115083100622715,CADM1/CDH1/CDH13/CDH2/CDH5/FLNA/ITGB1/PVR,8.0,,
R-HSA-421270,discovery_tumor_LIHC,R-HSA-421270,Cell-cell junction organization,6/92,88/11009,9.031934135068978e-05,0.003084752889208174,0.002720550201008631,CADM1/CDH1/CDH13/CDH2/CDH5/PVR,6.0,,
R-HSA-166658,discovery_tumor_LIHC,R-HSA-166658,Complement cascade,5/92,58/11009,0.00011802585392438768,0.0035422596431655138,0.003124041221568447,C1QA/C1QB/C1QC/C7/COLEC11,5.0,,
R-HSA-198933,discovery_tumor_LIHC,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,7/92,133/11009,0.0001196709338907268,0.0035422596431655138,0.003124041221568447,CDH1/FCGR3A/ICAM1/ICAM2/ICAM3/ITGB1/PVR,7.0,,
R-HSA-2022377,discovery_tumor_LIHC,R-HSA-2022377,Metabolism of Angiotensinogen to Angiotensins,3/92,18/11009,0.00042082453159647326,0.011677880751802133,0.01029912669433474,ACE/AGT/CTSD,3.0,,
R-HSA-373760,discovery_tumor_LIHC,R-HSA-373760,L1CAM interactions,6/92,119/11009,0.0004702384287023604,0.012281521314344,0.010831498171967682,ALCAM/CNTN1/ITGB1/LAMB1/NCAM1/NRP1,6.0,,
R-HSA-977606,discovery_tumor_LIHC,R-HSA-977606,Regulation of Complement cascade,4/92,47/11009,0.0006189732672373053,0.015268007258520198,0.013465383357443132,C1QA/C1QB/C1QC/C7,4.0,,
R-HSA-445144,discovery_tumor_LIHC,R-HSA-445144,Signal transduction by L1,3/92,21/11009,0.0006735654819579127,0.015740161788911224,0.013881792758356982,ITGB1/NCAM1/NRP1,3.0,,
R-HSA-1474228,discovery_tumor_LIHC,R-HSA-1474228,Degradation of the extracellular matrix,6/92,140/11009,0.0011054109490645815,0.02454012306923371,0.021642782792211806,CDH1/CTSD/HSPG2/LAMB1/SPP1/TIMP1,6.0,,
R-HSA-9759194,discovery_tumor_LIHC,R-HSA-9759194,Nuclear events mediated by NFE2L2,5/92,97/11009,0.0012857161016265842,0.027183711862962066,0.023974255128074655,PSMA1/PSMB2/SOD3/TALDO1/TKT,5.0,,
R-HSA-3000157,discovery_tumor_LIHC,R-HSA-3000157,Laminin interactions,3/92,30/11009,0.0019474028368838992,0.03930212998074779,0.03466190695314883,HSPG2/ITGB1/LAMB1,3.0,,
R-HSA-9711123,discovery_tumor_LIHC,R-HSA-9711123,Cellular response to chemical stress,7/92,215/11009,0.0021139948312887927,0.03941058726956485,0.03475755918510698,GPX3/PSMA1/PSMB2/SOD2/SOD3/TALDO1/TKT,7.0,,
R-HSA-6798695,discovery_tumor_LIHC,R-HSA-6798695,Neutrophil degranulation,11/92,480/11009,0.002130302014571073,0.03941058726956485,0.03475755918510698,ADA2/AGA/BST1/CD93/CST3/CTSD/FCGR2A/FTL/FUCA1/FUCA2/PTPRJ,11.0,,
GO:0098742,discovery_tumor_LIHC,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,14/111,279/18870,1.005918709498152e-09,2.4775777814939485e-06,1.907010100848602e-06,ADIPOQ/ALCAM/CADM1/CDH1/CDH13/CDH2/CDH5/DSG2/ICAM1/ITGB1/PTPRF/PVR/ROBO4/UMOD,14.0,,
GO:0048771,discovery_tumor_LIHC,GO:0048771,tissue remodeling,10/111,184/18870,1.338389472610963e-07,0.0001648226635520401,0.0001268652336932813,ACE/AGT/AXL/CSF1R/CST3/FLNA/SPP1/TFRC/TIMP1/UMOD,10.0,,
GO:0001667,discovery_tumor_LIHC,GO:0001667,ameboidal-type cell migration,15/111,497/18870,2.204160710441449e-07,0.00018096159432724296,0.00013928748910544035,AGT/APOE/CALR/CD248/CDH13/CDH2/CDH5/ENPP2/GLIPR2/ITGB1/MMRN2/NRP1/PTPRG/SERPINF1/TIMP1,15.0,,
GO:0044409,discovery_tumor_LIHC,GO:0044409,entry into host,9/111,163/18870,5.108144132628492e-07,0.0002720903797562858,0.0002094299950599699,AXL/FUCA2/ICAM1/ITGB1/NCAM1/NRP1/PVR/SLC3A2/TFRC,9.0,,
GO:0007156,discovery_tumor_LIHC,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,9/111,168/18870,6.587610489807361e-07,0.0002720903797562858,0.0002094299950599699,CADM1/CDH1/CDH13/CDH2/CDH5/DSG2/ITGB1/PVR/ROBO4,9.0,,
GO:0007157,discovery_tumor_LIHC,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,6/111,53/18870,6.628267472747521e-07,0.0002720903797562858,0.0002094299950599699,ALCAM/CADM1/CDH2/ICAM1/PVR/UMOD,6.0,,
GO:0098883,discovery_tumor_LIHC,GO:0098883,synapse pruning,4/111,14/18870,1.0847099200797746e-06,0.00034432354308113904,0.0002650283997218332,C1QA/C1QB/C1QC/ITGB1,4.0,,
GO:0040013,discovery_tumor_LIHC,GO:0040013,negative regulation of locomotion,13/111,423/18870,1.2320135544924616e-06,0.00034432354308113904,0.0002650283997218332,ADIPOQ/APOE/CALR/CDH1/DDT/ENG/FBLN1/MMRN2/NRP1/PTPRG/PTPRJ/SERPINF1/TIMP1,13.0,,
GO:0006909,discovery_tumor_LIHC,GO:0006909,phagocytosis,10/111,237/18870,1.373934123185992e-06,0.00034432354308113904,0.0002650283997218332,ADIPOQ/AXL/CALR/CD93/COLEC11/ICAM3/ITGB1/LMAN2/MARCO/PTPRJ,10.0,,
GO:0007566,discovery_tumor_LIHC,GO:0007566,embryo implantation,6/111,60/18870,1.397984340564917e-06,0.00034432354308113904,0.0002650283997218332,CALR/FBLN1/HSPG2/IGFBP7/SPP1/TIMP1,6.0,,
GO:0044000,discovery_tumor_LIHC,GO:0044000,movement in host,9/111,188/18870,1.6836482092814391e-06,0.00037698413995092587,0.0002901675047766385,AXL/FUCA2/ICAM1/ITGB1/NCAM1/NRP1/PVR/SLC3A2/TFRC,9.0,,
GO:0010631,discovery_tumor_LIHC,GO:0010631,epithelial cell migration,12/111,372/18870,1.9721159129482846e-06,0.0004047767911326354,0.0003115597157210404,AGT/APOE/CALR/CDH13/CDH5/ENPP2/GLIPR2/ITGB1/MMRN2/NRP1/PTPRG/SERPINF1,12.0,,
GO:0090132,discovery_tumor_LIHC,GO:0090132,epithelium migration,12/111,375/18870,2.1431670716988748e-06,0.0004060477305841791,0.0003125379672979493,AGT/APOE/CALR/CDH13/CDH5/ENPP2/GLIPR2/ITGB1/MMRN2/NRP1/PTPRG/SERPINF1,12.0,,
GO:0090130,discovery_tumor_LIHC,GO:0090130,tissue migration,12/111,380/18870,2.457540143636581e-06,0.0004323515266983499,0.0003327841953901867,AGT/APOE/CALR/CDH13/CDH5/ENPP2/GLIPR2/ITGB1/MMRN2/NRP1/PTPRG/SERPINF1,12.0,,
GO:0006956,discovery_tumor_LIHC,GO:0006956,complement activation,6/111,67/18870,2.695243566173246e-06,0.000442558993565647,0.0003406409587844222,C1QA/C1QB/C1QC/C7/CD5L/COLEC11,6.0,,
GO:2000146,discovery_tumor_LIHC,GO:2000146,negative regulation of cell motility,12/111,388/18870,3.0457061839082493e-06,0.00045286880580144417,0.0003485764981722764,ADIPOQ/APOE/CALR/CDH1/DDT/ENG/FBLN1/MMRN2/PTPRG/PTPRJ/SERPINF1/TIMP1,12.0,,
GO:0044403,discovery_tumor_LIHC,GO:0044403,biological process involved in symbiotic interaction,11/111,322/18870,3.1257692645653882e-06,0.00045286880580144417,0.0003485764981722764,APOE/AXL/CSF1R/FUCA2/ICAM1/ITGB1/NCAM1/NRP1/PVR/SLC3A2/TFRC,11.0,,
GO:0046718,discovery_tumor_LIHC,GO:0046718,viral entry into host cell,8/111,156/18870,3.915766242872738e-06,0.0005358073475664197,0.0004124149124803393,AXL/ICAM1/ITGB1/NCAM1/NRP1/PVR/SLC3A2/TFRC,8.0,,
GO:0051701,discovery_tumor_LIHC,GO:0051701,biological process involved in interaction with host,9/111,211/18870,4.345323388316647e-06,0.0005632911318644158,0.00043356938628023715,AXL/FUCA2/ICAM1/ITGB1/NCAM1/NRP1/PVR/SLC3A2/TFRC,9.0,,
GO:0045216,discovery_tumor_LIHC,GO:0045216,cell-cell junction organization,9/111,214/18870,4.874412168274952e-06,0.000599225547129711,0.0004612283737763572,ACE/AGT/CDH1/CDH13/CDH2/CDH5/CSF1R/DSG2/FLNA,9.0,,
GO:0006098,discovery_tumor_LIHC,GO:0006098,pentose-phosphate shunt,4/111,20/18870,5.109109415235051e-06,0.000599225547129711,0.0004612283737763572,ALDOB/H6PD/TALDO1/TKT,4.0,,
GO:2001044,discovery_tumor_LIHC,GO:2001044,regulation of integrin-mediated signaling pathway,4/111,21/18870,6.282684566234392e-06,0.0007033750948470595,0.0005413930575975187,BST1/FLNA/LAMB1/TIMP1,4.0,,
GO:0031589,discovery_tumor_LIHC,GO:0031589,cell-substrate adhesion,11/111,356/18870,8.119808574249334e-06,0.000869525587755483,0.0006692803314518559,AXL/BST1/CALR/CDH13/FBLN1/FLNA/ITGB1/LAMB1/LYVE1/NRP1/PTPRJ,11.0,,
GO:0006740,discovery_tumor_LIHC,GO:0006740,NADPH regeneration,4/111,23/18870,9.211490570240313e-06,0.000945329219770912,0.0007276269525001229,ALDOB/H6PD/TALDO1/TKT,4.0,,
GO:0001974,discovery_tumor_LIHC,GO:0001974,blood vessel remodeling,5/111,51/18870,1.2179939915282586e-05,0.0011908347692906477,0.0009165944054073793,ACE/AGT/AXL/CST3/FLNA,5.0,,
GO:0030336,discovery_tumor_LIHC,GO:0030336,negative regulation of cell migration,11/111,373/18870,1.2572356028897913e-05,0.0011908347692906477,0.0009165944054073793,ADIPOQ/APOE/CALR/CDH1/DDT/ENG/MMRN2/PTPRG/PTPRJ/SERPINF1/TIMP1,11.0,,
GO:0007409,discovery_tumor_LIHC,GO:0007409,axonogenesis,12/111,448/18870,1.305421793375862e-05,0.0011908347692906477,0.0009165944054073793,ALCAM/APOE/CDH1/CDH2/CNTN1/CSF1R/ITGB1/NCAM1/NRP1/OLFM1/ROBO4/SPP1,12.0,,
GO:0007565,discovery_tumor_LIHC,GO:0007565,female pregnancy,8/111,186/18870,1.4245349321164082e-05,0.0012530819777866833,0.0009645065461434778,ACE/CALR/DSG2/FBLN1/HSPG2/IGFBP7/SPP1/TIMP1,8.0,,
GO:0150146,discovery_tumor_LIHC,GO:0150146,cell junction disassembly,4/111,27/18870,1.79284407862936e-05,0.0015226810226427977,0.0011720189421457268,C1QA/C1QB/C1QC/ITGB1,4.0,,
GO:0051156,discovery_tumor_LIHC,GO:0051156,glucose 6-phosphate metabolic process,4/111,29/18870,2.4044243413064582e-05,0.001955130547625075,0.0015048785675461076,ALDOB/H6PD/TALDO1/TKT,4.0,,
GO:0048762,discovery_tumor_LIHC,GO:0048762,mesenchymal cell differentiation,9/111,262/18870,2.460781444432697e-05,0.001955130547625075,0.0015048785675461076,AGT/CDH2/ENG/FLNA/GLIPR2/NCAM1/NRP1/OLFM1/VASN,9.0,,
GO:0034446,discovery_tumor_LIHC,GO:0034446,substrate adhesion-dependent cell spreading,6/111,100/18870,2.7513601282941544e-05,0.002117687498746407,0.0016299998654795303,AXL/CALR/FBLN1/FLNA/LAMB1/NRP1,6.0,,
GO:0044703,discovery_tumor_LIHC,GO:0044703,multi-organism reproductive process,8/111,206/18870,2.971052303231395e-05,0.002192299805038347,0.0016874295142312809,ACE/CALR/DSG2/FBLN1/HSPG2/IGFBP7/SPP1/TIMP1,8.0,,
GO:0003018,discovery_tumor_LIHC,GO:0003018,vascular process in circulatory system,9/111,269/18870,3.0263172298539912e-05,0.002192299805038347,0.0016874295142312809,ACE/AGT/APOE/CDH5/COMP/PTPRJ/SOD2/SOD3/TFRC,9.0,,
GO:0016049,discovery_tumor_LIHC,GO:0016049,cell growth,12/111,497/18870,3.622700272455842e-05,0.002530406311023641,0.0019476726141220923,AGT/ALCAM/APOE/CDH1/ENO1/HNF4A/IGFBP7/ITGB1/NRP1/OLFM1/PTPRJ/SPP1,12.0,,
GO:0018108,discovery_tumor_LIHC,GO:0018108,peptidyl-tyrosine phosphorylation,9/111,276/18870,3.698523231703251e-05,0.002530406311023641,0.0019476726141220923,ACE/ADIPOQ/AGT/BST1/CSF1R/EFEMP1/ENPP2/NRP1/PTPRJ,9.0,,
GO:0018212,discovery_tumor_LIHC,GO:0018212,peptidyl-tyrosine modification,9/111,278/18870,3.9123414854143305e-05,0.002591677151848137,0.0019948332373778215,ACE/ADIPOQ/AGT/BST1/CSF1R/EFEMP1/ENPP2/NRP1/PTPRJ,9.0,,
GO:0042060,discovery_tumor_LIHC,GO:0042060,wound healing,11/111,423/18870,3.9985274774758106e-05,0.002591677151848137,0.0019948332373778215,APOE/AXL/COMP/FBLN1/FLNA/GP1BA/HNF4A/ITGB1/MCAM/PROCR/TIMP1,11.0,,
GO:0044706,discovery_tumor_LIHC,GO:0044706,multi-multicellular organism process,8/111,216/18870,4.16250236224574e-05,0.0026287803380028864,0.0020233918365464448,ACE/CALR/DSG2/FBLN1/HSPG2/IGFBP7/SPP1/TIMP1,8.0,,
GO:0043542,discovery_tumor_LIHC,GO:0043542,endothelial cell migration,9/111,284/18870,4.617690711833909e-05,0.0028433430558117297,0.0021885423610560183,AGT/APOE/CALR/CDH13/CDH5/ITGB1/MMRN2/NRP1/SERPINF1,9.0,,
GO:0007229,discovery_tumor_LIHC,GO:0007229,integrin-mediated signaling pathway,6/111,111/18870,4.959779278517305e-05,0.002979496673899542,0.0022933408165878477,BST1/FLNA/ITGB1/LAMB1/NRP1/TIMP1,6.0,,
GO:0007596,discovery_tumor_LIHC,GO:0007596,blood coagulation,8/111,224/18870,5.381858305680093e-05,0.003156075477830969,0.0024292548392305384,APOE/AXL/COMP/FBLN1/FLNA/GP1BA/HNF4A/PROCR,8.0,,
GO:0050731,discovery_tumor_LIHC,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,7/111,168/18870,6.110147694122558e-05,0.0034278566759663046,0.002638446854890405,ACE/ADIPOQ/AGT/CSF1R/ENPP2/NRP1/PTPRJ,7.0,,
GO:0010632,discovery_tumor_LIHC,GO:0010632,regulation of epithelial cell migration,9/111,295/18870,6.191506123569087e-05,0.0034278566759663046,0.002638446854890405,AGT/APOE/CALR/ENPP2/GLIPR2/MMRN2/NRP1/PTPRG/SERPINF1,9.0,,
GO:0050817,discovery_tumor_LIHC,GO:0050817,coagulation,8/111,229/18870,6.285282590357818e-05,0.0034278566759663046,0.002638446854890405,APOE/AXL/COMP/FBLN1/FLNA/GP1BA/HNF4A/PROCR,8.0,,
GO:0002685,discovery_tumor_LIHC,GO:0002685,regulation of leukocyte migration,8/111,230/18870,6.480313067032872e-05,0.0034278566759663046,0.002638446854890405,BST1/CALR/CSF1R/DDT/GP1BA/ICAM1/LYVE1/PLA2G7,8.0,,
GO:0007599,discovery_tumor_LIHC,GO:0007599,hemostasis,8/111,231/18870,6.680354057912408e-05,0.0034278566759663046,0.002638446854890405,APOE/AXL/COMP/FBLN1/FLNA/GP1BA/HNF4A/PROCR,8.0,,
GO:0050730,discovery_tumor_LIHC,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,8/111,231/18870,6.680354057912408e-05,0.0034278566759663046,0.002638446854890405,ACE/ADIPOQ/AGT/BST1/CSF1R/ENPP2/NRP1/PTPRJ,8.0,,
GO:0045123,discovery_tumor_LIHC,GO:0045123,cellular extravasation,5/111,74/18870,7.502092973287246e-05,0.0037709499986135686,0.0029025283447669885,BST1/GP1BA/ICAM1/ITGB1/LYVE1,5.0,,
GO:0048675,discovery_tumor_LIHC,GO:0048675,axon extension,6/111,121/18870,8.02809555558139e-05,0.0039546398706793925,0.0030439158096004387,ALCAM/APOE/CDH1/ITGB1/NRP1/OLFM1,6.0,,
GO:0001837,discovery_tumor_LIHC,GO:0001837,epithelial to mesenchymal transition,7/111,178/18870,8.791868411862184e-05,0.004245955274199326,0.0032681434488676555,AGT/ENG/FLNA/GLIPR2/NCAM1/OLFM1/VASN,7.0,,
GO:0002691,discovery_tumor_LIHC,GO:0002691,regulation of cellular extravasation,4/111,41/18870,9.709976846648272e-05,0.0045242463358074435,0.0034823461550053236,BST1/GP1BA/ICAM1/LYVE1,4.0,,
GO:0070372,discovery_tumor_LIHC,GO:0070372,regulation of ERK1 and ERK2 cascade,9/111,313/18870,9.735487446114271e-05,0.0045242463358074435,0.0034823461550053236,ADIPOQ/APOE/CSF1R/DDT/FBLN1/GLIPR2/ICAM1/MARCO/NRP1,9.0,,
GO:0019362,discovery_tumor_LIHC,GO:0019362,pyridine nucleotide metabolic process,5/111,79/18870,0.00010254234871942348,0.0045333386367923355,0.003489344566900869,ALDOB/H6PD/LDHB/TALDO1/TKT,5.0,,
GO:0046496,discovery_tumor_LIHC,GO:0046496,nicotinamide nucleotide metabolic process,5/111,79/18870,0.00010254234871942348,0.0045333386367923355,0.003489344566900869,ALDOB/H6PD/LDHB/TALDO1/TKT,5.0,,
GO:0034374,discovery_tumor_LIHC,GO:0034374,low-density lipoprotein particle remodeling,3/111,16/18870,0.00010491283081492616,0.0045333386367923355,0.003489344566900869,AGT/APOE/PLA2G7,3.0,,
GO:0072378,discovery_tumor_LIHC,GO:0072378,"blood coagulation, fibrin clot formation",3/111,16/18870,0.00010491283081492616,0.0045333386367923355,0.003489344566900869,FBLN1/FLNA/GP1BA,3.0,,
GO:0006958,discovery_tumor_LIHC,GO:0006958,"complement activation, classical pathway",4/111,42/18870,0.0001068365542656913,0.0045368695371792705,0.0034920623272687848,C1QA/C1QB/C1QC/C7,4.0,,
GO:0050900,discovery_tumor_LIHC,GO:0050900,leukocyte migration,10/111,396/18870,0.00011589906136102199,0.004753451976767021,0.003658767446698466,BST1/CALR/CSF1R/DDT/GP1BA/ICAM1/ITGB1/LYVE1/PLA2G7/UMOD,10.0,,
GO:0019058,discovery_tumor_LIHC,GO:0019058,viral life cycle,9/111,321/18870,0.00011785994185320888,0.004753451976767021,0.003658767446698466,APOE/AXL/ICAM1/ITGB1/NCAM1/NRP1/PVR/SLC3A2/TFRC,9.0,,
GO:0030198,discovery_tumor_LIHC,GO:0030198,extracellular matrix organization,9/111,321/18870,0.00011785994185320888,0.004753451976767021,0.003658767446698466,AGT/COMP/CST3/ENG/FBLN1/ITGB1/LAMB1/LUM/TGFBI,9.0,,
GO:0043062,discovery_tumor_LIHC,GO:0043062,extracellular structure organization,9/111,322/18870,0.00012066039945517003,0.004753451976767021,0.003658767446698466,AGT/COMP/CST3/ENG/FBLN1/ITGB1/LAMB1/LUM/TGFBI,9.0,,
GO:0043086,discovery_tumor_LIHC,GO:0043086,negative regulation of catalytic activity,11/111,480/18870,0.0001234758521471297,0.004753451976767021,0.003658767446698466,ADIPOQ/AGT/AOC3/APOE/CST3/PTPRJ/SERPINA6/SERPINA7/SERPINF1/TIMP1/YWHAG,11.0,,
GO:0045229,discovery_tumor_LIHC,GO:0045229,external encapsulating structure organization,9/111,323/18870,0.00012351641352541183,0.004753451976767021,0.003658767446698466,AGT/COMP/CST3/ENG/FBLN1/ITGB1/LAMB1/LUM/TGFBI,9.0,,
GO:1900120,discovery_tumor_LIHC,GO:1900120,regulation of receptor binding,3/111,17/18870,0.00012684897871309152,0.004791922302348321,0.0036883783432824016,ADIPOQ/NRP1/PTPRF,3.0,,
GO:0006739,discovery_tumor_LIHC,GO:0006739,NADP metabolic process,4/111,44/18870,0.000128407174971575,0.004791922302348321,0.0036883783432824016,ALDOB/H6PD/TALDO1/TKT,4.0,,
GO:0060485,discovery_tumor_LIHC,GO:0060485,mesenchyme development,9/111,327/18870,0.00013551361074648578,0.004970497661316197,0.0038258291292307075,AGT/CDH2/ENG/FLNA/GLIPR2/NCAM1/NRP1/OLFM1/VASN,9.0,,
GO:0048678,discovery_tumor_LIHC,GO:0048678,response to axon injury,5/111,84/18870,0.00013722851846102371,0.004970497661316197,0.0038258291292307075,AXL/FLNA/PTPRF/SOD2/SPP1,5.0,,
GO:0072524,discovery_tumor_LIHC,GO:0072524,pyridine-containing compound metabolic process,5/111,85/18870,0.0001451277174317103,0.005180428522236268,0.003987414478939897,ALDOB/H6PD/LDHB/TALDO1/TKT,5.0,,
GO:0070371,discovery_tumor_LIHC,GO:0070371,ERK1 and ERK2 cascade,9/111,336/18870,0.00016611013087289696,0.005773957466939255,0.004444258135332436,ADIPOQ/APOE/CSF1R/DDT/FBLN1/GLIPR2/ICAM1/MARCO/NRP1,9.0,,
GO:0016339,discovery_tumor_LIHC,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,4/111,47/18870,0.00016644375970470448,0.005773957466939255,0.004444258135332436,CDH1/CDH13/CDH2/CDH5,4.0,,
GO:0001558,discovery_tumor_LIHC,GO:0001558,regulation of cell growth,10/111,417/18870,0.0001764021642579714,0.005936043153887785,0.004569016697716478,AGT/APOE/CDH1/ENO1/HNF4A/IGFBP7/NRP1/OLFM1/PTPRJ/SPP1,10.0,,
GO:0010977,discovery_tumor_LIHC,GO:0010977,negative regulation of neuron projection development,6/111,140/18870,0.0001790699629958343,0.005936043153887785,0.004569016697716478,APOE/CDH1/FLNA/NRP1/PTPRG/SPP1,6.0,,
GO:0072376,discovery_tumor_LIHC,GO:0072376,protein activation cascade,3/111,19/18870,0.0001792165895715929,0.005936043153887785,0.004569016697716478,FBLN1/FLNA/GP1BA,3.0,,
GO:0044331,discovery_tumor_LIHC,GO:0044331,cell-cell adhesion mediated by cadherin,4/111,48/18870,0.00018075649067867796,0.005936043153887785,0.004569016697716478,CDH1/CDH13/CDH2/CDH5,4.0,,
GO:0035296,discovery_tumor_LIHC,GO:0035296,regulation of tube diameter,6/111,146/18870,0.00022489358607457224,0.007193674058463266,0.005537024586743741,ACE/AGT/APOE/COMP/SOD2/SOD3,6.0,,
GO:0097746,discovery_tumor_LIHC,GO:0097746,blood vessel diameter maintenance,6/111,146/18870,0.00022489358607457224,0.007193674058463266,0.005537024586743741,ACE/AGT/APOE/COMP/SOD2/SOD3,6.0,,
GO:0043407,discovery_tumor_LIHC,GO:0043407,negative regulation of MAP kinase activity,4/111,51/18870,0.00022902203897930853,0.007214732180397922,0.005553233180287906,ADIPOQ/AGT/APOE/PTPRJ,4.0,,
GO:0035150,discovery_tumor_LIHC,GO:0035150,regulation of tube size,6/111,147/18870,0.0002333545323882411,0.007214732180397922,0.005553233180287906,ACE/AGT/APOE/COMP/SOD2/SOD3,6.0,,
GO:0016032,discovery_tumor_LIHC,GO:0016032,viral process,10/111,432/18870,0.00023433965669177173,0.007214732180397922,0.005553233180287906,APOE/AXL/CSF1R/ICAM1/ITGB1/NCAM1/NRP1/PVR/SLC3A2/TFRC,10.0,,
GO:0009410,discovery_tumor_LIHC,GO:0009410,response to xenobiotic stimulus,10/111,434/18870,0.00024315280618148903,0.007393646439814908,0.005690944820440048,ACE/ADIPOQ/CALR/CDH1/ENG/HNF4A/HSPG2/SOD2/TFRC/UMOD,10.0,,
GO:0006968,discovery_tumor_LIHC,GO:0006968,cellular defense response,4/111,52/18870,0.0002469894715283557,0.0074187203460285385,0.00571024439310101,CD5L/ITGB1/LGALS3BP/UMOD,4.0,,
GO:0002064,discovery_tumor_LIHC,GO:0002064,epithelial cell development,7/111,214/18870,0.0002740227812227369,0.008131543495802421,0.00625890968905706,ADIPOQ/CDH2/CDH5/FLNA/ICAM1/PODXL/ROBO4,7.0,,
GO:0050878,discovery_tumor_LIHC,GO:0050878,regulation of body fluid levels,9/111,365/18870,0.00030654406645090073,0.008694448929922615,0.00669218220090631,APOE/AXL/COMP/FBLN1/FLNA/GP1BA/HNF4A/PROCR/UMOD,9.0,,
GO:0070374,discovery_tumor_LIHC,GO:0070374,positive regulation of ERK1 and ERK2 cascade,7/111,218/18870,0.00030658496629657,0.008694448929922615,0.00669218220090631,APOE/CSF1R/DDT/GLIPR2/ICAM1/MARCO/NRP1,7.0,,
GO:0002455,discovery_tumor_LIHC,GO:0002455,humoral immune response mediated by circulating immunoglobulin,4/111,55/18870,0.00030696830325765604,0.008694448929922615,0.00669218220090631,C1QA/C1QB/C1QC/C7,4.0,,
GO:0045807,discovery_tumor_LIHC,GO:0045807,positive regulation of endocytosis,6/111,155/18870,0.00031044143066246685,0.008694448929922615,0.00669218220090631,APOE/AXL/CALR/COLEC11/LMAN2/PTPRJ,6.0,,
GO:0050764,discovery_tumor_LIHC,GO:0050764,regulation of phagocytosis,5/111,100/18870,0.00031064210549459605,0.008694448929922615,0.00669218220090631,ADIPOQ/CALR/COLEC11/LMAN2/PTPRJ,5.0,,
GO:0010810,discovery_tumor_LIHC,GO:0010810,regulation of cell-substrate adhesion,7/111,220/18870,0.00032399354477141636,0.008809103448013047,0.006780432638789451,BST1/CALR/CDH13/FBLN1/FLNA/NRP1/PTPRJ,7.0,,
GO:0030100,discovery_tumor_LIHC,GO:0030100,regulation of endocytosis,8/111,291/18870,0.00032509787015855377,0.008809103448013047,0.006780432638789451,ADIPOQ/APOE/AXL/CALR/CDH13/COLEC11/LMAN2/PTPRJ,8.0,,
GO:0002449,discovery_tumor_LIHC,GO:0002449,lymphocyte mediated immunity,9/111,368/18870,0.00032546829629280847,0.008809103448013047,0.006780432638789451,C1QA/C1QB/C1QC/C7/CADM1/FCGR3A/ICAM1/PVR/TFRC,9.0,,
GO:0007043,discovery_tumor_LIHC,GO:0007043,cell-cell junction assembly,6/111,157/18870,0.00033252201856686286,0.008902192736197644,0.006852084158340046,ACE/AGT/CDH1/CDH13/CDH2/CDH5,6.0,,
GO:0010975,discovery_tumor_LIHC,GO:0010975,regulation of neuron projection development,10/111,453/18870,0.00034168397801556037,0.009049114385508874,0.006965170847832759,APOE/CDH1/CDH2/CNTN1/FLNA/NRP1/PTPRF/PTPRG/SERPINF1/SPP1,10.0,,
GO:0034332,discovery_tumor_LIHC,GO:0034332,adherens junction organization,4/111,57/18870,0.0003523368885628706,0.009231976133301598,0.007105920899235498,CDH1/CDH13/CDH2/CDH5,4.0,,
GO:0045936,discovery_tumor_LIHC,GO:0045936,negative regulation of phosphate metabolic process,9/111,376/18870,0.00038071456474890784,0.009774524726832037,0.007523524599023228,ADIPOQ/AGT/ALDOB/APOE/CADM1/ENG/FBLN1/PTPRJ/YWHAG,9.0,,
GO:0001666,discovery_tumor_LIHC,GO:0001666,response to hypoxia,8/111,298/18870,0.0003809802573186665,0.009774524726832037,0.007523524599023228,ACE/ADIPOQ/ENO1/HSPG2/SOD2/SOD3/TFRC/VASN,8.0,,
GO:0010563,discovery_tumor_LIHC,GO:0010563,negative regulation of phosphorus metabolic process,9/111,377/18870,0.0003881345478916929,0.009855416406775666,0.007585787528518057,ADIPOQ/AGT/ALDOB/APOE/CADM1/ENG/FBLN1/PTPRJ/YWHAG,9.0,,
GO:0010718,discovery_tumor_LIHC,GO:0010718,positive regulation of epithelial to mesenchymal transition,4/111,59/18870,0.00040231278220771716,0.010111187577322524,0.007782656506510189,AGT/ENG/GLIPR2/OLFM1,4.0,,
GO:0008211,discovery_tumor_LIHC,GO:0008211,glucocorticoid metabolic process,3/111,25/18870,0.0004145936394225385,0.010314587211088003,0.00793921472195632,DKK3/H6PD/SERPINA6,3.0,,
GO:0002443,discovery_tumor_LIHC,GO:0002443,leukocyte mediated immunity,10/111,466/18870,0.00042676023332050564,0.010511104546684054,0.008090475581160323,ACE/C1QA/C1QB/C1QC/C7/CADM1/FCGR3A/ICAM1/PVR/TFRC,10.0,,
GO:0001933,discovery_tumor_LIHC,GO:0001933,negative regulation of protein phosphorylation,8/111,304/18870,0.0004348964338873431,0.010605444719450753,0.00816308991590521,ADIPOQ/AGT/APOE/CADM1/ENG/FBLN1/PTPRJ/YWHAG,8.0,,
GO:0050920,discovery_tumor_LIHC,GO:0050920,regulation of chemotaxis,7/111,232/18870,0.00044585483670875613,0.010766082968761435,0.008286734374741691,BST1/CALR/CDH13/CSF1R/DDT/NRP1/PLA2G7,7.0,,
GO:1900024,discovery_tumor_LIHC,GO:1900024,regulation of substrate adhesion-dependent cell spreading,4/111,61/18870,0.00045715707637344736,0.010834042227692537,0.008339043123308871,CALR/FBLN1/FLNA/NRP1,4.0,,
GO:0019318,discovery_tumor_LIHC,GO:0019318,hexose metabolic process,7/111,233/18870,0.0004574666632886821,0.010834042227692537,0.008339043123308871,ADIPOQ/ALDOB/ENO1/FUCA1/FUCA2/GOT1/H6PD,7.0,,
GO:0061387,discovery_tumor_LIHC,GO:0061387,regulation of extent of cell growth,5/111,109/18870,0.00046229238173063733,0.010844058440024378,0.008346752676660431,APOE/CDH1/NRP1/OLFM1/SPP1,5.0,,
GO:0019932,discovery_tumor_LIHC,GO:0019932,second-messenger-mediated signaling,8/111,310/18870,0.0004948643376373654,0.011498593052838027,0.008850552850892701,ADGRG6/AGT/APOE/BST1/CAMKK2/CDH13/FCGR3A/PTPRJ,8.0,,
GO:0010717,discovery_tumor_LIHC,GO:0010717,regulation of epithelial to mesenchymal transition,5/111,111/18870,0.000502460758850409,0.011565989243444461,0.00890242820156996,AGT/ENG/GLIPR2/OLFM1/VASN,5.0,,
GO:0051897,discovery_tumor_LIHC,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,6/111,171/18870,0.0005237015346225809,0.011943304442364971,0.009192850524905148,AGT/AXL/CSF1R/ENG/ITGB1/PTPRJ,6.0,,
GO:0048588,discovery_tumor_LIHC,GO:0048588,developmental cell growth,7/111,239/18870,0.0005323135663809575,0.012028333155929343,0.009258297760039638,ALCAM/APOE/CDH1/ITGB1/NRP1/OLFM1/SPP1,7.0,,
GO:0036293,discovery_tumor_LIHC,GO:0036293,response to decreased oxygen levels,8/111,315/18870,0.0005498178046351302,0.012245308240366256,0.009425305101138802,ACE/ADIPOQ/ENO1/HSPG2/SOD2/SOD3/TFRC/VASN,8.0,,
GO:0045785,discovery_tumor_LIHC,GO:0045785,positive regulation of cell adhesion,10/111,482/18870,0.0005550333750617385,0.012245308240366256,0.009425305101138802,CALR/CDH13/FLNA/GP1BA/ICOSLG/LAMB1/NRP1/PODXL/PTPRJ/TFRC,10.0,,
GO:1903034,discovery_tumor_LIHC,GO:1903034,regulation of response to wounding,6/111,173/18870,0.0005568309065858793,0.012245308240366256,0.009425305101138802,APOE/FLNA/GP1BA/ITGB1/PTPRF/SPP1,6.0,,
GO:0050808,discovery_tumor_LIHC,GO:0050808,synapse organization,10/111,483/18870,0.0005640107453271571,0.012293437749918477,0.009462350743681508,APOE/C1QA/C1QB/C1QC/CDH1/CDH2/FLNA/ITGB1/NRP1/PTPRF,10.0,,
GO:0060560,discovery_tumor_LIHC,GO:0060560,developmental growth involved in morphogenesis,7/111,244/18870,0.0006018725166016024,0.013003614108681987,0.010008978784852131,ALCAM/APOE/CDH1/ITGB1/NRP1/OLFM1/SPP1,7.0,,
GO:1901136,discovery_tumor_LIHC,GO:1901136,carbohydrate derivative catabolic process,6/111,178/18870,0.0006468052184075457,0.013852880460328567,0.010662665431139496,ADA2/CST3/FUCA1/FUCA2/LYVE1/MAN1A1,6.0,,
GO:1990138,discovery_tumor_LIHC,GO:1990138,neuron projection extension,6/111,179/18870,0.0006660796828555573,0.014142709128217567,0.010885748718900716,ALCAM/APOE/CDH1/ITGB1/NRP1/OLFM1,6.0,,
GO:0042326,discovery_tumor_LIHC,GO:0042326,negative regulation of phosphorylation,8/111,327/18870,0.0007020767342812195,0.014779615354996955,0.011375980192896774,ADIPOQ/AGT/APOE/CADM1/ENG/FBLN1/PTPRJ/YWHAG,8.0,,
GO:0048679,discovery_tumor_LIHC,GO:0048679,regulation of axon regeneration,3/111,30/18870,0.0007163645973137955,0.014826941203225868,0.011412407251323711,FLNA/PTPRF/SPP1,3.0,,
GO:0061098,discovery_tumor_LIHC,GO:0061098,positive regulation of protein tyrosine kinase activity,3/111,30/18870,0.0007163645973137955,0.014826941203225868,0.011412407251323711,ACE/AGT/CSF1R,3.0,,
GO:0048545,discovery_tumor_LIHC,GO:0048545,response to steroid hormone,8/111,330/18870,0.000745017260262391,0.015291479266885575,0.011769965664320757,ACE/ADIPOQ/CALR/DSG2/GOT1/IGFBP7/SERPINF1/SPP1,8.0,,
GO:0006081,discovery_tumor_LIHC,GO:0006081,cellular aldehyde metabolic process,4/111,70/18870,0.0007713050201203321,0.015571510365216212,0.011985507689704212,ALDOB/DKK3/TALDO1/TKT,4.0,,
GO:1901184,discovery_tumor_LIHC,GO:1901184,regulation of ERBB signaling pathway,4/111,70/18870,0.0007713050201203321,0.015571510365216212,0.011985507689704212,AGT/CADM1/CDH13/PTPRJ,4.0,,
GO:0010811,discovery_tumor_LIHC,GO:0010811,positive regulation of cell-substrate adhesion,5/111,123/18870,0.0008011959793967067,0.016043460953285273,0.012348771578035676,CALR/CDH13/FLNA/NRP1/PTPRJ,5.0,,
GO:0038127,discovery_tumor_LIHC,GO:0038127,ERBB signaling pathway,5/111,124/18870,0.0008309959267462237,0.01633646725924348,0.012574300717523563,AGT/CADM1/CDH13/EFEMP1/PTPRJ,5.0,,
GO:0006898,discovery_tumor_LIHC,GO:0006898,receptor-mediated endocytosis,7/111,258/18870,0.0008357267051013718,0.01633646725924348,0.012574300717523563,ADIPOQ/APOE/HSPG2/ITGB1/LYVE1/MARCO/TFRC,7.0,,
GO:0006959,discovery_tumor_LIHC,GO:0006959,humoral immune response,7/111,258/18870,0.0008357267051013718,0.01633646725924348,0.012574300717523563,BST1/C1QA/C1QB/C1QC/C7/CD5L/COLEC11,7.0,,
GO:0050766,discovery_tumor_LIHC,GO:0050766,positive regulation of phagocytosis,4/111,72/18870,0.0008576767855161621,0.016633526950600844,0.01280294977799095,CALR/COLEC11/LMAN2/PTPRJ,4.0,,
GO:0070570,discovery_tumor_LIHC,GO:0070570,regulation of neuron projection regeneration,3/111,32/18870,0.0008677175728426075,0.01669678423368236,0.012851639380670528,FLNA/PTPRF/SPP1,3.0,,
GO:0030308,discovery_tumor_LIHC,GO:0030308,negative regulation of cell growth,6/111,189/18870,0.0008843204057168628,0.016810493381397864,0.012939162159923736,CDH1/ENO1/HNF4A/NRP1/PTPRJ/SPP1,6.0,,
GO:0002688,discovery_tumor_LIHC,GO:0002688,regulation of leukocyte chemotaxis,5/111,126/18870,0.000893067574186073,0.016810493381397864,0.012939162159923736,BST1/CALR/CSF1R/DDT/PLA2G7,5.0,,
GO:0005996,discovery_tumor_LIHC,GO:0005996,monosaccharide metabolic process,7/111,261/18870,0.0008941025712395941,0.016810493381397864,0.012939162159923736,ADIPOQ/ALDOB/ENO1/FUCA1/FUCA2/GOT1/H6PD,7.0,,
GO:0051384,discovery_tumor_LIHC,GO:0051384,response to glucocorticoid,5/111,127/18870,0.0009253675936269993,0.017124721339333848,0.013181025763249893,ACE/ADIPOQ/GOT1/IGFBP7/SERPINF1,5.0,,
GO:0031099,discovery_tumor_LIHC,GO:0031099,regeneration,6/111,191/18870,0.000933903778363682,0.017124721339333848,0.013181025763249893,ACE/AXL/FLNA/HSPG2/PTPRF/SPP1,6.0,,
GO:0034368,discovery_tumor_LIHC,GO:0034368,protein-lipid complex remodeling,3/111,33/18870,0.0009504211884526033,0.017124721339333848,0.013181025763249893,AGT/APOE/PLA2G7,3.0,,
GO:0034369,discovery_tumor_LIHC,GO:0034369,plasma lipoprotein particle remodeling,3/111,33/18870,0.0009504211884526033,0.017124721339333848,0.013181025763249893,AGT/APOE/PLA2G7,3.0,,
GO:0070482,discovery_tumor_LIHC,GO:0070482,response to oxygen levels,8/111,343/18870,0.0009562518249175863,0.017124721339333848,0.013181025763249893,ACE/ADIPOQ/ENO1/HSPG2/SOD2/SOD3/TFRC/VASN,8.0,,
GO:0010951,discovery_tumor_LIHC,GO:0010951,negative regulation of endopeptidase activity,5/111,128/18870,0.0009585294087110048,0.017124721339333848,0.013181025763249893,CST3/SERPINA6/SERPINA7/SERPINF1/TIMP1,5.0,,
GO:0031345,discovery_tumor_LIHC,GO:0031345,negative regulation of cell projection organization,6/111,192/18870,0.0009594849958701059,0.017124721339333848,0.013181025763249893,APOE/CDH1/FLNA/NRP1/PTPRG/SPP1,6.0,,
GO:1901658,discovery_tumor_LIHC,GO:1901658,glycosyl compound catabolic process,3/111,34/18870,0.0010379557567491544,0.018391978624986812,0.014156443149604145,ADA2/FUCA1/FUCA2,3.0,,
GO:0034367,discovery_tumor_LIHC,GO:0034367,protein-containing complex remodeling,3/111,35/18870,0.001130427969918028,0.01987465381781086,0.01529766930609969,AGT/APOE/PLA2G7,3.0,,
GO:0030168,discovery_tumor_LIHC,GO:0030168,platelet activation,5/111,133/18870,0.001137769463382595,0.01987465381781086,0.01529766930609969,APOE/AXL/COMP/FLNA/GP1BA,5.0,,
GO:0048844,discovery_tumor_LIHC,GO:0048844,artery morphogenesis,4/111,80/18870,0.001271927507183805,0.022061672184462762,0.016981033657806024,APOE/COMP/ENG/NRP1,4.0,,
GO:0010466,discovery_tumor_LIHC,GO:0010466,negative regulation of peptidase activity,5/111,137/18870,0.0012981531556454623,0.02235909945702639,0.017209965648269987,CST3/SERPINA6/SERPINA7/SERPINF1/TIMP1,5.0,,
GO:0050810,discovery_tumor_LIHC,GO:0050810,regulation of steroid biosynthetic process,4/111,81/18870,0.0013320020271811745,0.022782784673244676,0.01753607931983403,APOE/DKK3/H6PD/IGFBP7,4.0,,
GO:0016064,discovery_tumor_LIHC,GO:0016064,immunoglobulin mediated immune response,6/111,205/18870,0.0013436362281986293,0.022823282965884303,0.017567251157791154,C1QA/C1QB/C1QC/C7/FCGR3A/TFRC,6.0,,
GO:0034284,discovery_tumor_LIHC,GO:0034284,response to monosaccharide,6/111,206/18870,0.0013774280911379646,0.023237023208717855,0.01788571010915266,ACE/ADIPOQ/HNF4A/ICAM1/SERPINF1/SOD2,6.0,,
GO:0019724,discovery_tumor_LIHC,GO:0019724,B cell mediated immunity,6/111,208/18870,0.0014469572043281057,0.023931245412765187,0.018420058118422164,C1QA/C1QB/C1QC/C7/FCGR3A/TFRC,6.0,,
GO:1901654,discovery_tumor_LIHC,GO:1901654,response to ketone,6/111,208/18870,0.0014469572043281057,0.023931245412765187,0.018420058118422164,ACE/CALR/DSG2/IGFBP7/SERPINF1/SPP1,6.0,,
GO:0010572,discovery_tumor_LIHC,GO:0010572,positive regulation of platelet activation,2/111,10/18870,0.0014963101070100846,0.023931245412765187,0.018420058118422164,FLNA/GP1BA,2.0,,
GO:0034651,discovery_tumor_LIHC,GO:0034651,cortisol biosynthetic process,2/111,10/18870,0.0014963101070100846,0.023931245412765187,0.018420058118422164,DKK3/H6PD,2.0,,
GO:0098903,discovery_tumor_LIHC,GO:0098903,regulation of membrane repolarization during action potential,2/111,10/18870,0.0014963101070100846,0.023931245412765187,0.018420058118422164,CACNA2D1/FLNA,2.0,,
GO:1902645,discovery_tumor_LIHC,GO:1902645,tertiary alcohol biosynthetic process,2/111,10/18870,0.0014963101070100846,0.023931245412765187,0.018420058118422164,DKK3/H6PD,2.0,,
GO:1903596,discovery_tumor_LIHC,GO:1903596,regulation of gap junction assembly,2/111,10/18870,0.0014963101070100846,0.023931245412765187,0.018420058118422164,ACE/AGT,2.0,,
GO:1905918,discovery_tumor_LIHC,GO:1905918,regulation of CoA-transferase activity,2/111,10/18870,0.0014963101070100846,0.023931245412765187,0.018420058118422164,AGT/APOE,2.0,,
GO:0055094,discovery_tumor_LIHC,GO:0055094,response to lipoprotein particle,3/111,39/18870,0.0015517460813411466,0.024657745795762867,0.018979250882821087,APOE/CDH13/ITGB1,3.0,,
GO:0034103,discovery_tumor_LIHC,GO:0034103,regulation of tissue remodeling,4/111,85/18870,0.0015921886028296946,0.025138208517753446,0.019349066624131443,CSF1R/CST3/SPP1/TFRC,4.0,,
GO:0043491,discovery_tumor_LIHC,GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,7/111,290/18870,0.0016406412065913777,0.025738212049901676,0.01981089381878023,AGT/AXL/CSF1R/ENG/FCGR3A/ITGB1/PTPRJ,7.0,,
GO:0050921,discovery_tumor_LIHC,GO:0050921,positive regulation of chemotaxis,5/111,145/18870,0.0016682645467604223,0.025875848321066326,0.019916833483445712,CALR/CDH13/CSF1R/NRP1/PLA2G7,5.0,,
GO:0035886,discovery_tumor_LIHC,GO:0035886,vascular associated smooth muscle cell differentiation,3/111,40/18870,0.0016704262618958772,0.025875848321066326,0.019916833483445712,COMP/ENG/SOD2,3.0,,
GO:0044282,discovery_tumor_LIHC,GO:0044282,small molecule catabolic process,8/111,375/18870,0.0016846513007876237,0.02593310096149948,0.01996090126788494,ADA2/ADIPOQ/ALDOB/APOE/DPEP2/ENO1/FAH/GOT1,8.0,,
GO:0006935,discovery_tumor_LIHC,GO:0006935,chemotaxis,9/111,468/18870,0.0017800395750777014,0.02686487933559939,0.02067809803338441,BST1/CALR/CDH13/CSF1R/DDT/ENPP2/NRP1/PLA2G7/PTPRJ,9.0,,
GO:0031952,discovery_tumor_LIHC,GO:0031952,regulation of protein autophosphorylation,3/111,41/18870,0.0017946362482192514,0.02686487933559939,0.02067809803338441,ACE/ADIPOQ/ENG,3.0,,
GO:0031943,discovery_tumor_LIHC,GO:0031943,regulation of glucocorticoid metabolic process,2/111,11/18870,0.0018218051698410287,0.02686487933559939,0.02067809803338441,DKK3/H6PD,2.0,,
GO:0031953,discovery_tumor_LIHC,GO:0031953,negative regulation of protein autophosphorylation,2/111,11/18870,0.0018218051698410287,0.02686487933559939,0.02067809803338441,ADIPOQ/ENG,2.0,,
GO:0042447,discovery_tumor_LIHC,GO:0042447,hormone catabolic process,2/111,11/18870,0.0018218051698410287,0.02686487933559939,0.02067809803338441,ACE/SPP1,2.0,,
GO:0072015,discovery_tumor_LIHC,GO:0072015,podocyte development,2/111,11/18870,0.0018218051698410287,0.02686487933559939,0.02067809803338441,ADIPOQ/PODXL,2.0,,
GO:0002460,discovery_tumor_LIHC,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,8/111,380/18870,0.0018301877144815603,0.02686487933559939,0.02067809803338441,C1QA/C1QB/C1QC/C7/FCGR3A/ICAM1/PVR/TFRC,8.0,,
GO:0042330,discovery_tumor_LIHC,GO:0042330,taxis,9/111,470/18870,0.001832440003402638,0.02686487933559939,0.02067809803338441,BST1/CALR/CDH13/CSF1R/DDT/ENPP2/NRP1/PLA2G7/PTPRJ,9.0,,
GO:0002687,discovery_tumor_LIHC,GO:0002687,positive regulation of leukocyte migration,5/111,149/18870,0.0018799224264328725,0.02723675844884803,0.02096433616102541,CALR/CSF1R/ICAM1/LYVE1/PLA2G7,5.0,,
GO:0031960,discovery_tumor_LIHC,GO:0031960,response to corticosteroid,5/111,149/18870,0.0018799224264328725,0.02723675844884803,0.02096433616102541,ACE/ADIPOQ/GOT1/IGFBP7/SERPINF1,5.0,,
GO:0045124,discovery_tumor_LIHC,GO:0045124,regulation of bone resorption,3/111,42/18870,0.0019244669939079853,0.027398625468181316,0.021088926413314765,CSF1R/SPP1/TFRC,3.0,,
GO:0071402,discovery_tumor_LIHC,GO:0071402,cellular response to lipoprotein particle stimulus,3/111,42/18870,0.0019244669939079853,0.027398625468181316,0.021088926413314765,APOE/CDH13/ITGB1,3.0,,
GO:1900026,discovery_tumor_LIHC,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,3/111,42/18870,0.0019244669939079853,0.027398625468181316,0.021088926413314765,CALR/FLNA/NRP1,3.0,,
GO:0043410,discovery_tumor_LIHC,GO:0043410,positive regulation of MAPK cascade,9/111,474/18870,0.0019409541991516905,0.027474541336267894,0.02114735942330426,APOE/CDH2/CSF1R/DDT/GLIPR2/ICAM1/MARCO/NRP1/PTPRJ,9.0,,
GO:0006094,discovery_tumor_LIHC,GO:0006094,gluconeogenesis,4/111,90/18870,0.0019646777548305338,0.02765143605798631,0.02128351661022431,ADIPOQ/ALDOB/ENO1/GOT1,4.0,,
GO:0097006,discovery_tumor_LIHC,GO:0097006,regulation of plasma lipoprotein particle levels,4/111,91/18870,0.002045808388967144,0.028504483219931463,0.021940113374402874,ADIPOQ/AGT/APOE/PLA2G7,4.0,,
GO:0001906,discovery_tumor_LIHC,GO:0001906,cell killing,6/111,223/18870,0.002057418765453725,0.028504483219931463,0.021940113374402874,C7/CADM1/CD5L/FCGR3A/ICAM1/PVR,6.0,,
GO:0010712,discovery_tumor_LIHC,GO:0010712,regulation of collagen metabolic process,3/111,43/18870,0.002060007313498904,0.028504483219931463,0.021940113374402874,CST3/ENG/ITGB1,3.0,,
GO:0002697,discovery_tumor_LIHC,GO:0002697,regulation of immune effector process,8/111,389/18870,0.0021171002660343293,0.028683812669379166,0.022078144589418924,AXL/CADM1/CD5L/COLEC11/ICAM1/PTPRJ/PVR/TFRC,8.0,,
GO:0030516,discovery_tumor_LIHC,GO:0030516,regulation of axon extension,4/111,92/18870,0.002129226810447669,0.028683812669379166,0.022078144589418924,APOE/CDH1/NRP1/OLFM1,4.0,,
GO:0034650,discovery_tumor_LIHC,GO:0034650,cortisol metabolic process,2/111,12/18870,0.002177780336652011,0.028683812669379166,0.022078144589418924,DKK3/H6PD,2.0,,
GO:0070327,discovery_tumor_LIHC,GO:0070327,thyroid hormone transport,2/111,12/18870,0.002177780336652011,0.028683812669379166,0.022078144589418924,SERPINA7/SLC3A2,2.0,,
GO:0071679,discovery_tumor_LIHC,GO:0071679,commissural neuron axon guidance,2/111,12/18870,0.002177780336652011,0.028683812669379166,0.022078144589418924,NCAM1/NRP1,2.0,,
GO:0072310,discovery_tumor_LIHC,GO:0072310,glomerular epithelial cell development,2/111,12/18870,0.002177780336652011,0.028683812669379166,0.022078144589418924,ADIPOQ/PODXL,2.0,,
GO:0097084,discovery_tumor_LIHC,GO:0097084,vascular associated smooth muscle cell development,2/111,12/18870,0.002177780336652011,0.028683812669379166,0.022078144589418924,COMP/ENG,2.0,,
GO:1900121,discovery_tumor_LIHC,GO:1900121,negative regulation of receptor binding,2/111,12/18870,0.002177780336652011,0.028683812669379166,0.022078144589418924,ADIPOQ/PTPRF,2.0,,
GO:2001046,discovery_tumor_LIHC,GO:2001046,positive regulation of integrin-mediated signaling pathway,2/111,12/18870,0.002177780336652011,0.028683812669379166,0.022078144589418924,FLNA/LAMB1,2.0,,
GO:0071526,discovery_tumor_LIHC,GO:0071526,semaphorin-plexin signaling pathway,3/111,44/18870,0.0022013439090009033,0.028839947063134176,0.022198322397035983,FLNA/NCAM1/NRP1,3.0,,
GO:0019319,discovery_tumor_LIHC,GO:0019319,hexose biosynthetic process,4/111,93/18870,0.0022149657351315803,0.028864870929254403,0.022217506482717773,ADIPOQ/ALDOB/ENO1/GOT1,4.0,,
GO:0009743,discovery_tumor_LIHC,GO:0009743,response to carbohydrate,6/111,230/18870,0.002401256257862472,0.031127864016396146,0.023959349143547432,ACE/ADIPOQ/HNF4A/ICAM1/SERPINF1/SOD2,6.0,,
GO:0010976,discovery_tumor_LIHC,GO:0010976,positive regulation of neuron projection development,5/111,158/18870,0.0024272659310127323,0.03130029313133172,0.024092069119613837,APOE/CNTN1/FLNA/NRP1/SERPINF1,5.0,,
GO:0010594,discovery_tumor_LIHC,GO:0010594,regulation of endothelial cell migration,6/111,231/18870,0.002453703628910766,0.031476416864620924,0.024227632870988433,AGT/APOE/CALR/MMRN2/NRP1/SERPINF1,6.0,,
GO:0007162,discovery_tumor_LIHC,GO:0007162,negative regulation of cell adhesion,7/111,312/18870,0.0024770600084244167,0.03161139274999657,0.024331524816865967,ADIPOQ/CDH1/CDH13/FBLN1/HSPG2/PODXL/TGFBI,7.0,,
GO:0007411,discovery_tumor_LIHC,GO:0007411,axon guidance,6/111,233/18870,0.0025611822834833396,0.03177001255371802,0.02445361566307505,ALCAM/CNTN1/CSF1R/NCAM1/NRP1/ROBO4,6.0,,
GO:0097485,discovery_tumor_LIHC,GO:0097485,neuron projection guidance,6/111,233/18870,0.0025611822834833396,0.03177001255371802,0.02445361566307505,ALCAM/CNTN1/CSF1R/NCAM1/NRP1/ROBO4,6.0,,
GO:0010642,discovery_tumor_LIHC,GO:0010642,negative regulation of platelet-derived growth factor receptor signaling pathway,2/111,13/18870,0.0025638722813799233,0.03177001255371802,0.02445361566307505,ADIPOQ/PTPRJ,2.0,,
GO:0071285,discovery_tumor_LIHC,GO:0071285,cellular response to lithium ion,2/111,13/18870,0.0025638722813799233,0.03177001255371802,0.02445361566307505,CALR/CDH1,2.0,,
GO:1905065,discovery_tumor_LIHC,GO:1905065,positive regulation of vascular associated smooth muscle cell differentiation,2/111,13/18870,0.0025638722813799233,0.03177001255371802,0.02445361566307505,ENG/SOD2,2.0,,
GO:0001822,discovery_tumor_LIHC,GO:0001822,kidney development,7/111,314/18870,0.002566882865688139,0.03177001255371802,0.02445361566307505,ACE/ADIPOQ/AGT/NRP1/PODXL/SERPINF1/UMOD,7.0,,
GO:0061337,discovery_tumor_LIHC,GO:0061337,cardiac conduction,4/111,97/18870,0.0025817764397657577,0.0317945768557153,0.0244725229895691,AGT/CACNA2D1/DSG2/FLNA,4.0,,
GO:0003044,discovery_tumor_LIHC,GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,3/111,47/18870,0.0026609672330667254,0.03260677758728032,0.025097679951574615,ACE/AGT/SOD2,3.0,,
GO:0098869,discovery_tumor_LIHC,GO:0098869,cellular oxidant detoxification,4/111,99/18870,0.002779946031946143,0.03389607463704629,0.026090061508780633,APOE/GPX3/SOD2/SOD3,4.0,,
GO:0071901,discovery_tumor_LIHC,GO:0071901,negative regulation of protein serine/threonine kinase activity,4/111,100/18870,0.002882833695548296,0.03497743542923868,0.026922392977352768,ADIPOQ/AGT/APOE/PTPRJ,4.0,,
GO:0007160,discovery_tumor_LIHC,GO:0007160,cell-matrix adhesion,6/111,239/18870,0.0029049306010537424,0.03506368658482586,0.026988781135231482,BST1/CDH13/ITGB1/LYVE1/NRP1/PTPRJ,6.0,,
GO:0032908,discovery_tumor_LIHC,GO:0032908,regulation of transforming growth factor beta1 production,2/111,14/18870,0.002979720830711142,0.03506368658482586,0.026988781135231482,AGT/LUM,2.0,,
GO:0034309,discovery_tumor_LIHC,GO:0034309,primary alcohol biosynthetic process,2/111,14/18870,0.002979720830711142,0.03506368658482586,0.026988781135231482,DKK3/H6PD,2.0,,
GO:0010543,discovery_tumor_LIHC,GO:0010543,regulation of platelet activation,3/111,49/18870,0.00299786100733295,0.03506368658482586,0.026988781135231482,APOE/FLNA/GP1BA,3.0,,
GO:0046850,discovery_tumor_LIHC,GO:0046850,regulation of bone remodeling,3/111,49/18870,0.00299786100733295,0.03506368658482586,0.026988781135231482,CSF1R/SPP1/TFRC,3.0,,
GO:0061028,discovery_tumor_LIHC,GO:0061028,establishment of endothelial barrier,3/111,49/18870,0.00299786100733295,0.03506368658482586,0.026988781135231482,CDH5/ICAM1/ROBO4,3.0,,
GO:1900047,discovery_tumor_LIHC,GO:1900047,negative regulation of hemostasis,3/111,49/18870,0.00299786100733295,0.03506368658482586,0.026988781135231482,APOE/COMP/GP1BA,3.0,,
GO:0070665,discovery_tumor_LIHC,GO:0070665,positive regulation of leukocyte proliferation,5/111,166/18870,0.0030038318592765963,0.03506368658482586,0.026988781135231482,BST1/CSF1R/FCGR3A/ICOSLG/TFRC,5.0,,
GO:0072001,discovery_tumor_LIHC,GO:0072001,renal system development,7/111,324/18870,0.0030542638127171277,0.03548420646567116,0.027312458424545914,ACE/ADIPOQ/AGT/NRP1/PODXL/SERPINF1/UMOD,7.0,,
GO:0046364,discovery_tumor_LIHC,GO:0046364,monosaccharide biosynthetic process,4/111,102/18870,0.003096372761603466,0.03580453573628797,0.02755901825375756,ADIPOQ/ALDOB/ENO1/GOT1,4.0,,
GO:0043114,discovery_tumor_LIHC,GO:0043114,regulation of vascular permeability,3/111,50/18870,0.003175680977022927,0.03638001044840684,0.0280019654326477,APOE/CDH5/PTPRJ,3.0,,
GO:0071827,discovery_tumor_LIHC,GO:0071827,plasma lipoprotein particle organization,3/111,50/18870,0.003175680977022927,0.03638001044840684,0.0280019654326477,AGT/APOE/PLA2G7,3.0,,
GO:0019218,discovery_tumor_LIHC,GO:0019218,regulation of steroid metabolic process,4/111,104/18870,0.003320472244702431,0.03786260712362078,0.029143131153553017,APOE/DKK3/H6PD/IGFBP7,4.0,,
GO:0045926,discovery_tumor_LIHC,GO:0045926,negative regulation of growth,6/111,247/18870,0.003415675210362497,0.038170581445644426,0.029380181286666075,CDH1/ENO1/HNF4A/NRP1/PTPRJ/SPP1,6.0,,
GO:0010226,discovery_tumor_LIHC,GO:0010226,response to lithium ion,2/111,15/18870,0.0034249689401085743,0.038170581445644426,0.029380181286666075,CALR/CDH1,2.0,,
GO:0042159,discovery_tumor_LIHC,GO:0042159,lipoprotein catabolic process,2/111,15/18870,0.0034249689401085743,0.038170581445644426,0.029380181286666075,APOE/CTSD,2.0,,
GO:0086069,discovery_tumor_LIHC,GO:0086069,bundle of His cell to Purkinje myocyte communication,2/111,15/18870,0.0034249689401085743,0.038170581445644426,0.029380181286666075,CACNA2D1/DSG2,2.0,,
GO:0090030,discovery_tumor_LIHC,GO:0090030,regulation of steroid hormone biosynthetic process,2/111,15/18870,0.0034249689401085743,0.038170581445644426,0.029380181286666075,DKK3/H6PD,2.0,,
GO:0051896,discovery_tumor_LIHC,GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,6/111,248/18870,0.0034839340497793067,0.03865283587660555,0.02975137611973699,AGT/AXL/CSF1R/ENG/ITGB1/PTPRJ,6.0,,
GO:0031103,discovery_tumor_LIHC,GO:0031103,axon regeneration,3/111,52/18870,0.0035504302844744703,0.03903888299402063,0.03004851946587651,FLNA/PTPRF/SPP1,3.0,,
GO:0050819,discovery_tumor_LIHC,GO:0050819,negative regulation of coagulation,3/111,52/18870,0.0035504302844744703,0.03903888299402063,0.03004851946587651,APOE/GP1BA/PROCR,3.0,,
GO:0016042,discovery_tumor_LIHC,GO:0016042,lipid catabolic process,7/111,334/18870,0.003609669932186543,0.03951385352433536,0.03041410782628287,ADIPOQ/APOE/DPEP2/ENPP2/FUCA1/PLA2G7/SPP1,7.0,,
GO:0050727,discovery_tumor_LIHC,GO:0050727,regulation of inflammatory response,8/111,425/18870,0.0036364629919442863,0.039631010394507865,0.030504284343230836,ADIPOQ/AGT/APOE/BST1/CDH5/DDT/PLA2G7/PSMA1,8.0,,
GO:0007173,discovery_tumor_LIHC,GO:0007173,epidermal growth factor receptor signaling pathway,4/111,107/18870,0.0036769642269520544,0.03989587176644453,0.03070815011704452,AGT/CDH13/EFEMP1/PTPRJ,4.0,,
GO:0071825,discovery_tumor_LIHC,GO:0071825,protein-lipid complex organization,3/111,53/18870,0.00374749918959793,0.04030607206978035,0.031023884350567094,AGT/APOE/PLA2G7,3.0,,
GO:0086002,discovery_tumor_LIHC,GO:0086002,cardiac muscle cell action potential involved in contraction,3/111,53/18870,0.00374749918959793,0.04030607206978035,0.031023884350567094,CACNA2D1/DSG2/FLNA,3.0,,
GO:0010634,discovery_tumor_LIHC,GO:0010634,positive regulation of epithelial cell migration,5/111,176/18870,0.0038563356948006864,0.04051587519128501,0.03118537137829532,AGT/CALR/ENPP2/GLIPR2/NRP1,5.0,,
GO:0043409,discovery_tumor_LIHC,GO:0043409,negative regulation of MAPK cascade,5/111,176/18870,0.0038563356948006864,0.04051587519128501,0.03118537137829532,ADIPOQ/AGT/APOE/FBLN1/PTPRJ,5.0,,
GO:0006004,discovery_tumor_LIHC,GO:0006004,fucose metabolic process,2/111,16/18870,0.0038992626700076623,0.04051587519128501,0.03118537137829532,FUCA1/FUCA2,2.0,,
GO:0006517,discovery_tumor_LIHC,GO:0006517,protein deglycosylation,2/111,16/18870,0.0038992626700076623,0.04051587519128501,0.03118537137829532,AGA/MAN1A1,2.0,,
GO:0006704,discovery_tumor_LIHC,GO:0006704,glucocorticoid biosynthetic process,2/111,16/18870,0.0038992626700076623,0.04051587519128501,0.03118537137829532,DKK3/H6PD,2.0,,
GO:0030852,discovery_tumor_LIHC,GO:0030852,regulation of granulocyte differentiation,2/111,16/18870,0.0038992626700076623,0.04051587519128501,0.03118537137829532,ADIPOQ/C1QC,2.0,,
GO:0034638,discovery_tumor_LIHC,GO:0034638,phosphatidylcholine catabolic process,2/111,16/18870,0.0038992626700076623,0.04051587519128501,0.03118537137829532,ENPP2/PLA2G7,2.0,,
GO:0046184,discovery_tumor_LIHC,GO:0046184,aldehyde biosynthetic process,2/111,16/18870,0.0038992626700076623,0.04051587519128501,0.03118537137829532,DKK3/TKT,2.0,,
GO:0097305,discovery_tumor_LIHC,GO:0097305,response to alcohol,6/111,254/18870,0.003915054119174109,0.04051587519128501,0.03118537137829532,ACE/ADIPOQ/CDH1/H6PD/IGFBP7/SOD2,6.0,,
GO:0019216,discovery_tumor_LIHC,GO:0019216,regulation of lipid metabolic process,7/111,342/18870,0.004106942108574975,0.04232384273397558,0.03257697748312499,ADIPOQ/APOE/DKK3/GOLM1/H6PD/HNF4A/IGFBP7,7.0,,
GO:0006469,discovery_tumor_LIHC,GO:0006469,negative regulation of protein kinase activity,5/111,179/18870,0.004142771296676112,0.042354471142382895,0.03260055239756036,ADIPOQ/AGT/APOE/PTPRJ/YWHAG,5.0,,
GO:1902930,discovery_tumor_LIHC,GO:1902930,regulation of alcohol biosynthetic process,3/111,55/18870,0.004161360426355517,0.042354471142382895,0.03260055239756036,APOE/DKK3/H6PD,3.0,,
GO:0031341,discovery_tumor_LIHC,GO:0031341,regulation of cell killing,4/111,111/18870,0.004191539676666309,0.042354471142382895,0.03260055239756036,CADM1/CD5L/ICAM1/PVR,4.0,,
GO:0060840,discovery_tumor_LIHC,GO:0060840,artery development,4/111,111/18870,0.004191539676666309,0.042354471142382895,0.03260055239756036,APOE/COMP/ENG/NRP1,4.0,,
GO:0031400,discovery_tumor_LIHC,GO:0031400,negative regulation of protein modification process,8/111,437/18870,0.004296895077029554,0.042354471142382895,0.03260055239756036,ADIPOQ/AGT/APOE/CADM1/ENG/FBLN1/PTPRJ/YWHAG,8.0,,
GO:0001936,discovery_tumor_LIHC,GO:0001936,regulation of endothelial cell proliferation,5/111,181/18870,0.004341984587840568,0.042354471142382895,0.03260055239756036,APOE/CDH13/HSPG2/MMRN2/NRP1,5.0,,
GO:0043534,discovery_tumor_LIHC,GO:0043534,blood vessel endothelial cell migration,5/111,181/18870,0.004341984587840568,0.042354471142382895,0.03260055239756036,APOE/CDH5/ITGB1/MMRN2/NRP1,5.0,,
GO:0001954,discovery_tumor_LIHC,GO:0001954,positive regulation of cell-matrix adhesion,3/111,56/18870,0.0043782812295488464,0.042354471142382895,0.03260055239756036,CDH13/NRP1/PTPRJ,3.0,,
GO:0061097,discovery_tumor_LIHC,GO:0061097,regulation of protein tyrosine kinase activity,3/111,56/18870,0.0043782812295488464,0.042354471142382895,0.03260055239756036,ACE/AGT/CSF1R,3.0,,
GO:0006491,discovery_tumor_LIHC,GO:0006491,N-glycan processing,2/111,17/18870,0.004402251162180276,0.042354471142382895,0.03260055239756036,GNPTG/PRKCSH,2.0,,
GO:0021535,discovery_tumor_LIHC,GO:0021535,cell migration in hindbrain,2/111,17/18870,0.004402251162180276,0.042354471142382895,0.03260055239756036,FLNA/ITGB1,2.0,,
GO:0032488,discovery_tumor_LIHC,GO:0032488,Cdc42 protein signal transduction,2/111,17/18870,0.004402251162180276,0.042354471142382895,0.03260055239756036,APOE/NRP1,2.0,,
GO:0032905,discovery_tumor_LIHC,GO:0032905,transforming growth factor beta1 production,2/111,17/18870,0.004402251162180276,0.042354471142382895,0.03260055239756036,AGT/LUM,2.0,,
GO:0033631,discovery_tumor_LIHC,GO:0033631,cell-cell adhesion mediated by integrin,2/111,17/18870,0.004402251162180276,0.042354471142382895,0.03260055239756036,ITGB1/PODXL,2.0,,
GO:0036005,discovery_tumor_LIHC,GO:0036005,response to macrophage colony-stimulating factor,2/111,17/18870,0.004402251162180276,0.042354471142382895,0.03260055239756036,CSF1R/SPP1,2.0,,
GO:0055089,discovery_tumor_LIHC,GO:0055089,fatty acid homeostasis,2/111,17/18870,0.004402251162180276,0.042354471142382895,0.03260055239756036,APOE/GOT1,2.0,,
GO:1901163,discovery_tumor_LIHC,GO:1901163,regulation of trophoblast cell migration,2/111,17/18870,0.004402251162180276,0.042354471142382895,0.03260055239756036,CALR/TIMP1,2.0,,
GO:0043113,discovery_tumor_LIHC,GO:0043113,receptor clustering,3/111,57/18870,0.004601944804048073,0.04410346323879535,0.03394676466144002,APOE/CDH2/FLNA,3.0,,
GO:0048732,discovery_tumor_LIHC,GO:0048732,gland development,8/111,443/18870,0.004660041113069364,0.04448713667244125,0.03424208096547501,CADM1/CDH1/CSF1R/DKK3/NRP1/PRKCSH/SERPINF1/SOD2,8.0,,
GO:0062014,discovery_tumor_LIHC,GO:0062014,negative regulation of small molecule metabolic process,4/111,115/18870,0.004752725870171346,0.044674352337725175,0.03438618225965042,ADIPOQ/ALDOB/APOE/DKK3,4.0,,
GO:0031102,discovery_tumor_LIHC,GO:0031102,neuron projection regeneration,3/111,58/18870,0.004832410920976357,0.044674352337725175,0.03438618225965042,FLNA/PTPRF/SPP1,3.0,,
GO:0048008,discovery_tumor_LIHC,GO:0048008,platelet-derived growth factor receptor signaling pathway,3/111,58/18870,0.004832410920976357,0.044674352337725175,0.03438618225965042,ADIPOQ/NRP1/PTPRJ,3.0,,
GO:0086065,discovery_tumor_LIHC,GO:0086065,cell communication involved in cardiac conduction,3/111,58/18870,0.004832410920976357,0.044674352337725175,0.03438618225965042,CACNA2D1/DSG2/FLNA,3.0,,
GO:0034329,discovery_tumor_LIHC,GO:0034329,cell junction assembly,8/111,446/18870,0.00485025523186818,0.044674352337725175,0.03438618225965042,ACE/AGT/CDH1/CDH13/CDH2/CDH5/NRP1/PTPRJ,8.0,,
GO:0032640,discovery_tumor_LIHC,GO:0032640,tumor necrosis factor production,5/111,186/18870,0.004869815428819542,0.044674352337725175,0.03438618225965042,ADIPOQ/AXL/DDT/FCGR3A/PTPRJ,5.0,,
GO:0032680,discovery_tumor_LIHC,GO:0032680,regulation of tumor necrosis factor production,5/111,186/18870,0.004869815428819542,0.044674352337725175,0.03438618225965042,ADIPOQ/AXL/DDT/FCGR3A/PTPRJ,5.0,,
GO:0010633,discovery_tumor_LIHC,GO:0010633,negative regulation of epithelial cell migration,4/111,116/18870,0.0049005245121349714,0.044674352337725175,0.03438618225965042,APOE/MMRN2/PTPRG/SERPINF1,4.0,,
GO:0019882,discovery_tumor_LIHC,GO:0019882,antigen processing and presentation,4/111,116/18870,0.0049005245121349714,0.044674352337725175,0.03438618225965042,ACE/CALR/CTSD/ICAM1,4.0,,
GO:0002693,discovery_tumor_LIHC,GO:0002693,positive regulation of cellular extravasation,2/111,18/18870,0.004933586616265225,0.044674352337725175,0.03438618225965042,ICAM1/LYVE1,2.0,,
GO:0010042,discovery_tumor_LIHC,GO:0010042,response to manganese ion,2/111,18/18870,0.004933586616265225,0.044674352337725175,0.03438618225965042,SOD2/TFRC,2.0,,
GO:0016264,discovery_tumor_LIHC,GO:0016264,gap junction assembly,2/111,18/18870,0.004933586616265225,0.044674352337725175,0.03438618225965042,ACE/AGT,2.0,,
GO:0045780,discovery_tumor_LIHC,GO:0045780,positive regulation of bone resorption,2/111,18/18870,0.004933586616265225,0.044674352337725175,0.03438618225965042,SPP1/TFRC,2.0,,
GO:0061450,discovery_tumor_LIHC,GO:0061450,trophoblast cell migration,2/111,18/18870,0.004933586616265225,0.044674352337725175,0.03438618225965042,CALR/TIMP1,2.0,,
GO:0008217,discovery_tumor_LIHC,GO:0008217,regulation of blood pressure,5/111,187/18870,0.004980612748762942,0.044770982482493164,0.03446055920292762,ACE/ADIPOQ/AGT/SOD2/UMOD,5.0,,
GO:0008361,discovery_tumor_LIHC,GO:0008361,regulation of cell size,5/111,187/18870,0.004980612748762942,0.044770982482493164,0.03446055920292762,APOE/CDH1/NRP1/OLFM1/SPP1,5.0,,
GO:0098900,discovery_tumor_LIHC,GO:0098900,regulation of action potential,3/111,59/18870,0.005069737606981823,0.0454064135490772,0.0349496552351168,CACNA2D1/DSG2/FLNA,3.0,,
GO:0090287,discovery_tumor_LIHC,GO:0090287,regulation of cellular response to growth factor stimulus,7/111,357/18870,0.0051776506298282735,0.04620490399009797,0.03556425928421327,AGT/CDH5/DKK3/ENG/MMRN2/NRP1/VASN,7.0,,
GO:1990748,discovery_tumor_LIHC,GO:1990748,cellular detoxification,4/111,119/18870,0.005362382692814692,0.04768068076679634,0.03670017567835554,APOE/GPX3/SOD2/SOD3,4.0,,
GO:0071706,discovery_tumor_LIHC,GO:0071706,tumor necrosis factor superfamily cytokine production,5/111,191/18870,0.005441748701028846,0.047926847047108215,0.03688965170068249,ADIPOQ/AXL/DDT/FCGR3A/PTPRJ,5.0,,
GO:1903555,discovery_tumor_LIHC,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,5/111,191/18870,0.005441748701028846,0.047926847047108215,0.03688965170068249,ADIPOQ/AXL/DDT/FCGR3A/PTPRJ,5.0,,
GO:0060977,discovery_tumor_LIHC,GO:0060977,coronary vasculature morphogenesis,2/111,19/18870,0.005492924266464476,0.047926847047108215,0.03688965170068249,ACE/NRP1,2.0,,
GO:0097254,discovery_tumor_LIHC,GO:0097254,renal tubular secretion,2/111,19/18870,0.005492924266464476,0.047926847047108215,0.03688965170068249,AGT/UMOD,2.0,,
GO:1902931,discovery_tumor_LIHC,GO:1902931,negative regulation of alcohol biosynthetic process,2/111,19/18870,0.005492924266464476,0.047926847047108215,0.03688965170068249,APOE/DKK3,2.0,,
GO:0072009,discovery_tumor_LIHC,GO:0072009,nephron epithelium development,4/111,120/18870,0.005522583086158186,0.047926847047108215,0.03688965170068249,ADIPOQ/AGT/PODXL/UMOD,4.0,,
GO:0034113,discovery_tumor_LIHC,GO:0034113,heterotypic cell-cell adhesion,3/111,61/18870,0.0055651962060385505,0.047926847047108215,0.03688965170068249,ADIPOQ/DSG2/ITGB1,3.0,,
GO:0048010,discovery_tumor_LIHC,GO:0048010,vascular endothelial growth factor receptor signaling pathway,3/111,61/18870,0.0055651962060385505,0.047926847047108215,0.03688965170068249,AXL/MMRN2/NRP1,3.0,,
GO:2000351,discovery_tumor_LIHC,GO:2000351,regulation of endothelial cell apoptotic process,3/111,61/18870,0.0055651962060385505,0.047926847047108215,0.03688965170068249,CD248/CDH5/ICAM1,3.0,,
GO:0006006,discovery_tumor_LIHC,GO:0006006,glucose metabolic process,5/111,193/18870,0.005683297259617728,0.04843585173162098,0.037281436403465776,ADIPOQ/ALDOB/ENO1/GOT1/H6PD,5.0,,
GO:0009749,discovery_tumor_LIHC,GO:0009749,response to glucose,5/111,193/18870,0.005683297259617728,0.04843585173162098,0.037281436403465776,ACE/ADIPOQ/HNF4A/ICAM1/SERPINF1,5.0,,
GO:0033673,discovery_tumor_LIHC,GO:0033673,negative regulation of kinase activity,5/111,193/18870,0.005683297259617728,0.04843585173162098,0.037281436403465776,ADIPOQ/AGT/APOE/PTPRJ/YWHAG,5.0,,
GO:1903053,discovery_tumor_LIHC,GO:1903053,regulation of extracellular matrix organization,3/111,62/18870,0.0058234356526175824,0.04945904142205899,0.03806899314106811,AGT/CST3/LAMB1,3.0,,
HALLMARK_COAGULATION,discovery_tumor_OVCA,HALLMARK_COAGULATION,HALLMARK_COAGULATION,3/5,138/4383,0.0002916227611957611,0.002916227611957611,0.002455770620595883,C2/CFB/F9,3.0,,
hsa04610,discovery_tumor_OVCA,hsa04610,Complement and coagulation cascades,5/7,88/8843,1.7992314530823095e-09,3.598462906164619e-08,2.4621061989547394e-08,C2/C6/CFB/CFHR5/F9,5.0,Organismal Systems,Immune system
hsa05171,discovery_tumor_OVCA,hsa05171,Coronavirus disease - COVID-19,3/7,238/8843,0.0006219217900950466,0.006219217900950466,0.004255254353281898,C2/C6/CFB,3.0,Human Diseases,Infectious disease: viral
hsa05150,discovery_tumor_OVCA,hsa05150,Staphylococcus aureus infection,2/7,100/8843,0.002562273034910832,0.01708182023273888,0.011687561211873969,C2/CFB,2.0,Human Diseases,Infectious disease: bacterial
hsa05322,discovery_tumor_OVCA,hsa05322,Systemic lupus erythematosus,2/7,139/8843,0.004891804630106568,0.02445902315053284,0.016735121102996155,C2/C6,2.0,Human Diseases,Immune disease
R-HSA-977606,discovery_tumor_OVCA,R-HSA-977606,Regulation of Complement cascade,4/9,47/11009,3.616921440045284e-08,1.1574148608144908e-06,4.949471444272494e-07,C2/C6/CFB/CFHR5,4.0,,
R-HSA-166658,discovery_tumor_OVCA,R-HSA-166658,Complement cascade,4/9,58/11009,8.568997139076161e-08,1.3710395422521858e-06,5.862998042525794e-07,C2/C6/CFB/CFHR5,4.0,,
R-HSA-166663,discovery_tumor_OVCA,R-HSA-166663,Initial triggering of complement,2/9,23/11009,0.00014898022130300365,0.0015891223605653722,0.0006795589041891394,C2/CFB,2.0,,
R-HSA-159740,discovery_tumor_OVCA,R-HSA-159740,Gamma-carboxylation of protein precursors,1/9,10/11009,0.00814843921178321,0.04162919547015847,0.0178019585892125,F9,1.0,,
R-HSA-159782,discovery_tumor_OVCA,R-HSA-159782,Removal of aminoterminal propeptides from gamma-carboxylated proteins,1/9,10/11009,0.00814843921178321,0.04162919547015847,0.0178019585892125,F9,1.0,,
R-HSA-159854,discovery_tumor_OVCA,R-HSA-159854,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",1/9,11/11009,0.008960027905945633,0.04162919547015847,0.0178019585892125,F9,1.0,,
R-HSA-3371568,discovery_tumor_OVCA,R-HSA-3371568,Attenuation phase,1/9,14/11009,0.01139125336939617,0.04162919547015847,0.0178019585892125,HSPA1L,1.0,,
R-HSA-2022857,discovery_tumor_OVCA,R-HSA-2022857,Keratan sulfate degradation,1/9,15/11009,0.012200482902791077,0.04162919547015847,0.0178019585892125,OGN,1.0,,
R-HSA-9651496,discovery_tumor_OVCA,R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),1/9,16/11009,0.01300912358442452,0.04162919547015847,0.0178019585892125,F9,1.0,,
R-HSA-9671793,discovery_tumor_OVCA,R-HSA-9671793,Diseases of hemostasis,1/9,16/11009,0.01300912358442452,0.04162919547015847,0.0178019585892125,F9,1.0,,
R-HSA-9629569,discovery_tumor_OVCA,R-HSA-9629569,Protein hydroxylation,1/9,20/11009,0.016237805289520346,0.047237251751331914,0.02020014055155641,F9,1.0,,
R-HSA-140837,discovery_tumor_OVCA,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,1/9,23/11009,0.018653151977600868,0.04789438849626776,0.020481152975377656,F9,1.0,,
R-HSA-3371571,discovery_tumor_OVCA,R-HSA-3371571,HSF1-dependent transactivation,1/9,24/11009,0.019457095326608775,0.04789438849626776,0.020481152975377656,HSPA1L,1.0,,
GO:0006956,discovery_tumor_OVCA,GO:0006956,complement activation,4/13,67/18870,1.0130143989843966e-07,2.2083713897859846e-05,1.5675064910600662e-05,C2/C6/CFB/CFHR5,4.0,,
GO:0006959,discovery_tumor_OVCA,GO:0006959,humoral immune response,5/13,258/18870,5.408870989752355e-07,5.895669378830067e-05,4.184758081545243e-05,C2/C6/CFB/CFHR5/RARRES2,5.0,,
GO:0006957,discovery_tumor_OVCA,GO:0006957,"complement activation, alternative pathway",2/13,18/18870,6.66183969753646e-05,0.004840936846876495,0.003436106791360911,CFB/CFHR5,2.0,,
GO:0006958,discovery_tumor_OVCA,GO:0006958,"complement activation, classical pathway",2/13,42/18870,0.0003714112300904963,0.014730372026546479,0.010455647937722513,C2/C6,2.0,,
GO:0007596,discovery_tumor_OVCA,GO:0007596,blood coagulation,3/13,224/18870,0.000432313417431084,0.014730372026546479,0.010455647937722513,CLIC1/F9/FGL1,3.0,,
GO:0050817,discovery_tumor_OVCA,GO:0050817,coagulation,3/13,229/18870,0.00046112928561831465,0.014730372026546479,0.010455647937722513,CLIC1/F9/FGL1,3.0,,
GO:0007599,discovery_tumor_OVCA,GO:0007599,hemostasis,3/13,231/18870,0.0004729935971826851,0.014730372026546479,0.010455647937722513,CLIC1/F9/FGL1,3.0,,
GO:0002455,discovery_tumor_OVCA,GO:0002455,humoral immune response mediated by circulating immunoglobulin,2/13,55/18870,0.000637359534389983,0.017368047312127037,0.012327875204648356,C2/C6,2.0,,
GO:0070527,discovery_tumor_OVCA,GO:0070527,platelet aggregation,2/13,72/18870,0.0010898090510801969,0.026397597015053658,0.01873706789576479,CLIC1/FGL1,2.0,,
GO:0031640,discovery_tumor_OVCA,GO:0031640,killing of cells of another organism,2/13,92/18870,0.001770984286522846,0.031870908530437295,0.02262203550929156,C6/CFHR5,2.0,,
GO:0141061,discovery_tumor_OVCA,GO:0141061,disruption of cell in another organism,2/13,92/18870,0.001770984286522846,0.031870908530437295,0.02262203550929156,C6/CFHR5,2.0,,
GO:0050878,discovery_tumor_OVCA,GO:0050878,regulation of body fluid levels,3/13,365/18870,0.0017772093266126617,0.031870908530437295,0.02262203550929156,CLIC1/F9/FGL1,3.0,,
GO:0034109,discovery_tumor_OVCA,GO:0034109,homotypic cell-cell adhesion,2/13,96/18870,0.0019262186766286927,0.031870908530437295,0.02262203550929156,CLIC1/FGL1,2.0,,
GO:0141060,discovery_tumor_OVCA,GO:0141060,disruption of anatomical structure in another organism,2/13,99/18870,0.002046755593697808,0.031870908530437295,0.02262203550929156,C6/CFHR5,2.0,,
GO:0042060,discovery_tumor_OVCA,GO:0042060,wound healing,3/13,423/18870,0.0027058188387213225,0.039324567122749884,0.027912657494177852,CLIC1/F9/FGL1,3.0,,
GO:0030168,discovery_tumor_OVCA,GO:0030168,platelet activation,2/13,133/18870,0.0036550748128655356,0.04980039432529292,0.03534842088758117,CLIC1/FGL1,2.0,,
HALLMARK_COAGULATION,discovery_tumor_PAAD,HALLMARK_COAGULATION,HALLMARK_COAGULATION,8/19,138/4383,4.4515457709491825e-08,4.6816254239391917e-07,4.2240229388925037e-07,APOC2/C3/C8G/CFI/DPP4/F8/LTA4H/MBL2,8.0,,
HALLMARK_COMPLEMENT,discovery_tumor_PAAD,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,9/19,200/4383,4.458690879942087e-08,4.6816254239391917e-07,4.2240229388925037e-07,C3/C4BPB/CP/DPP4/F8/LTA4H/PCSK9/S100A9/TIMP2,9.0,,
hsa04610,discovery_tumor_PAAD,hsa04610,Complement and coagulation cascades,8/26,88/8843,9.391552824664404e-11,5.82276275129193e-09,4.942922539297055e-09,C3/C4BPA/C4BPB/C8G/CFI/F8/MASP1/MBL2,8.0,Organismal Systems,Immune system
hsa05150,discovery_tumor_PAAD,hsa05150,Staphylococcus aureus infection,5/26,100/8843,9.110975219505933e-06,0.0002824402318046839,0.00023976250577647192,C3/CFI/FCGR3B/MASP1/MBL2,5.0,Human Diseases,Infectious disease: bacterial
hsa05133,discovery_tumor_PAAD,hsa05133,Pertussis,4/26,78/8843,7.226351654610624e-05,0.0012481437943872161,0.0010595448169670766,C3/C4BPA/C4BPB/CD14,4.0,Human Diseases,Infectious disease: bacterial
hsa04145,discovery_tumor_PAAD,hsa04145,Phagosome,5/26,157/8843,8.052540608949781e-05,0.0012481437943872161,0.0010595448169670766,C3/CD14/FCGR3B/MBL2/THBS4,5.0,Cellular Processes,Transport and catabolism
hsa05146,discovery_tumor_PAAD,hsa05146,Amoebiasis,3/26,103/8843,0.003284224684305021,0.040724386085382265,0.03457078615057917,C8G/CD14/PRDX1,3.0,Human Diseases,Infectious disease: parasitic
hsa05171,discovery_tumor_PAAD,hsa05171,Coronavirus disease - COVID-19,4/26,238/8843,0.004798840098134696,0.049588014347391865,0.04209508858012891,C3/C8G/MASP1/MBL2,4.0,Human Diseases,Infectious disease: viral
R-HSA-166658,discovery_tumor_PAAD,R-HSA-166658,Complement cascade,7/31,58/11009,1.8477157884431552e-10,2.9009137878557537e-08,1.983863267591598e-08,C3/C4BPA/C4BPB/C8G/CFI/MASP1/MBL2,7.0,,
R-HSA-977606,discovery_tumor_PAAD,R-HSA-977606,Regulation of Complement cascade,5/31,47/11009,1.7819689756599992e-07,1.3988456458930994e-05,9.566359764069468e-06,C3/C4BPA/C4BPB/C8G/CFI,5.0,,
R-HSA-8957275,discovery_tumor_PAAD,R-HSA-8957275,Post-translational protein phosphorylation,5/31,108/11009,1.1480402352508251e-05,0.0005034294258761173,0.00034428294629141107,C3/CP/MFGE8/PCSK9/RCN1,5.0,,
R-HSA-5602498,discovery_tumor_PAAD,R-HSA-5602498,MyD88 deficiency (TLR2/4),3/31,17/11009,1.3386175243409143e-05,0.0005034294258761173,0.00034428294629141107,CD14/S100A8/S100A9,3.0,,
R-HSA-5603041,discovery_tumor_PAAD,R-HSA-5603041,IRAK4 deficiency (TLR2/4),3/31,18/11009,1.6032784263570615e-05,0.0005034294258761173,0.00034428294629141107,CD14/S100A8/S100A9,3.0,,
R-HSA-381426,discovery_tumor_PAAD,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),5/31,125/11009,2.3357159221673755e-05,0.0005827548711448323,0.00039853165844299624,C3/CP/MFGE8/PCSK9/RCN1,5.0,,
R-HSA-5686938,discovery_tumor_PAAD,R-HSA-5686938,Regulation of TLR by endogenous ligand,3/31,21/11009,2.5982701261234563e-05,0.0005827548711448323,0.00039853165844299624,CD14/S100A8/S100A9,3.0,,
R-HSA-166663,discovery_tumor_PAAD,R-HSA-166663,Initial triggering of complement,3/31,23/11009,3.4466249955775104e-05,0.0006764001553820864,0.0004625733546696132,C3/MASP1/MBL2,3.0,,
R-HSA-6798695,discovery_tumor_PAAD,R-HSA-6798695,Neutrophil degranulation,8/31,480/11009,4.0003252368662483e-05,0.0006978345135422232,0.0004772317826436928,C3/CD14/FCGR3B/LRG1/LTA4H/S100A8/S100A9/TIMP2,8.0,,
R-HSA-5260271,discovery_tumor_PAAD,R-HSA-5260271,Diseases of Immune System,3/31,31/11009,8.615456676818547e-05,0.0012296606347822836,0.0008409345273066907,CD14/S100A8/S100A9,3.0,,
R-HSA-5602358,discovery_tumor_PAAD,R-HSA-5602358,Diseases associated with the TLR signaling cascade,3/31,31/11009,8.615456676818547e-05,0.0012296606347822836,0.0008409345273066907,CD14/S100A8/S100A9,3.0,,
R-HSA-166786,discovery_tumor_PAAD,R-HSA-166786,Creation of C4 and C2 activators,2/31,14/11009,0.0006837759818044346,0.008946069095274687,0.006117995626671258,MASP1/MBL2,2.0,,
R-HSA-9818027,discovery_tumor_PAAD,R-HSA-9818027,NFE2L2 regulating anti-oxidant/detoxification enzymes,2/31,19/11009,0.0012736769174394715,0.015382098156769,0.010519436888973771,PRDX1/TXN,2.0,,
R-HSA-5628897,discovery_tumor_PAAD,R-HSA-5628897,TP53 Regulates Metabolic Genes,3/31,87/11009,0.0018261365639229605,0.019996112975774805,0.013674847626745089,PRDX1/TXN/YWHAH,3.0,,
R-HSA-1236974,discovery_tumor_PAAD,R-HSA-1236974,ER-Phagosome pathway,3/31,90/11009,0.0020124999485472347,0.019996112975774805,0.013674847626745089,CD14/S100A8/S100A9,3.0,,
R-HSA-5668599,discovery_tumor_PAAD,R-HSA-5668599,RHO GTPases Activate NADPH Oxidases,2/31,24/11009,0.0020378204306522093,0.019996112975774805,0.013674847626745089,S100A8/S100A9,2.0,,
R-HSA-9660826,discovery_tumor_PAAD,R-HSA-9660826,Purinergic signaling in leishmaniasis infection,2/31,26/11009,0.0023912142108520047,0.02085670172798693,0.014263383012099676,C3/TXN,2.0,,
R-HSA-9664424,discovery_tumor_PAAD,R-HSA-9664424,Cell recruitment (pro-inflammatory response),2/31,26/11009,0.0023912142108520047,0.02085670172798693,0.014263383012099676,C3/TXN,2.0,,
R-HSA-1236975,discovery_tumor_PAAD,R-HSA-1236975,Antigen processing-Cross presentation,3/31,105/11009,0.0031211019397032226,0.025790158133337158,0.01763725195843372,CD14/S100A8/S100A9,3.0,,
R-HSA-166058,discovery_tumor_PAAD,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,3/31,113/11009,0.0038394913466636583,0.028210770022371205,0.01929264862408222,CD14/S100A8/S100A9,3.0,,
R-HSA-168188,discovery_tumor_PAAD,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,3/31,113/11009,0.0038394913466636583,0.028210770022371205,0.01929264862408222,CD14/S100A8/S100A9,3.0,,
R-HSA-168179,discovery_tumor_PAAD,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,3/31,116/11009,0.00413278796506075,0.028210770022371205,0.01929264862408222,CD14/S100A8/S100A9,3.0,,
R-HSA-181438,discovery_tumor_PAAD,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,3/31,116/11009,0.00413278796506075,0.028210770022371205,0.01929264862408222,CD14/S100A8/S100A9,3.0,,
R-HSA-3299685,discovery_tumor_PAAD,R-HSA-3299685,Detoxification of Reactive Oxygen Species,2/31,37/11009,0.00480671588547246,0.03144393308413234,0.021503728961324162,PRDX1/TXN,2.0,,
R-HSA-166016,discovery_tumor_PAAD,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,3/31,146/11009,0.007826630905537821,0.04915124208677752,0.03361332009957296,CD14/S100A8/S100A9,3.0,,
GO:0006956,discovery_tumor_PAAD,GO:0006956,complement activation,7/32,67/18870,1.6169186716245934e-11,1.2789826692550534e-08,8.084593358122968e-09,C3/C4BPA/C4BPB/C8G/CFI/MASP1/MBL2,7.0,,
GO:0006958,discovery_tumor_PAAD,GO:0006958,"complement activation, classical pathway",6/32,42/18870,7.270908544755637e-11,2.8756443294508543e-08,1.817727136188909e-08,C3/C4BPA/C4BPB/C8G/CFI/MBL2,6.0,,
GO:0002455,discovery_tumor_PAAD,GO:0002455,humoral immune response mediated by circulating immunoglobulin,6/32,55/18870,3.956776721929274e-10,1.043270129015352e-07,6.594627869882123e-08,C3/C4BPA/C4BPB/C8G/CFI/MBL2,6.0,,
GO:0006959,discovery_tumor_PAAD,GO:0006959,humoral immune response,8/32,258/18870,8.677533952172108e-09,1.7159823390420344e-06,1.0846917440215135e-06,C3/C4BPA/C4BPB/C8G/CFI/MASP1/MBL2/S100A9,8.0,,
GO:1903027,discovery_tumor_PAAD,GO:1903027,regulation of opsonization,3/32,11/18870,7.242076938056051e-07,0.00011456965716004672,7.242076938056052e-05,C4BPA/C4BPB/MBL2,3.0,,
GO:0030593,discovery_tumor_PAAD,GO:0030593,neutrophil chemotaxis,5/32,107/18870,9.511163158177549e-07,0.00011772764750403049,7.441697060937452e-05,CCL18/DPP4/S100A8/S100A9/THBS4,5.0,,
GO:0016064,discovery_tumor_PAAD,GO:0016064,immunoglobulin mediated immune response,6/32,205/18870,1.0939943630590075e-06,0.00011772764750403049,7.441697060937452e-05,C3/C4BPA/C4BPB/C8G/CFI/MBL2,6.0,,
GO:0019724,discovery_tumor_PAAD,GO:0019724,B cell mediated immunity,6/32,208/18870,1.1906715297499922e-06,0.00011772764750403049,7.441697060937452e-05,C3/C4BPA/C4BPB/C8G/CFI/MBL2,6.0,,
GO:0002449,discovery_tumor_PAAD,GO:0002449,lymphocyte mediated immunity,7/32,368/18870,2.2404545782870317e-06,0.0001435133237062031,9.071638666637365e-05,C3/C4BPA/C4BPB/C8G/CFI/MBL2/PRDX1,7.0,,
GO:1990266,discovery_tumor_PAAD,GO:1990266,neutrophil migration,5/32,129/18870,2.398568741341244e-06,0.0001435133237062031,9.071638666637365e-05,CCL18/DPP4/S100A8/S100A9/THBS4,5.0,,
GO:0017014,discovery_tumor_PAAD,GO:0017014,protein nitrosylation,3/32,16/18870,2.443787029076592e-06,0.0001435133237062031,9.071638666637365e-05,S100A8/S100A9/TXN,3.0,,
GO:0018119,discovery_tumor_PAAD,GO:0018119,peptidyl-cysteine S-nitrosylation,3/32,16/18870,2.443787029076592e-06,0.0001435133237062031,9.071638666637365e-05,S100A8/S100A9/TXN,3.0,,
GO:0071621,discovery_tumor_PAAD,GO:0071621,granulocyte chemotaxis,5/32,130/18870,2.4915324324664743e-06,0.0001435133237062031,9.071638666637365e-05,CCL18/DPP4/S100A8/S100A9/THBS4,5.0,,
GO:0006909,discovery_tumor_PAAD,GO:0006909,phagocytosis,6/32,237/18870,2.5400588266584618e-06,0.0001435133237062031,9.071638666637365e-05,C3/C4BPA/C4BPB/CD14/MBL2/MFGE8,6.0,,
GO:0008228,discovery_tumor_PAAD,GO:0008228,opsonization,3/32,17/18870,2.9640363213322765e-06,0.00015630351534492206,9.88012107110759e-05,C4BPA/C4BPB/MBL2,3.0,,
GO:0006898,discovery_tumor_PAAD,GO:0006898,receptor-mediated endocytosis,6/32,258/18870,4.1448421035081025e-06,0.00020491063149218183,0.00012952631573462823,APOC2/C3/CD14/DPP4/EPS15/PCSK9,6.0,,
GO:0097530,discovery_tumor_PAAD,GO:0097530,granulocyte migration,5/32,156/18870,6.089287217457906e-06,0.000283330952294659,0.000179096682866409,CCL18/DPP4/S100A8/S100A9/THBS4,5.0,,
GO:0030449,discovery_tumor_PAAD,GO:0030449,regulation of complement activation,3/32,22/18870,6.674088992111799e-06,0.00029328913293113514,0.0001853913608919944,C3/C4BPA/C4BPB,3.0,,
GO:0002443,discovery_tumor_PAAD,GO:0002443,leukocyte mediated immunity,7/32,466/18870,1.0554122007883091e-05,0.0004393847635913434,0.0002777400528390288,C3/C4BPA/C4BPB/C8G/CFI/MBL2/PRDX1,7.0,,
GO:0006910,discovery_tumor_PAAD,GO:0006910,"phagocytosis, recognition",3/32,29/18870,1.570854227123384e-05,0.0006212728468272984,0.000392713556780846,C4BPA/C4BPB/MBL2,3.0,,
GO:0002460,discovery_tumor_PAAD,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,6/32,380/18870,3.729598368315352e-05,0.0014048153853987826,0.0008879996115036554,C3/C4BPA/C4BPB/C8G/CFI/MBL2,6.0,,
GO:0030595,discovery_tumor_PAAD,GO:0030595,leukocyte chemotaxis,5/32,240/18870,4.8560174814650666e-05,0.0017372486198063504,0.001098134399371903,CCL18/DPP4/S100A8/S100A9/THBS4,5.0,,
GO:0097529,discovery_tumor_PAAD,GO:0097529,myeloid leukocyte migration,5/32,242/18870,5.051418237110753e-05,0.0017372486198063504,0.001098134399371903,CCL18/DPP4/S100A8/S100A9/THBS4,5.0,,
GO:0018198,discovery_tumor_PAAD,GO:0018198,peptidyl-cysteine modification,3/32,45/18870,5.988858119346508e-05,0.00197382782183462,0.001247678774863856,S100A8/S100A9/TXN,3.0,,
GO:0002920,discovery_tumor_PAAD,GO:0002920,regulation of humoral immune response,3/32,47/18870,6.827759108148023e-05,0.0021603029818180342,0.0013655518216296044,C3/C4BPA/C4BPB,3.0,,
GO:0030100,discovery_tumor_PAAD,GO:0030100,regulation of endocytosis,5/32,291/18870,0.00012061406789664617,0.0036694510656248894,0.0023195013057047344,APOC2/C3/CD14/MBL2/PCSK9,5.0,,
GO:0045807,discovery_tumor_PAAD,GO:0045807,positive regulation of endocytosis,4/32,155/18870,0.00013163940803895152,0.0038565471021781727,0.0024377668155361396,C3/CD14/MBL2/PCSK9,4.0,,
GO:0001867,discovery_tumor_PAAD,GO:0001867,"complement activation, lectin pathway",2/32,11/18870,0.00015177833003529736,0.0040018886352640075,0.0025296388339216226,MASP1/MBL2,2.0,,
GO:0002924,discovery_tumor_PAAD,GO:0002924,negative regulation of humoral immune response mediated by circulating immunoglobulin,2/32,11/18870,0.00015177833003529736,0.0040018886352640075,0.0025296388339216226,C4BPA/C4BPB,2.0,,
GO:0019065,discovery_tumor_PAAD,GO:0019065,receptor-mediated endocytosis of virus by host cell,2/32,11/18870,0.00015177833003529736,0.0040018886352640075,0.0025296388339216226,DPP4/EPS15,2.0,,
GO:0002712,discovery_tumor_PAAD,GO:0002712,regulation of B cell mediated immunity,3/32,64/18870,0.00017203697348771752,0.004252538938399518,0.0026880777107455866,C3/C4BPA/C4BPB,3.0,,
GO:0002889,discovery_tumor_PAAD,GO:0002889,regulation of immunoglobulin mediated immune response,3/32,64/18870,0.00017203697348771752,0.004252538938399518,0.0026880777107455866,C3/C4BPA/C4BPB,3.0,,
GO:0051238,discovery_tumor_PAAD,GO:0051238,sequestering of metal ion,2/32,12/18870,0.0001819410965612846,0.004361072950908367,0.002756683281231585,S100A8/S100A9,2.0,,
GO:0060326,discovery_tumor_PAAD,GO:0060326,cell chemotaxis,5/32,325/18870,0.00020195507286898794,0.004591938566467066,0.0029026160344292453,CCL18/DPP4/S100A8/S100A9/THBS4,5.0,,
GO:0045916,discovery_tumor_PAAD,GO:0045916,negative regulation of complement activation,2/32,13/18870,0.00021479358654776415,0.004591938566467066,0.0029026160344292453,C4BPA/C4BPB,2.0,,
GO:0070486,discovery_tumor_PAAD,GO:0070486,leukocyte aggregation,2/32,13/18870,0.00021479358654776415,0.004591938566467066,0.0029026160344292453,S100A8/S100A9,2.0,,
GO:0075509,discovery_tumor_PAAD,GO:0075509,endocytosis involved in viral entry into host cell,2/32,13/18870,0.00021479358654776415,0.004591938566467066,0.0029026160344292453,DPP4/EPS15,2.0,,
GO:1903727,discovery_tumor_PAAD,GO:1903727,positive regulation of phospholipid metabolic process,2/32,14/18870,0.000250327162835443,0.005210757521127247,0.003293778458361092,ADGRF5/APOC2,2.0,,
GO:0002713,discovery_tumor_PAAD,GO:0002713,negative regulation of B cell mediated immunity,2/32,16/18870,0.00032940312556870027,0.006513946808121047,0.004117539069608753,C4BPA/C4BPB,2.0,,
GO:0002890,discovery_tumor_PAAD,GO:0002890,negative regulation of immunoglobulin mediated immune response,2/32,16/18870,0.00032940312556870027,0.006513946808121047,0.004117539069608753,C4BPA/C4BPB,2.0,,
GO:0002921,discovery_tumor_PAAD,GO:0002921,negative regulation of humoral immune response,2/32,17/18870,0.00037292833746835,0.0070234836889872575,0.004439623065099405,C4BPA/C4BPB,2.0,,
GO:0043129,discovery_tumor_PAAD,GO:0043129,surfactant homeostasis,2/32,17/18870,0.00037292833746835,0.0070234836889872575,0.004439623065099405,ADGRF5/MBL2,2.0,,
GO:0002923,discovery_tumor_PAAD,GO:0002923,regulation of humoral immune response mediated by circulating immunoglobulin,2/32,18/18870,0.000419100286498281,0.007534280150457733,0.004762503255662284,C4BPA/C4BPB,2.0,,
GO:0006957,discovery_tumor_PAAD,GO:0006957,"complement activation, alternative pathway",2/32,18/18870,0.000419100286498281,0.007534280150457733,0.004762503255662284,C3/C8G,2.0,,
GO:0002523,discovery_tumor_PAAD,GO:0002523,leukocyte migration involved in inflammatory response,2/32,19/18870,0.0004679104350346966,0.008046025089400978,0.0050859829895075715,S100A8/S100A9,2.0,,
GO:0002544,discovery_tumor_PAAD,GO:0002544,chronic inflammatory response,2/32,19/18870,0.0004679104350346966,0.008046025089400978,0.0050859829895075715,S100A8/S100A9,2.0,,
GO:0050900,discovery_tumor_PAAD,GO:0050900,leukocyte migration,5/32,396/18870,0.0005009724350297355,0.008431259491670654,0.005329493989678037,CCL18/DPP4/S100A8/S100A9/THBS4,5.0,,
GO:0001906,discovery_tumor_PAAD,GO:0001906,cell killing,4/32,223/18870,0.0005265425816232068,0.008676982959665763,0.0054848185585750706,C3/C8G/MBL2/PRDX1,4.0,,
GO:0010985,discovery_tumor_PAAD,GO:0010985,negative regulation of lipoprotein particle clearance,2/32,21/18870,0.0005734112790363432,0.009256496361586684,0.005851135500370849,APOC2/PCSK9,2.0,,
GO:0098869,discovery_tumor_PAAD,GO:0098869,cellular oxidant detoxification,3/32,99/18870,0.0006220975529305341,0.009841583287361049,0.006220975529305341,PRDX1/S100A9/TXN,3.0,,
GO:0043171,discovery_tumor_PAAD,GO:0043171,peptide catabolic process,2/32,23/18870,0.0006893629635517085,0.01048627123402695,0.006628490034151042,ERAP1/LTA4H,2.0,,
GO:0046794,discovery_tumor_PAAD,GO:0046794,transport of virus,2/32,23/18870,0.0006893629635517085,0.01048627123402695,0.006628490034151042,DPP4/EPS15,2.0,,
GO:0006641,discovery_tumor_PAAD,GO:0006641,triglyceride metabolic process,3/32,106/18870,0.0007590317213631652,0.01132819040751441,0.007160676616633634,APOC2/C3/PCSK9,3.0,,
GO:0002526,discovery_tumor_PAAD,GO:0002526,acute inflammatory response,3/32,107/18870,0.0007800299680923766,0.011425994532612406,0.007222499704559043,C3/F8/MBL2,3.0,,
GO:0001919,discovery_tumor_PAAD,GO:0001919,regulation of receptor recycling,2/32,25/18870,0.0008156978973980095,0.011731218851669554,0.007415435430890995,EPS15/PCSK9,2.0,,
GO:0048259,discovery_tumor_PAAD,GO:0048259,regulation of receptor-mediated endocytosis,3/32,115/18870,0.0009614386039377063,0.013580320280620102,0.008584273249443806,APOC2/C3/PCSK9,3.0,,
GO:1990748,discovery_tumor_PAAD,GO:1990748,cellular detoxification,3/32,119/18870,0.0010613527454691627,0.014506489675414853,0.009169715344762866,PRDX1/S100A9/TXN,3.0,,
GO:0006935,discovery_tumor_PAAD,GO:0006935,chemotaxis,5/32,468/18870,0.0010636869799924924,0.014506489675414853,0.009169715344762866,CCL18/DPP4/S100A8/S100A9/THBS4,5.0,,
GO:0042330,discovery_tumor_PAAD,GO:0042330,taxis,5/32,470/18870,0.0010841092719530636,0.014534414137540226,0.00918736671146664,CCL18/DPP4/S100A8/S100A9/THBS4,5.0,,
GO:0031349,discovery_tumor_PAAD,GO:0031349,positive regulation of defense response,5/32,480/18870,0.0011906408383625488,0.015696615052412936,0.009922006986354573,C3/CD14/MBL2/S100A8/S100A9,5.0,,
GO:0032372,discovery_tumor_PAAD,GO:0032372,negative regulation of sterol transport,2/32,31/18870,0.0012563309779775132,0.016028351670648595,0.010131701435302527,APOC2/PCSK9,2.0,,
GO:0032375,discovery_tumor_PAAD,GO:0032375,negative regulation of cholesterol transport,2/32,31/18870,0.0012563309779775132,0.016028351670648595,0.010131701435302527,APOC2/PCSK9,2.0,,
GO:0097237,discovery_tumor_PAAD,GO:0097237,cellular response to toxic substance,3/32,128/18870,0.0013096052137652385,0.01644282101727466,0.010393692172739988,PRDX1/S100A9/TXN,3.0,,
GO:0006639,discovery_tumor_PAAD,GO:0006639,acylglycerol metabolic process,3/32,134/18870,0.0014938083954449198,0.018288948773547458,0.011560650299334677,APOC2/C3/PCSK9,3.0,,
GO:0090022,discovery_tumor_PAAD,GO:0090022,regulation of neutrophil chemotaxis,2/32,34/18870,0.0015109012380609568,0.018288948773547458,0.011560650299334677,DPP4/THBS4,2.0,,
GO:0006638,discovery_tumor_PAAD,GO:0006638,neutral lipid metabolic process,3/32,135/18870,0.0015260058395121772,0.018288948773547458,0.011560650299334677,APOC2/C3/PCSK9,3.0,,
GO:1903725,discovery_tumor_PAAD,GO:1903725,regulation of phospholipid metabolic process,2/32,35/18870,0.001600777489904697,0.018898731261412168,0.011946100670930574,ADGRF5/APOC2,2.0,,
GO:0006882,discovery_tumor_PAAD,GO:0006882,intracellular zinc ion homeostasis,2/32,36/18870,0.0016931497974942194,0.019409876664027936,0.012269201431117533,S100A8/S100A9,2.0,,
GO:0010984,discovery_tumor_PAAD,GO:0010984,regulation of lipoprotein particle clearance,2/32,36/18870,0.0016931497974942194,0.019409876664027936,0.012269201431117533,APOC2/PCSK9,2.0,,
GO:0048261,discovery_tumor_PAAD,GO:0048261,negative regulation of receptor-mediated endocytosis,2/32,37/18870,0.0017880099734508953,0.02020451269999512,0.012771499810363537,APOC2/PCSK9,2.0,,
GO:0050729,discovery_tumor_PAAD,GO:0050729,positive regulation of inflammatory response,3/32,152/18870,0.002141438646624297,0.023857436189856605,0.01508055384946688,C3/S100A8/S100A9,3.0,,
GO:0045454,discovery_tumor_PAAD,GO:0045454,cell redox homeostasis,2/32,41/18870,0.0021921662808131025,0.02408279316869943,0.015223004531415571,PRDX1/TXN,2.0,,
GO:0008037,discovery_tumor_PAAD,GO:0008037,cell recognition,3/32,154/18870,0.0022225586615866734,0.02408279316869943,0.015223004531415571,C4BPA/C4BPB/MBL2,3.0,,
GO:0098754,discovery_tumor_PAAD,GO:0098754,detoxification,3/32,158/18870,0.0023904869124323058,0.02540649995323278,0.016059734483712253,PRDX1/S100A9/TXN,3.0,,
GO:0014002,discovery_tumor_PAAD,GO:0014002,astrocyte development,2/32,43/18870,0.0024089601725568377,0.02540649995323278,0.016059734483712253,S100A8/S100A9,2.0,,
GO:0006509,discovery_tumor_PAAD,GO:0006509,membrane protein ectodomain proteolysis,2/32,44/18870,0.0025210077794620895,0.02589762537083783,0.016370180386117466,ERAP1/TIMP2,2.0,,
GO:0090207,discovery_tumor_PAAD,GO:0090207,regulation of triglyceride metabolic process,2/32,44/18870,0.0025210077794620895,0.02589762537083783,0.016370180386117466,APOC2/C3,2.0,,
GO:0045765,discovery_tumor_PAAD,GO:0045765,regulation of angiogenesis,4/32,349/18870,0.002747345444455683,0.027445892311401175,0.01734885733969733,C3/ERAP1/LRG1/THBS4,4.0,,
GO:1902622,discovery_tumor_PAAD,GO:1902622,regulation of neutrophil migration,2/32,46/18870,0.0027523641368004054,0.027445892311401175,0.01734885733969733,DPP4/THBS4,2.0,,
GO:0051235,discovery_tumor_PAAD,GO:0051235,maintenance of location,4/32,350/18870,0.002775817174351573,0.027445892311401175,0.01734885733969733,C3/S100A8/S100A9/TXN,4.0,,
GO:0001881,discovery_tumor_PAAD,GO:0001881,receptor recycling,2/32,47/18870,0.0028716568721656958,0.02785575053178362,0.01760793333235374,EPS15/PCSK9,2.0,,
GO:1901342,discovery_tumor_PAAD,GO:1901342,regulation of vasculature development,4/32,354/18870,0.002891738742343767,0.02785575053178362,0.01760793333235374,C3/ERAP1/LRG1/THBS4,4.0,,
GO:0006953,discovery_tumor_PAAD,GO:0006953,acute-phase response,2/32,48/18870,0.0029933486665001357,0.02785575053178362,0.01760793333235374,F8/MBL2,2.0,,
GO:0032369,discovery_tumor_PAAD,GO:0032369,negative regulation of lipid transport,2/32,48/18870,0.0029933486665001357,0.02785575053178362,0.01760793333235374,APOC2/PCSK9,2.0,,
GO:0043277,discovery_tumor_PAAD,GO:0043277,apoptotic cell clearance,2/32,48/18870,0.0029933486665001357,0.02785575053178362,0.01760793333235374,C3/MFGE8,2.0,,
GO:0042176,discovery_tumor_PAAD,GO:0042176,regulation of protein catabolic process,4/32,364/18870,0.0031960395699047323,0.029396131392960965,0.01858162540642286,C4BPA/C4BPB/PCSK9/TIMP2,4.0,,
GO:2000649,discovery_tumor_PAAD,GO:2000649,regulation of sodium ion transmembrane transporter activity,2/32,50/18870,0.0032438976076587835,0.02949336790411607,0.01864308969918841,PCSK9/YWHAH,2.0,,
GO:0010043,discovery_tumor_PAAD,GO:0010043,response to zinc ion,2/32,51/18870,0.0033727388888383,0.030316323421262444,0.019163289141126704,LTA4H/S100A8,2.0,,
GO:1905952,discovery_tumor_PAAD,GO:1905952,regulation of lipid localization,3/32,183/18870,0.00361876561968117,0.03161840437518964,0.01998634916257247,APOC2/C3/PCSK9,3.0,,
GO:0048260,discovery_tumor_PAAD,GO:0048260,positive regulation of receptor-mediated endocytosis,2/32,53/18870,0.003637515547588189,0.03161840437518964,0.01998634916257247,C3/PCSK9,2.0,,
GO:0071622,discovery_tumor_PAAD,GO:0071622,regulation of granulocyte chemotaxis,2/32,53/18870,0.003637515547588189,0.03161840437518964,0.01998634916257247,DPP4/THBS4,2.0,,
GO:0045766,discovery_tumor_PAAD,GO:0045766,positive regulation of angiogenesis,3/32,185/18870,0.0037308255157852683,0.03173207508587255,0.02005820169777026,C3/ERAP1/LRG1,3.0,,
GO:1904018,discovery_tumor_PAAD,GO:1904018,positive regulation of vasculature development,3/32,185/18870,0.0037308255157852683,0.03173207508587255,0.02005820169777026,C3/ERAP1/LRG1,3.0,,
GO:0042743,discovery_tumor_PAAD,GO:0042743,hydrogen peroxide metabolic process,2/32,54/18870,0.00377343517079986,0.03175305553300733,0.02007146367446734,PRDX1/TXN,2.0,,
GO:0002706,discovery_tumor_PAAD,GO:0002706,regulation of lymphocyte mediated immunity,3/32,188/18870,0.0039028709458369484,0.032230765912125585,0.020373429780104663,C3/C4BPA/C4BPB,3.0,,
GO:0034381,discovery_tumor_PAAD,GO:0034381,plasma lipoprotein particle clearance,2/32,55/18870,0.003911698517780096,0.032230765912125585,0.020373429780104663,APOC2/PCSK9,2.0,,
GO:0046890,discovery_tumor_PAAD,GO:0046890,regulation of lipid biosynthetic process,3/32,189/18870,0.0039612804404402955,0.032302812663796636,0.02041897134247575,ADGRF5/APOC2/C3,3.0,,
GO:0002697,discovery_tumor_PAAD,GO:0002697,regulation of immune effector process,4/32,389/18870,0.004051479018828608,0.03237744975917137,0.02046615029024739,C3/C4BPA/C4BPB/MBL2,4.0,,
GO:0050832,discovery_tumor_PAAD,GO:0050832,defense response to fungus,2/32,56/18870,0.004052297757468983,0.03237744975917137,0.02046615029024739,S100A8/S100A9,2.0,,
GO:0002822,discovery_tumor_PAAD,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3/32,193/18870,0.0042002640510347645,0.033224088643684986,0.021001320255173823,C3/C4BPA/C4BPB,3.0,,
GO:0002707,discovery_tumor_PAAD,GO:0002707,negative regulation of lymphocyte mediated immunity,2/32,58/18870,0.004340472682603513,0.033993206850884944,0.021487488527740167,C4BPA/C4BPB,2.0,,
GO:0002823,discovery_tumor_PAAD,GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2/32,59/18870,0.0044880327976896,0.0344663489608978,0.021786566979075727,C4BPA/C4BPB,2.0,,
GO:0033619,discovery_tumor_PAAD,GO:0033619,membrane protein proteolysis,2/32,59/18870,0.0044880327976896,0.0344663489608978,0.021786566979075727,ERAP1/TIMP2,2.0,,
GO:0032387,discovery_tumor_PAAD,GO:0032387,negative regulation of intracellular transport,2/32,60/18870,0.004637897664691922,0.03493882907401248,0.02208522697472344,PCSK9/TXN,2.0,,
GO:1902305,discovery_tumor_PAAD,GO:1902305,regulation of sodium ion transmembrane transport,2/32,60/18870,0.004637897664691922,0.03493882907401248,0.02208522697472344,PCSK9/YWHAH,2.0,,
GO:0002819,discovery_tumor_PAAD,GO:0002819,regulation of adaptive immune response,3/32,208/18870,0.0051740111508103955,0.0382071896654554,0.024151194478796083,C3/C4BPA/C4BPB,3.0,,
GO:0002820,discovery_tumor_PAAD,GO:0002820,negative regulation of adaptive immune response,2/32,64/18870,0.005260250134229228,0.0382071896654554,0.024151194478796083,C4BPA/C4BPB,2.0,,
GO:2001244,discovery_tumor_PAAD,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,2/32,64/18870,0.005260250134229228,0.0382071896654554,0.024151194478796083,S100A8/S100A9,2.0,,
GO:0007159,discovery_tumor_PAAD,GO:0007159,leukocyte cell-cell adhesion,4/32,419/18870,0.005269073779598041,0.0382071896654554,0.024151194478796083,DPP4/LRG1/S100A8/S100A9,4.0,,
GO:0045732,discovery_tumor_PAAD,GO:0045732,positive regulation of protein catabolic process,3/32,210/18870,0.005313262785335138,0.0382071896654554,0.024151194478796083,C4BPA/C4BPB/PCSK9,3.0,,
GO:1905953,discovery_tumor_PAAD,GO:1905953,negative regulation of lipid localization,2/32,66/18870,0.005585054515698495,0.03979980290015774,0.025157903223867094,APOC2/PCSK9,2.0,,
GO:0009620,discovery_tumor_PAAD,GO:0009620,response to fungus,2/32,67/18870,0.005750836956128809,0.04061528600265971,0.02567337926843219,S100A8/S100A9,2.0,,
GO:0006919,discovery_tumor_PAAD,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,2/32,68/18870,0.005918862739837784,0.04143203917886449,0.026189658140875153,S100A8/S100A9,2.0,,
GO:0002704,discovery_tumor_PAAD,GO:0002704,negative regulation of leukocyte mediated immunity,2/32,69/18870,0.006089124271876592,0.0422499763074946,0.026706685402967507,C4BPA/C4BPB,2.0,,
GO:0002752,discovery_tumor_PAAD,GO:0002752,cell surface pattern recognition receptor signaling pathway,2/32,70/18870,0.006261613975205209,0.0430690143859767,0.027224408587848734,CD14/MBL2,2.0,,
GO:0050766,discovery_tumor_PAAD,GO:0050766,positive regulation of phagocytosis,2/32,72/18870,0.006613247676900602,0.04509550786576186,0.028505377917675007,C3/MBL2,2.0,,
GO:0043112,discovery_tumor_PAAD,GO:0043112,receptor metabolic process,2/32,73/18870,0.00679237661040869,0.04553194829519724,0.028781256823765634,EPS15/PCSK9,2.0,,
GO:0140962,discovery_tumor_PAAD,GO:0140962,multicellular organismal-level chemical homeostasis,2/32,73/18870,0.00679237661040869,0.04553194829519724,0.028781256823765634,ADGRF5/MBL2,2.0,,
GO:0045806,discovery_tumor_PAAD,GO:0045806,negative regulation of endocytosis,2/32,75/18870,0.0071572211138947505,0.047574469757065106,0.03007235762140651,APOC2/PCSK9,2.0,,
GO:0051651,discovery_tumor_PAAD,GO:0051651,maintenance of location in cell,3/32,237/18870,0.007417348811634308,0.048892690916689484,0.030905620048476287,S100A8/S100A9/TXN,3.0,,
hsa04142,discovery_tumor_RCC,hsa04142,Lysosome,4/10,132/8843,9.293086089588905e-06,0.00040889578794191185,0.00032281246416466727,CTSL/HEXA/IGF2R/LAMP2,4.0,Cellular Processes,Transport and catabolism
hsa05205,discovery_tumor_RCC,hsa05205,Proteoglycans in cancer,3/10,204/8843,0.0012879160253202024,0.028334152557044454,0.02236906780819299,CTSL/CTTN/FGFR1,3.0,Human Diseases,Cancer: overview
R-HSA-1236977,discovery_tumor_RCC,R-HSA-1236977,Endosomal/Vacuolar pathway,2/10,11/11009,4.06681570992351e-05,0.007198263806564613,0.0038955813642425202,B2M/CTSL,2.0,,
GO:0006898,discovery_tumor_RCC,GO:0006898,receptor-mediated endocytosis,4/12,258/18870,1.5503115605550656e-05,0.008092626346097443,0.005548483479881287,B2M/CTSL/CTTN/IGF2R,4.0,,
GO:0019886,discovery_tumor_RCC,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,2/12,31/18870,0.00017063005911403947,0.02978630300074578,0.020422147651247356,B2M/CTSL,2.0,,
GO:0002495,discovery_tumor_RCC,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,2/12,35/18870,0.00021802471656017893,0.02978630300074578,0.020422147651247356,B2M/CTSL,2.0,,
GO:0002504,discovery_tumor_RCC,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,2/12,37/18870,0.0002438687131428886,0.02978630300074578,0.020422147651247356,B2M/CTSL,2.0,,
GO:0002478,discovery_tumor_RCC,GO:0002478,antigen processing and presentation of exogenous peptide antigen,2/12,40/18870,0.0002853094157159557,0.02978630300074578,0.020422147651247356,B2M/CTSL,2.0,,
GO:0019884,discovery_tumor_RCC,GO:0019884,antigen processing and presentation of exogenous antigen,2/12,49/18870,0.00042879310741441364,0.03730500034505398,0.02557713272296502,B2M/CTSL,2.0,,
hsa05146,discovery_tumor_SARC,hsa05146,Amoebiasis,5/17,103/8843,1.0767198304528602e-06,5.921959067490731e-05,4.533557180854149e-05,ACTN1/C8B/C9/LAMB3/VCL,5.0,Human Diseases,Infectious disease: parasitic
hsa04510,discovery_tumor_SARC,hsa04510,Focal adhesion,5/17,203/8843,2.99917676474087e-05,0.0008247736103037393,0.0006314056346822885,ACTN1/LAMB3/TNC/TNXB/VCL,5.0,Cellular Processes,Cellular community - eukaryotes
hsa04610,discovery_tumor_SARC,hsa04610,Complement and coagulation cascades,3/17,88/8843,0.0005854180176491122,0.008320391614561882,0.006369677791052159,C8B/C9/SERPIND1,3.0,Organismal Systems,Immune system
hsa04512,discovery_tumor_SARC,hsa04512,ECM-receptor interaction,3/17,89/8843,0.0006051193901499551,0.008320391614561882,0.006369677791052159,LAMB3/TNC/TNXB,3.0,Environmental Information Processing,Signaling molecules and interaction
hsa04810,discovery_tumor_SARC,hsa04810,Regulation of actin cytoskeleton,4/17,230/8843,0.0008125978554283378,0.008938576409711716,0.006842929308870214,ACTN1/C8B/C9/VCL,4.0,Cellular Processes,Cell motility
hsa04670,discovery_tumor_SARC,hsa04670,Leukocyte transendothelial migration,3/17,116/8843,0.0013078591542864503,0.01198870891429246,0.009177958977448776,ACTN1/VCAM1/VCL,3.0,Organismal Systems,Immune system
hsa05322,discovery_tumor_SARC,hsa05322,Systemic lupus erythematosus,3/17,139/8843,0.002199026365812363,0.01727806430281142,0.013227226260525492,ACTN1/C8B/C9,3.0,Human Diseases,Immune disease
R-HSA-1474244,discovery_tumor_SARC,R-HSA-1474244,Extracellular matrix organization,6/25,300/11009,4.454044363363752e-05,0.0043486524746492805,0.003383390941374726,ACTN1/LAMB3/NID1/TNC/TNXB/VCAM1,6.0,,
R-HSA-6785807,discovery_tumor_SARC,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,4/25,108/11009,9.453592336194088e-05,0.0043486524746492805,0.003383390941374726,HSPA8/LBP/SAA1/VCAM1,4.0,,
R-HSA-8957275,discovery_tumor_SARC,R-HSA-8957275,Post-translational protein phosphorylation,4/25,108/11009,9.453592336194088e-05,0.0043486524746492805,0.003383390941374726,ANO8/SERPINA10/SERPIND1/TNC,4.0,,
R-HSA-381426,discovery_tumor_SARC,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),4/25,125/11009,0.00016657075074578758,0.005006714658259596,0.003895384402307237,ANO8/SERPINA10/SERPIND1/TNC,4.0,,
R-HSA-114608,discovery_tumor_SARC,R-HSA-114608,Platelet degranulation,4/25,129/11009,0.0001880697168565897,0.005006714658259596,0.003895384402307237,ACTN1/ISLR/SERPINA3/VCL,4.0,,
R-HSA-76005,discovery_tumor_SARC,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,4/25,134/11009,0.0002176832460112868,0.005006714658259596,0.003895384402307237,ACTN1/ISLR/SERPINA3/VCL,4.0,,
R-HSA-166658,discovery_tumor_SARC,R-HSA-166658,Complement cascade,3/25,58/11009,0.0002939574033060258,0.005334416884071996,0.004150347232458761,C8B/C9/CRP,3.0,,
R-HSA-3000171,discovery_tumor_SARC,R-HSA-3000171,Non-integrin membrane-ECM interactions,3/25,59/11009,0.0003092415584969273,0.005334416884071996,0.004150347232458761,ACTN1/LAMB3/TNC,3.0,,
R-HSA-449147,discovery_tumor_SARC,R-HSA-449147,Signaling by Interleukins,6/25,473/11009,0.000536975423436702,0.008233623159362765,0.006406022595385216,HNRNPA2B1/HSPA8/LBP/MIF/SAA1/VCAM1,6.0,,
R-HSA-3000170,discovery_tumor_SARC,R-HSA-3000170,Syndecan interactions,2/25,27/11009,0.0016783637829243206,0.023161420204355625,0.0180203269324506,ACTN1/TNC,2.0,,
R-HSA-3000157,discovery_tumor_SARC,R-HSA-3000157,Laminin interactions,2/25,30/11009,0.0020713670705969625,0.025986241431125528,0.02021812834458279,LAMB3/NID1,2.0,,
R-HSA-76002,discovery_tumor_SARC,R-HSA-76002,"Platelet activation, signaling and aggregation",4/25,263/11009,0.002711213990492132,0.031178960890659517,0.024258230441245393,ACTN1/ISLR/SERPINA3/VCL,4.0,,
R-HSA-8950505,discovery_tumor_SARC,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,2/25,38/11009,0.003310520259143305,0.035142445827828925,0.027341948698997337,HNRNPA2B1/MIF,2.0,,
R-HSA-6798695,discovery_tumor_SARC,R-HSA-6798695,Neutrophil degranulation,5/25,480/11009,0.003973025008529714,0.03916267508407861,0.030469815854889535,HSPA8/MIF/MPO/SERPINA3/VCL,5.0,,
R-HSA-9020591,discovery_tumor_SARC,R-HSA-9020591,Interleukin-12 signaling,2/25,47/11009,0.005027377011276697,0.043361126722261514,0.033736345733567305,HNRNPA2B1/MIF,2.0,,
R-HSA-977606,discovery_tumor_SARC,R-HSA-977606,Regulation of Complement cascade,2/25,47/11009,0.005027377011276697,0.043361126722261514,0.033736345733567305,C8B/C9,2.0,,
GO:0006953,discovery_tumor_SARC,GO:0006953,acute-phase response,5/28,48/18870,8.083668967584506e-09,6.539688194775866e-06,4.6544915002828685e-06,CRP/LBP/SAA1/SAA2/SERPINA3,5.0,,
GO:0002526,discovery_tumor_SARC,GO:0002526,acute inflammatory response,5/28,107/18870,4.7262801612188917e-07,0.00019117803252130416,0.00013606711832561756,CRP/LBP/SAA1/SAA2/SERPINA3,5.0,,
GO:0007160,discovery_tumor_SARC,GO:0007160,cell-matrix adhesion,5/28,239/18870,2.4212943669270955e-05,0.0065294238094800675,0.004647186030558319,ACTN1/NID1/TNXB/VCAM1/VCL,5.0,,
GO:0031589,discovery_tumor_SARC,GO:0031589,cell-substrate adhesion,5/28,356/18870,0.00015975905313045505,0.028770363350169754,0.020476727281950238,ACTN1/NID1/TNXB/VCAM1/VCL,5.0,,
GO:0002679,discovery_tumor_SARC,GO:0002679,respiratory burst involved in defense response,2/28,16/18870,0.0002515340853867101,0.028770363350169754,0.020476727281950238,LBP/MPO,2.0,,
GO:0008228,discovery_tumor_SARC,GO:0008228,opsonization,2/28,17/18870,0.00028481035505147984,0.028770363350169754,0.020476727281950238,CRP/LBP,2.0,,
GO:0007596,discovery_tumor_SARC,GO:0007596,blood coagulation,4/28,224/18870,0.00031643190936638514,0.028770363350169754,0.020476727281950238,SAA1/SERPINA10/SERPIND1/VCL,4.0,,
GO:0006957,discovery_tumor_SARC,GO:0006957,"complement activation, alternative pathway",2/28,18/18870,0.00032011763238345807,0.028770363350169754,0.020476727281950238,C8B/C9,2.0,,
GO:0050817,discovery_tumor_SARC,GO:0050817,coagulation,4/28,229/18870,0.0003440929063349418,0.028770363350169754,0.020476727281950238,SAA1/SERPINA10/SERPIND1/VCL,4.0,,
GO:0007599,discovery_tumor_SARC,GO:0007599,hemostasis,4/28,231/18870,0.00035562871879072624,0.028770363350169754,0.020476727281950238,SAA1/SERPINA10/SERPIND1/VCL,4.0,,
GO:0097305,discovery_tumor_SARC,GO:0097305,response to alcohol,4/28,254/18870,0.0005090315092381926,0.03573281362898577,0.025432111189974908,CRHBP/CSN1S1/TNC/VCAM1,4.0,,
GO:0006935,discovery_tumor_SARC,GO:0006935,chemotaxis,5/28,468/18870,0.0005631849250444058,0.03573281362898577,0.025432111189974908,LBP/MIF/SAA1/SERPIND1/VCAM1,5.0,,
GO:0042330,discovery_tumor_SARC,GO:0042330,taxis,5/28,470/18870,0.0005741984884756674,0.03573281362898577,0.025432111189974908,LBP/MIF/SAA1/SERPIND1/VCAM1,5.0,,
GO:0045471,discovery_tumor_SARC,GO:0045471,response to ethanol,3/28,121/18870,0.0007494295485223018,0.04330632176818158,0.03082240323621798,CRHBP/TNC/VCAM1,3.0,,
GO:0006910,discovery_tumor_SARC,GO:0006910,"phagocytosis, recognition",2/28,29/18870,0.0008409312346844475,0.04460839623703277,0.03174912854291448,CRP/LBP,2.0,,
GO:0010951,discovery_tumor_SARC,GO:0010951,negative regulation of endopeptidase activity,3/28,128/18870,0.0008822426944283367,0.04460839623703277,0.03174912854291448,SERPINA10/SERPINA3/SERPIND1,3.0,,
GO:0010466,discovery_tumor_SARC,GO:0010466,negative regulation of peptidase activity,3/28,137/18870,0.0010738003747330278,0.04639488764931728,0.033020627863088355,SERPINA10/SERPINA3/SERPIND1,3.0,,
GO:0034368,discovery_tumor_SARC,GO:0034368,protein-lipid complex remodeling,2/28,33/18870,0.0010896203527033725,0.04639488764931728,0.033020627863088355,MPO/PLTP,2.0,,
GO:0034369,discovery_tumor_SARC,GO:0034369,plasma lipoprotein particle remodeling,2/28,33/18870,0.0010896203527033725,0.04639488764931728,0.033020627863088355,MPO/PLTP,2.0,,
GO:0034367,discovery_tumor_SARC,GO:0034367,protein-containing complex remodeling,2/28,35/18870,0.0012256369625762412,0.049151849508724074,0.03498283999905285,MPO/PLTP,2.0,,
GO:0060326,discovery_tumor_SARC,GO:0060326,cell chemotaxis,4/28,325/18870,0.0012758823729087832,0.049151849508724074,0.03498283999905285,LBP/MIF/SAA1/VCAM1,4.0,,
HALLMARK_ANDROGEN_RESPONSE,discovery_tumor_STAD,HALLMARK_ANDROGEN_RESPONSE,HALLMARK_ANDROGEN_RESPONSE,1/1,100/4383,0.02281542322610075,0.02281542322610075,-2147483648.0,AZGP1,1.0,,
hsa04970,discovery_tumor_STAD,hsa04970,Salivary secretion,1/1,97/8843,0.010969128123939798,0.010969128123939798,-2147483648.0,LYZ,1.0,Organismal Systems,Digestive system
R-HSA-5223345,discovery_tumor_STAD,R-HSA-5223345,Miscellaneous transport and binding events,1/2,26/11009,0.004718044512206698,0.018872178048826793,0.004966362644428103,AZGP1,1.0,,
R-HSA-6803157,discovery_tumor_STAD,R-HSA-6803157,Antimicrobial peptides,1/2,95/11009,0.017184918866593568,0.02651294906000127,0.006977091857895071,LYZ,1.0,,
R-HSA-977225,discovery_tumor_STAD,R-HSA-977225,Amyloid fiber formation,1/2,110/11009,0.019884711795000953,0.02651294906000127,0.006977091857895071,LYZ,1.0,,
GO:0001895,discovery_tumor_STAD,GO:0001895,retina homeostasis,2/2,83/18870,1.9114861698246242e-05,0.00034406751056843235,2.0120907050785515e-05,AZGP1/LYZ,2.0,,
GO:0001894,discovery_tumor_STAD,GO:0001894,tissue homeostasis,2/2,279/18870,0.00021783527814272277,0.0013070116688563365,7.643343092727115e-05,AZGP1/LYZ,2.0,,
GO:0060249,discovery_tumor_STAD,GO:0060249,anatomical structure homeostasis,2/2,279/18870,0.00021783527814272277,0.0013070116688563365,7.643343092727115e-05,AZGP1/LYZ,2.0,,
GO:0001580,discovery_tumor_STAD,GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,1/2,39/18870,0.004129383067136505,0.014291743399243662,0.000835774467792027,AZGP1,1.0,,
GO:0050913,discovery_tumor_STAD,GO:0050913,sensory perception of bitter taste,1/2,44/18870,0.004658173275856159,0.014291743399243662,0.000835774467792027,AZGP1,1.0,,
GO:0050912,discovery_tumor_STAD,GO:0050912,detection of chemical stimulus involved in sensory perception of taste,1/2,45/18870,0.004763914466414554,0.014291743399243662,0.000835774467792027,AZGP1,1.0,,
GO:0050909,discovery_tumor_STAD,GO:0050909,sensory perception of taste,1/2,66/18870,0.006983181926833781,0.015698396129417425,0.0009180348613694399,AZGP1,1.0,,
GO:0071806,discovery_tumor_STAD,GO:0071806,protein transmembrane transport,1/2,67/18870,0.0070887995420299,0.015698396129417425,0.0009180348613694399,AZGP1,1.0,,
GO:0050829,discovery_tumor_STAD,GO:0050829,defense response to Gram-negative bacterium,1/2,89/18870,0.009410965959678053,0.015698396129417425,0.0009180348613694399,LYZ,1.0,,
GO:0031640,discovery_tumor_STAD,GO:0031640,killing of cells of another organism,1/2,92/18870,0.009727414376808241,0.015698396129417425,0.0009180348613694399,LYZ,1.0,,
GO:0141061,discovery_tumor_STAD,GO:0141061,disruption of cell in another organism,1/2,92/18870,0.009727414376808241,0.015698396129417425,0.0009180348613694399,LYZ,1.0,,
GO:0141060,discovery_tumor_STAD,GO:0141060,disruption of anatomical structure in another organism,1/2,99/18870,0.010465597419611616,0.015698396129417425,0.0009180348613694399,LYZ,1.0,,
GO:0050830,discovery_tumor_STAD,GO:0050830,defense response to Gram-positive bacterium,1/2,118/18870,0.012467849692927913,0.017263176497900184,0.0010095424852573209,LYZ,1.0,,
GO:0019730,discovery_tumor_STAD,GO:0019730,antimicrobial humoral response,1/2,133/18870,0.014047142821073444,0.018060612198523,0.0010561761519604093,LYZ,1.0,,
GO:0001906,discovery_tumor_STAD,GO:0001906,cell killing,1/2,223/18870,0.023496360972395602,0.02819563316687472,0.0016488674366593405,LYZ,1.0,,
GO:0006959,discovery_tumor_STAD,GO:0006959,humoral immune response,1/2,258/18870,0.027158769597191768,0.03055361579684074,0.0017867611577099846,LYZ,1.0,,
GO:0042742,discovery_tumor_STAD,GO:0042742,defense response to bacterium,1/2,330/18870,0.034671230417131826,0.03671071455931605,0.0021468254128254997,LYZ,1.0,,
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,discovery_tumor_TGCT,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,4/33,49/4383,0.00044463940010959783,0.009776554666085504,0.00908039133072957,CAT/PRDX2/PRDX6/SOD1,4.0,,
HALLMARK_HEME_METABOLISM,discovery_tumor_TGCT,HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,7/33,200/4383,0.0005750914509462062,0.009776554666085504,0.00908039133072957,BLVRB/CA1/CA2/CAT/HBB/PRDX2/SLC4A1,7.0,,
hsa05143,discovery_tumor_TGCT,hsa05143,African trypanosomiasis,4/39,37/8843,1.9215233664483e-05,0.002132890936757613,0.0018810702429441252,APOL1/HBA1/HBB/HPR,4.0,Human Diseases,Infectious disease: parasitic
R-HSA-1237044,discovery_tumor_TGCT,R-HSA-1237044,Erythrocytes take up carbon dioxide and release oxygen,5/56,13/11009,3.5400894675449944e-09,1.840846523123397e-07,1.403614420465208e-07,CA1/CA2/HBA1/HBB/SLC4A1,5.0,,
R-HSA-1480926,discovery_tumor_TGCT,R-HSA-1480926,O2/CO2 exchange in erythrocytes,5/56,13/11009,3.5400894675449944e-09,1.840846523123397e-07,1.403614420465208e-07,CA1/CA2/HBA1/HBB/SLC4A1,5.0,,
R-HSA-2168880,discovery_tumor_TGCT,R-HSA-2168880,Scavenging of heme from plasma,5/56,13/11009,3.5400894675449944e-09,1.840846523123397e-07,1.403614420465208e-07,APOL1/HBA1/HBB/HPR/JCHAIN,5.0,,
R-HSA-447115,discovery_tumor_TGCT,R-HSA-447115,Interleukin-12 family signaling,7/56,57/11009,1.299482963702799e-08,5.067983558440915e-07,3.8642519710109544e-07,CA1/CFL1/IL6ST/LCP1/MSN/P4HB/SOD1,7.0,,
R-HSA-9020591,discovery_tumor_TGCT,R-HSA-9020591,Interleukin-12 signaling,6/56,47/11009,1.203145138120052e-07,3.7538128309345625e-06,2.8622189601592816e-06,CA1/CFL1/LCP1/MSN/P4HB/SOD1,6.0,,
R-HSA-3299685,discovery_tumor_TGCT,R-HSA-3299685,Detoxification of Reactive Oxygen Species,5/56,37/11009,1.0927285034405716e-06,2.4442060871099625e-05,1.8636659098746676e-05,CAT/P4HB/PRDX2/PRDX6/SOD1,5.0,,
R-HSA-9711123,discovery_tumor_TGCT,R-HSA-9711123,Cellular response to chemical stress,9/56,215/11009,1.1945537322198843e-06,2.4442060871099625e-05,1.8636659098746676e-05,BLVRB/CAT/HBA1/HBB/P4HB/PGD/PRDX2/PRDX6/SOD1,9.0,,
R-HSA-8950505,discovery_tumor_TGCT,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,5/56,38/11009,1.25343901903075e-06,2.4442060871099625e-05,1.8636659098746676e-05,CA1/CFL1/LCP1/MSN/SOD1,5.0,,
R-HSA-2173782,discovery_tumor_TGCT,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,5/56,42/11009,2.091681317793081e-06,3.62558095084134e-05,2.7644443147440718e-05,APOL1/HBA1/HBB/HPR/JCHAIN,5.0,,
R-HSA-8957275,discovery_tumor_TGCT,R-HSA-8957275,Post-translational protein phosphorylation,6/56,108/11009,1.6900566202420043e-05,0.0002636488327577527,0.00020102778746036474,APOA2/APOL1/IGFBP5/NUCB1/P4HB/SERPINC1,6.0,,
R-HSA-6798695,discovery_tumor_TGCT,R-HSA-6798695,Neutrophil degranulation,11/56,480/11009,2.4212015837507824e-05,0.0003433704064228382,0.00026181414254912764,ANPEP/CALML5/CAT/CEACAM8/HBB/MANBA/OSCAR/PNP/PRDX6/S100A7/SERPINB1,11.0,,
R-HSA-381426,discovery_tumor_TGCT,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),6/56,125/11009,3.877027802304693e-05,0.0005040136142996101,0.00038430187864950025,APOA2/APOL1/IGFBP5/NUCB1/P4HB/SERPINC1,6.0,,
R-HSA-140837,discovery_tumor_TGCT,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,3/56,23/11009,0.00020542888320947454,0.0024651465985136944,0.00187963269657252,F10/F12/SERPINC1,3.0,,
R-HSA-114608,discovery_tumor_TGCT,R-HSA-114608,Platelet degranulation,5/56,129/11009,0.0004838103163421031,0.005031627289957872,0.0038365309295900103,APOH/CFL1/PFN1/SOD1/TAGLN2,5.0,,
R-HSA-6809371,discovery_tumor_TGCT,R-HSA-6809371,Formation of the cornified envelope,5/56,129/11009,0.0004838103163421031,0.005031627289957872,0.0038365309295900103,KRT2/KRT7/KRT77/KRT78/KRT9,5.0,,
R-HSA-76005,discovery_tumor_TGCT,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,5/56,134/11009,0.0005756737251815605,0.005612818820520215,0.0042796796674681795,APOH/CFL1/PFN1/SOD1/TAGLN2,5.0,,
R-HSA-8963899,discovery_tumor_TGCT,R-HSA-8963899,Plasma lipoprotein remodeling,3/56,34/11009,0.0006671509683601623,0.006122091239069724,0.0046679912956469555,APOA2/CETP/P4HB,3.0,,
R-HSA-140877,discovery_tumor_TGCT,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),3/56,39/11009,0.0010007357775597468,0.008673043405517805,0.006613049290307098,F10/F12/SERPINC1,3.0,,
R-HSA-8963888,discovery_tumor_TGCT,R-HSA-8963888,Chylomicron assembly,2/56,10/11009,0.001114137032224334,0.00914765142247348,0.006974929897027685,APOA2/P4HB,2.0,,
R-HSA-1475029,discovery_tumor_TGCT,R-HSA-1475029,Reversible hydration of carbon dioxide,2/56,12/11009,0.0016234273311229283,0.01266273318275884,0.009655120442994257,CA1/CA2,2.0,,
R-HSA-9651496,discovery_tumor_TGCT,R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),2/56,16/11009,0.00291341077955842,0.02065873098232334,0.01575193387990916,F10/F12,2.0,,
R-HSA-9671793,discovery_tumor_TGCT,R-HSA-9671793,Diseases of hemostasis,2/56,16/11009,0.00291341077955842,0.02065873098232334,0.01575193387990916,F10/F12,2.0,,
R-HSA-8963898,discovery_tumor_TGCT,R-HSA-8963898,Plasma lipoprotein assembly,2/56,19/11009,0.004111217469242256,0.027110821270504216,0.02067154388371779,APOA2/P4HB,2.0,,
R-HSA-9707564,discovery_tumor_TGCT,R-HSA-9707564,Cytoprotection by HMOX1,3/56,64/11009,0.004170895580077572,0.027110821270504216,0.02067154388371779,BLVRB/HBA1/HBB,3.0,,
R-HSA-6805567,discovery_tumor_TGCT,R-HSA-6805567,Keratinization,5/56,214/11009,0.004524888135344296,0.028235301964548407,0.021528941443953915,KRT2/KRT7/KRT77/KRT78/KRT9,5.0,,
R-HSA-140875,discovery_tumor_TGCT,R-HSA-140875,Common Pathway of Fibrin Clot Formation,2/56,22/11009,0.005499771560010262,0.03299862936006157,0.025160898230006463,F10/SERPINC1,2.0,,
R-HSA-174824,discovery_tumor_TGCT,R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",3/56,75/11009,0.006499071742286851,0.03755019228876847,0.02863138818239432,APOA2/CETP/P4HB,3.0,,
GO:0007596,discovery_tumor_TGCT,GO:0007596,blood coagulation,9/62,224/18870,4.6841722197776265e-08,2.7532230681612423e-05,2.2260374647342704e-05,APOH/F10/F12/HBB/IL6ST/PDIA3/PRDX2/SERPINC1/SLC4A1,9.0,,
GO:0050817,discovery_tumor_TGCT,GO:0050817,coagulation,9/62,229/18870,5.661860811270549e-08,2.7532230681612423e-05,2.2260374647342704e-05,APOH/F10/F12/HBB/IL6ST/PDIA3/PRDX2/SERPINC1/SLC4A1,9.0,,
GO:0007599,discovery_tumor_TGCT,GO:0007599,hemostasis,9/62,231/18870,6.100198821627568e-08,2.7532230681612423e-05,2.2260374647342704e-05,APOH/F10/F12/HBB/IL6ST/PDIA3/PRDX2/SERPINC1/SLC4A1,9.0,,
GO:0008544,discovery_tumor_TGCT,GO:0008544,epidermis development,10/62,385/18870,4.6501808561652993e-07,0.0001534049147244306,0.00012403102799767385,CALML5/CST6/IGFBP5/KRT2/KRT7/KRT77/KRT78/KRT9/S100A7/SOD1,10.0,,
GO:0045104,discovery_tumor_TGCT,GO:0045104,intermediate filament cytoskeleton organization,6/62,94/18870,6.384750585004642e-07,0.0001534049147244306,0.00012403102799767385,KRT2/KRT7/KRT77/KRT78/KRT9/SOD1,6.0,,
GO:0045103,discovery_tumor_TGCT,GO:0045103,intermediate filament-based process,6/62,95/18870,6.797854419103278e-07,0.0001534049147244306,0.00012403102799767385,KRT2/KRT7/KRT77/KRT78/KRT9/SOD1,6.0,,
GO:0098869,discovery_tumor_TGCT,GO:0098869,cellular oxidant detoxification,6/62,99/18870,8.675586150672138e-07,0.00015362790639082065,0.0001242113213452954,CAT/HBA1/HBB/PRDX2/PRDX6/SOD1,6.0,,
GO:0042743,discovery_tumor_TGCT,GO:0042743,hydrogen peroxide metabolic process,5/62,54/18870,9.076981175233126e-07,0.00015362790639082065,0.0001242113213452954,CAT/HBA1/HBB/PRDX2/SOD1,5.0,,
GO:1990748,discovery_tumor_TGCT,GO:1990748,cellular detoxification,6/62,119/18870,2.5533384760624606e-06,0.0003821217626328184,0.0003089533026029162,CAT/HBA1/HBB/PRDX2/PRDX6/SOD1,6.0,,
GO:0050878,discovery_tumor_TGCT,GO:0050878,regulation of body fluid levels,9/62,365/18870,2.8221695910843308e-06,0.0003821217626328184,0.0003089533026029162,APOH/F10/F12/HBB/IL6ST/PDIA3/PRDX2/SERPINC1/SLC4A1,9.0,,
GO:0042744,discovery_tumor_TGCT,GO:0042744,hydrogen peroxide catabolic process,4/62,31/18870,3.109928088566317e-06,0.0003828038756289812,0.0003095048049865042,CAT/HBA1/HBB/PRDX2,4.0,,
GO:0097237,discovery_tumor_TGCT,GO:0097237,cellular response to toxic substance,6/62,128/18870,3.900370318710444e-06,0.0004280511025646308,0.00034608811837613,CAT/HBA1/HBB/PRDX2/PRDX6/SOD1,6.0,,
GO:0045109,discovery_tumor_TGCT,GO:0045109,intermediate filament organization,5/62,73/18870,4.109796405716544e-06,0.0004280511025646308,0.00034608811837613,KRT2/KRT7/KRT77/KRT78/KRT9,5.0,,
GO:0000302,discovery_tumor_TGCT,GO:0000302,response to reactive oxygen species,7/62,205/18870,4.779725035604676e-06,0.00046226769272919506,0.0003737529351149521,APOD/CAT/HBA1/HBB/PRDX2/S100A7/SOD1,7.0,,
GO:0042060,discovery_tumor_TGCT,GO:0042060,wound healing,9/62,423/18870,9.304500946032254e-06,0.0008398862853951782,0.0006790653322016522,APOH/F10/F12/HBB/IL6ST/PDIA3/PRDX2/SERPINC1/SLC4A1,9.0,,
GO:0098754,discovery_tumor_TGCT,GO:0098754,detoxification,6/62,158/18870,1.3078473533336053e-05,0.0011067658227585635,0.0008948429259650984,CAT/HBA1/HBB/PRDX2/PRDX6/SOD1,6.0,,
GO:0015670,discovery_tumor_TGCT,GO:0015670,carbon dioxide transport,3/62,15/18870,1.4941972934096301e-05,0.0011900841972215523,0.000962207544982053,CA2/HBA1/HBB,3.0,,
GO:0009313,discovery_tumor_TGCT,GO:0009313,oligosaccharide catabolic process,3/62,18/18870,2.6609208800631755e-05,0.0020016038175586334,0.0016183378451846214,CTBS/MANBA/PGD,3.0,,
GO:0006979,discovery_tumor_TGCT,GO:0006979,response to oxidative stress,8/62,400/18870,4.725891309080098e-05,0.0032076764504438953,0.0025934723691686625,APOD/CAT/HBA1/HBB/PRDX2/PRDX6/S100A7/SOD1,8.0,,
GO:0019755,discovery_tumor_TGCT,GO:0019755,one-carbon compound transport,4/62,61/18870,4.791476928374104e-05,0.0032076764504438953,0.0025934723691686625,CA2/HBA1/HBB/SLC4A1,4.0,,
GO:0015669,discovery_tumor_TGCT,GO:0015669,gas transport,3/62,22/18870,4.974978246626425e-05,0.0032076764504438953,0.0025934723691686625,CA2/HBA1/HBB,3.0,,
GO:0030193,discovery_tumor_TGCT,GO:0030193,regulation of blood coagulation,4/62,68/18870,7.350054536906424e-05,0.004523624474077862,0.003657443405924728,APOH/F12/PRDX2/SERPINC1,4.0,,
GO:0043588,discovery_tumor_TGCT,GO:0043588,skin development,7/62,317/18870,7.873711754226253e-05,0.0046352198761836294,0.003747670583247278,IGFBP5/KRT2/KRT7/KRT77/KRT78/KRT9/S100A7,7.0,,
GO:1900046,discovery_tumor_TGCT,GO:1900046,regulation of hemostasis,4/62,70/18870,8.234740835275657e-05,0.004645766287901349,0.0037561975739853876,APOH/F12/PRDX2/SERPINC1,4.0,,
GO:0008203,discovery_tumor_TGCT,GO:0008203,cholesterol metabolic process,5/62,140/18870,9.640535917823113e-05,0.005046282409608961,0.0040800230941408075,APOA2/APOL1/CAT/CETP/SOD1,5.0,,
GO:0050818,discovery_tumor_TGCT,GO:0050818,regulation of coagulation,4/62,73/18870,9.703661708992512e-05,0.005046282409608961,0.0040800230941408075,APOH/F12/PRDX2/SERPINC1,4.0,,
GO:0030194,discovery_tumor_TGCT,GO:0030194,positive regulation of blood coagulation,3/62,28/18870,0.0001043544368309091,0.005046282409608961,0.0040800230941408075,APOH/F12/PRDX2,3.0,,
GO:1900048,discovery_tumor_TGCT,GO:1900048,positive regulation of hemostasis,3/62,28/18870,0.0001043544368309091,0.005046282409608961,0.0040800230941408075,APOH/F12/PRDX2,3.0,,
GO:0050820,discovery_tumor_TGCT,GO:0050820,positive regulation of coagulation,3/62,30/18870,0.00012872400215782178,0.006010079273161748,0.004859272676738099,APOH/F12/PRDX2,3.0,,
GO:1902652,discovery_tumor_TGCT,GO:1902652,secondary alcohol metabolic process,5/62,150/18870,0.00013339102442823795,0.006020381569194473,0.004867602294925174,APOA2/APOL1/CAT/CETP/SOD1,5.0,,
GO:0009913,discovery_tumor_TGCT,GO:0009913,epidermal cell differentiation,6/62,245/18870,0.00015082282886940633,0.006384836938665957,0.005162271955385676,KRT2/KRT7/KRT77/KRT78/S100A7/SOD1,6.0,,
GO:0016125,discovery_tumor_TGCT,GO:0016125,sterol metabolic process,5/62,154/18870,0.00015089718023435054,0.006384836938665957,0.005162271955385676,APOA2/APOL1/CAT/CETP/SOD1,5.0,,
GO:0031424,discovery_tumor_TGCT,GO:0031424,keratinization,4/62,83/18870,0.0001598617910790778,0.006559177730941556,0.005303230070884878,KRT2/KRT7/KRT77/KRT78,4.0,,
GO:0016052,discovery_tumor_TGCT,GO:0016052,carbohydrate catabolic process,5/62,163/18870,0.00019669576109448815,0.007722434274731289,0.006243746906414166,CTBS/LDHA/MANBA/PGD/SLC4A1,5.0,,
GO:0009636,discovery_tumor_TGCT,GO:0009636,response to toxic substance,6/62,258/18870,0.00019961979292141443,0.007722434274731289,0.006243746906414166,CAT/HBA1/HBB/PRDX2/PRDX6/SOD1,6.0,,
GO:0030216,discovery_tumor_TGCT,GO:0030216,keratinocyte differentiation,5/62,177/18870,0.0002881498254079963,0.010837635100067418,0.008762450831120356,KRT2/KRT7/KRT77/KRT78/S100A7,5.0,,
GO:0042542,discovery_tumor_TGCT,GO:0042542,response to hydrogen peroxide,4/62,101/18870,0.00033987145688365385,0.01243745817893155,0.010055940687311521,CAT/HBA1/HBB/SOD1,4.0,,
GO:0006641,discovery_tumor_TGCT,GO:0006641,triglyceride metabolic process,4/62,106/18870,0.0004084920112708311,0.014555215348965927,0.011768190906417297,APOA2/APOH/CAT/CETP,4.0,,
GO:0071803,discovery_tumor_TGCT,GO:0071803,positive regulation of podosome assembly,2/62,10/18870,0.00046994352821485555,0.01631547531289524,0.013191397283224014,LCP1/MSN,2.0,,
GO:0034975,discovery_tumor_TGCT,GO:0034975,protein folding in endoplasmic reticulum,2/62,11/18870,0.0005731599579039046,0.01940146457504717,0.015686483058422653,P4HB/PDIA3,2.0,,
GO:0044403,discovery_tumor_TGCT,GO:0044403,biological process involved in symbiotic interaction,6/62,322/18870,0.0006488276939610735,0.0202021747584534,0.016333873706593748,ANPEP/APOL1/CFL1/DCD/FCN3/P4HB,6.0,,
GO:0002064,discovery_tumor_TGCT,GO:0002064,epithelial cell development,5/62,214/18870,0.0006852716799479574,0.0202021747584534,0.016333873706593748,COL18A1/EZR/IL6ST/KRT2/MSN,5.0,,
GO:0034370,discovery_tumor_TGCT,GO:0034370,triglyceride-rich lipoprotein particle remodeling,2/62,12/18870,0.0006863368086328334,0.0202021747584534,0.016333873706593748,APOA2/CETP,2.0,,
GO:0034372,discovery_tumor_TGCT,GO:0034372,very-low-density lipoprotein particle remodeling,2/62,12/18870,0.0006863368086328334,0.0202021747584534,0.016333873706593748,APOA2/CETP,2.0,,
GO:1902946,discovery_tumor_TGCT,GO:1902946,protein localization to early endosome,2/62,12/18870,0.0006863368086328334,0.0202021747584534,0.016333873706593748,EZR/MSN,2.0,,
GO:1905668,discovery_tumor_TGCT,GO:1905668,positive regulation of protein localization to endosome,2/62,12/18870,0.0006863368086328334,0.0202021747584534,0.016333873706593748,EZR/MSN,2.0,,
GO:0008202,discovery_tumor_TGCT,GO:0008202,steroid metabolic process,6/62,327/18870,0.0007032072016544447,0.020258352149789747,0.01637929428265672,APOA2/APOL1/CAT/CETP/GC/SOD1,6.0,,
GO:0071801,discovery_tumor_TGCT,GO:0071801,regulation of podosome assembly,2/62,13/18870,0.0008094096365622831,0.021918812958106625,0.01772181098999525,LCP1/MSN,2.0,,
GO:0098761,discovery_tumor_TGCT,GO:0098761,cellular response to interleukin-7,2/62,13/18870,0.0008094096365622831,0.021918812958106625,0.01772181098999525,P4HB/PDIA3,2.0,,
GO:1905666,discovery_tumor_TGCT,GO:1905666,regulation of protein localization to endosome,2/62,13/18870,0.0008094096365622831,0.021918812958106625,0.01772181098999525,EZR/MSN,2.0,,
GO:0098760,discovery_tumor_TGCT,GO:0098760,response to interleukin-7,2/62,14/18870,0.0009423143019635841,0.02496936792900174,0.020188247412082565,P4HB/PDIA3,2.0,,
GO:0061041,discovery_tumor_TGCT,GO:0061041,regulation of wound healing,4/62,133/18870,0.000958941752073922,0.02496936792900174,0.020188247412082565,APOH/F12/PRDX2/SERPINC1,4.0,,
GO:0006639,discovery_tumor_TGCT,GO:0006639,acylglycerol metabolic process,4/62,134/18870,0.000986036499117105,0.025185156793152155,0.02036271714598324,APOA2/APOH/CAT/CETP,4.0,,
GO:0006638,discovery_tumor_TGCT,GO:0006638,neutral lipid metabolic process,4/62,135/18870,0.0010136659400213893,0.025185156793152155,0.02036271714598324,APOA2/APOH/CAT/CETP,4.0,,
GO:0072593,discovery_tumor_TGCT,GO:0072593,reactive oxygen species metabolic process,5/62,234/18870,0.001023030741228485,0.025185156793152155,0.02036271714598324,CAT/HBA1/HBB/PRDX2/SOD1,5.0,,
GO:0015671,discovery_tumor_TGCT,GO:0015671,oxygen transport,2/62,15/18870,0.00108498696796812,0.02577319920401464,0.020838161526996208,HBA1/HBB,2.0,,
GO:1903651,discovery_tumor_TGCT,GO:1903651,positive regulation of cytoplasmic transport,2/62,15/18870,0.00108498696796812,0.02577319920401464,0.020838161526996208,EZR/MSN,2.0,,
GO:0090303,discovery_tumor_TGCT,GO:0090303,positive regulation of wound healing,3/62,62/18870,0.001112716103749079,0.025976165594418153,0.021002264027205845,APOH/F12/PRDX2,3.0,,
GO:0001885,discovery_tumor_TGCT,GO:0001885,endothelial cell development,3/62,64/18870,0.0012201087795752185,0.027022435330341852,0.02184819462299271,COL18A1/EZR/MSN,3.0,,
GO:0034374,discovery_tumor_TGCT,GO:0034374,low-density lipoprotein particle remodeling,2/62,16/18870,0.001237364099321414,0.027022435330341852,0.02184819462299271,APOA2/CETP,2.0,,
GO:0034375,discovery_tumor_TGCT,GO:0034375,high-density lipoprotein particle remodeling,2/62,16/18870,0.001237364099321414,0.027022435330341852,0.02184819462299271,APOA2/CETP,2.0,,
GO:0072378,discovery_tumor_TGCT,GO:0072378,"blood coagulation, fibrin clot formation",2/62,16/18870,0.001237364099321414,0.027022435330341852,0.02184819462299271,APOH/F12,2.0,,
GO:2000401,discovery_tumor_TGCT,GO:2000401,regulation of lymphocyte migration,3/62,69/18870,0.0015165549919560568,0.03259389617632541,0.02635283528211026,APOD/MSN/S100A7,3.0,,
GO:0051917,discovery_tumor_TGCT,GO:0051917,regulation of fibrinolysis,2/62,18/18870,0.0015709791176845944,0.03292872260961341,0.0266235493384109,APOH/F12,2.0,,
GO:0009311,discovery_tumor_TGCT,GO:0009311,oligosaccharide metabolic process,3/62,70/18870,0.0015807732419681473,0.03292872260961341,0.0266235493384109,CTBS/MANBA/PGD,3.0,,
GO:0050766,discovery_tumor_TGCT,GO:0050766,positive regulation of phagocytosis,3/62,72/18870,0.0017142696728608855,0.03389045425316479,0.02740112914817024,APOA2/FCN3/SOD1,3.0,,
GO:0070527,discovery_tumor_TGCT,GO:0070527,platelet aggregation,3/62,72/18870,0.0017142696728608855,0.03389045425316479,0.02740112914817024,HBB/IL6ST/PDIA3,3.0,,
GO:0071800,discovery_tumor_TGCT,GO:0071800,podosome assembly,2/62,19/18870,0.0017520914311089624,0.03389045425316479,0.02740112914817024,LCP1/MSN,2.0,,
GO:0072376,discovery_tumor_TGCT,GO:0072376,protein activation cascade,2/62,19/18870,0.0017520914311089624,0.03389045425316479,0.02740112914817024,APOH/F12,2.0,,
GO:2000641,discovery_tumor_TGCT,GO:2000641,regulation of early endosome to late endosome transport,2/62,19/18870,0.0017520914311089624,0.03389045425316479,0.02740112914817024,EZR/MSN,2.0,,
GO:0072678,discovery_tumor_TGCT,GO:0072678,T cell migration,3/62,73/18870,0.0017835796609653523,0.03401361775981813,0.027500709375892756,APOD/MSN/S100A7,3.0,,
GO:0043691,discovery_tumor_TGCT,GO:0043691,reverse cholesterol transport,2/62,20/18870,0.0019426570602520913,0.036532745271962944,0.029537475769914837,APOA2/CETP,2.0,,
GO:1903036,discovery_tumor_TGCT,GO:1903036,positive regulation of response to wounding,3/62,77/18870,0.0020782597700961768,0.03854744833849621,0.03116640462725341,APOH/F12/PRDX2,3.0,,
GO:0015698,discovery_tumor_TGCT,GO:0015698,inorganic anion transport,4/62,169/18870,0.0023122496872843594,0.04230791995382463,0.03420682325427786,APOL1/CA2/SLC25A3/SLC4A1,4.0,,
GO:1903034,discovery_tumor_TGCT,GO:1903034,regulation of response to wounding,4/62,173/18870,0.0025165308407584666,0.04543177011182619,0.03673252034229903,APOH/F12/PRDX2/SERPINC1,4.0,,
GO:0019430,discovery_tumor_TGCT,GO:0019430,removal of superoxide radicals,2/62,23/18870,0.002570454854887123,0.04579468254627848,0.03702594250806936,PRDX2/SOD1,2.0,,
GO:0072524,discovery_tumor_TGCT,GO:0072524,pyridine-containing compound metabolic process,3/62,85/18870,0.002754402833823798,0.04843456411684965,0.03916034104137731,MDH1/PGD/PNP,3.0,,
HALLMARK_COAGULATION,discovery_tumor_THCA,HALLMARK_COAGULATION,HALLMARK_COAGULATION,10/27,138/4383,3.6950875678951612e-09,8.498701406158871e-08,7.77913172188455e-08,APOC1/APOC3/CLU/CPB2/F2/HRG/ITIH1/MST1/PLG/PROC,10.0,,
HALLMARK_COMPLEMENT,discovery_tumor_THCA,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,8/27,200/4383,1.7150523894106042e-05,0.00019723102478221949,0.00018053183046427414,APOA4/APOC1/CLU/F2/F7/FCN1/ITIH1/PLG,8.0,,
HALLMARK_XENOBIOTIC_METABOLISM,discovery_tumor_THCA,HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,7/27,200/4383,0.00015098081799891426,0.0011575196046583428,0.0010595145122730826,FBP1/FETUB/HRG/ITIH1/LCAT/PLG/RBP4,7.0,,
hsa04610,discovery_tumor_THCA,hsa04610,Complement and coagulation cascades,8/31,88/8843,4.554479258045416e-10,3.005956310309975e-08,2.8285713286808374e-08,CLU/CPB2/F2/F7/KNG1/PLG/PROC/SERPINF2,8.0,Organismal Systems,Immune system
hsa04979,discovery_tumor_THCA,hsa04979,Cholesterol metabolism,5/31,51/8843,7.920004904412571e-07,2.6136016184561485e-05,2.4593699440017985e-05,APOA4/APOC1/APOC3/LCAT/LPA,5.0,Organismal Systems,Digestive system
hsa00531,discovery_tumor_THCA,hsa00531,Glycosaminoglycan degradation,2/31,19/8843,0.0019597056973317205,0.04311352534129785,0.04056934601493738,HEXB/NAGLU,2.0,Metabolism,Glycan biosynthesis and metabolism
R-HSA-114608,discovery_tumor_THCA,R-HSA-114608,Platelet degranulation,11/46,129/11009,3.498956500157167e-12,4.048802109165775e-10,2.9440735558338394e-10,AHSG/CD109/CLEC3B/CLU/ECM1/HRG/KNG1/PLG/PPIA/SERPINA4/SERPINF2,11.0,,
R-HSA-76005,discovery_tumor_THCA,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,11/46,134/11009,5.327371196270757e-12,4.048802109165775e-10,2.9440735558338394e-10,AHSG/CD109/CLEC3B/CLU/ECM1/HRG/KNG1/PLG/PPIA/SERPINA4/SERPINF2,11.0,,
R-HSA-76002,discovery_tumor_THCA,R-HSA-76002,"Platelet activation, signaling and aggregation",12/46,263/11009,5.08608944749255e-10,2.5769519867295584e-08,1.8738224280235713e-08,AHSG/CD109/CLEC3B/CLU/ECM1/F2/HRG/KNG1/PLG/PPIA/SERPINA4/SERPINF2,12.0,,
R-HSA-381426,discovery_tumor_THCA,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),8/46,125/11009,4.0086858308358005e-08,1.523300615717604e-06,1.107663190099366e-06,AHSG/F2/IGFALS/IGFBP3/ITIH2/KNG1/PLG/PROC,8.0,,
R-HSA-975634,discovery_tumor_THCA,R-HSA-975634,Retinoid metabolism and transport,5/46,44/11009,9.794213969980098e-07,2.9774410468739496e-05,2.1650367723113902e-05,APOA4/APOC3/APOM/RBP4/TTR,5.0,,
R-HSA-6806667,discovery_tumor_THCA,R-HSA-6806667,Metabolism of fat-soluble vitamins,5/46,48/11009,1.525169155906154e-06,3.863761861628923e-05,2.80952212930081e-05,APOA4/APOC3/APOM/RBP4/TTR,5.0,,
R-HSA-166658,discovery_tumor_THCA,R-HSA-166658,Complement cascade,5/46,58/11009,3.9564534784406115e-06,8.5911561246139e-05,6.247031808064124e-05,CLU/CPB2/F2/FCN1/FCN2,5.0,,
R-HSA-159740,discovery_tumor_THCA,R-HSA-159740,Gamma-carboxylation of protein precursors,3/46,10/11009,8.02714664386973e-06,0.00013556958776313324,9.857899387208442e-05,F2/F7/PROC,3.0,,
R-HSA-159782,discovery_tumor_THCA,R-HSA-159782,Removal of aminoterminal propeptides from gamma-carboxylated proteins,3/46,10/11009,8.02714664386973e-06,0.00013556958776313324,9.857899387208442e-05,F2/F7/PROC,3.0,,
R-HSA-159854,discovery_tumor_THCA,R-HSA-159854,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",3/46,11/11009,1.1005012883228515e-05,0.00015598098967227217,0.00011342107974784332,F2/F7/PROC,3.0,,
R-HSA-8963899,discovery_tumor_THCA,R-HSA-8963899,Plasma lipoprotein remodeling,4/46,34/11009,1.128809793680917e-05,0.00015598098967227217,0.00011342107974784332,APOA4/APOC3/LCAT/LPA,4.0,,
R-HSA-174824,discovery_tumor_THCA,R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",5/46,75/11009,1.4135952960943327e-05,0.0001790554041719488,0.00013019956674553066,APOA4/APOC1/APOC3/LCAT/LPA,5.0,,
R-HSA-75205,discovery_tumor_THCA,R-HSA-75205,Dissolution of Fibrin Clot,3/46,13/11009,1.8963846965157135e-05,0.00021406994042136863,0.0001556602752371448,HRG/PLG/SERPINF2,3.0,,
R-HSA-140877,discovery_tumor_THCA,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),4/46,39/11009,1.9716968196705005e-05,0.00021406994042136863,0.0001556602752371448,F2/F7/KNG1/PROC,4.0,,
R-HSA-8963898,discovery_tumor_THCA,R-HSA-8963898,Plasma lipoprotein assembly,3/46,19/11009,6.313198079280924e-05,0.0006397374053671336,0.00046518301636806807,APOA4/APOC1/APOC3,3.0,,
R-HSA-2187338,discovery_tumor_THCA,R-HSA-2187338,Visual phototransduction,5/46,104/11009,6.88323312803545e-05,0.0006539071471633678,0.0004754864989761331,APOA4/APOC3/APOM/RBP4/TTR,5.0,,
R-HSA-8957275,discovery_tumor_THCA,R-HSA-8957275,Post-translational protein phosphorylation,5/46,108/11009,8.240289600813279e-05,0.0007367788348962461,0.0005357463827154144,AHSG/IGFBP3/ITIH2/KNG1/PROC,5.0,,
R-HSA-140837,discovery_tumor_THCA,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,3/46,23/11009,0.00011404009475559618,0.0009630052446028121,0.0007002461958676958,F2/KNG1/PROC,3.0,,
R-HSA-196854,discovery_tumor_THCA,R-HSA-196854,Metabolism of vitamins and cofactors,6/46,194/11009,0.00014438815865029246,0.0011551052692023397,0.0008399311168022554,APOA4/APOC3/APOM/BTD/RBP4/TTR,6.0,,
R-HSA-8963888,discovery_tumor_THCA,R-HSA-8963888,Chylomicron assembly,2/46,10/11009,0.0007524260277053955,0.005198579827782733,0.003780130761199356,APOA4/APOC3,2.0,,
R-HSA-8963901,discovery_tumor_THCA,R-HSA-8963901,Chylomicron remodeling,2/46,10/11009,0.0007524260277053955,0.005198579827782733,0.003780130761199356,APOA4/APOC3,2.0,,
R-HSA-8964058,discovery_tumor_THCA,R-HSA-8964058,HDL remodeling,2/46,10/11009,0.0007524260277053955,0.005198579827782733,0.003780130761199356,APOC3/LCAT,2.0,,
R-HSA-977606,discovery_tumor_THCA,R-HSA-977606,Regulation of Complement cascade,3/46,47/11009,0.000973399546438632,0.006432901350377046,0.004677663724304639,CLU/CPB2/F2,3.0,,
R-HSA-166786,discovery_tumor_THCA,R-HSA-166786,Creation of C4 and C2 activators,2/46,14/11009,0.0015054584075883802,0.008475173257534585,0.006162695235741908,FCN1/FCN2,2.0,,
R-HSA-2453864,discovery_tumor_THCA,R-HSA-2453864,Retinoid cycle disease events,2/46,14/11009,0.0015054584075883802,0.008475173257534585,0.006162695235741908,RBP4/TTR,2.0,,
R-HSA-2474795,discovery_tumor_THCA,R-HSA-2474795,Diseases associated with visual transduction,2/46,14/11009,0.0015054584075883802,0.008475173257534585,0.006162695235741908,RBP4/TTR,2.0,,
R-HSA-9675143,discovery_tumor_THCA,R-HSA-9675143,Diseases of the neuronal system,2/46,14/11009,0.0015054584075883802,0.008475173257534585,0.006162695235741908,RBP4/TTR,2.0,,
R-HSA-163841,discovery_tumor_THCA,R-HSA-163841,"Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation",3/46,61/11009,0.002074098164791315,0.011259390037438567,0.008187229597860456,F2/F7/PROC,3.0,,
R-HSA-140875,discovery_tumor_THCA,R-HSA-140875,Common Pathway of Fibrin Clot Formation,2/46,22/11009,0.003741161869186376,0.019608848417804452,0.014258511661145898,F2/PROC,2.0,,
R-HSA-166663,discovery_tumor_THCA,R-HSA-166663,Initial triggering of complement,2/46,23/11009,0.004086602038179785,0.02003753257430088,0.014570227979927925,FCN1/FCN2,2.0,,
R-HSA-2453902,discovery_tumor_THCA,R-HSA-2453902,The canonical retinoid cycle in rods (twilight vision),2/46,23/11009,0.004086602038179785,0.02003753257430088,0.014570227979927925,RBP4/TTR,2.0,,
R-HSA-6803157,discovery_tumor_THCA,R-HSA-6803157,Antimicrobial peptides,3/46,95/11009,0.007226384960642117,0.03432532856305005,0.02495955331800731,CLU/PGLYRP2/SEMG1,3.0,,
R-HSA-1638074,discovery_tumor_THCA,R-HSA-1638074,Keratan sulfate/keratin metabolism,2/46,36/11009,0.00983164410453168,0.04528514860269138,0.03292895154627836,B4GAT1/HEXB,2.0,,
R-HSA-9748784,discovery_tumor_THCA,R-HSA-9748784,Drug ADME,3/46,110/11009,0.010788583323414406,0.0468532761473997,0.03406921049499286,BCHE/PON1/PON3,3.0,,
R-HSA-977225,discovery_tumor_THCA,R-HSA-977225,Amyloid fiber formation,3/46,110/11009,0.010788583323414406,0.0468532761473997,0.03406921049499286,APOA4/SEMG1/TTR,3.0,,
GO:0030193,discovery_tumor_THCA,GO:0030193,regulation of blood coagulation,8/53,68/18870,1.4487444283976776e-11,1.2069725910892164e-08,8.830043105489686e-09,CPB2/F2/F7/HRG/KNG1/PLG/PROC/SERPINF2,8.0,,
GO:1900046,discovery_tumor_THCA,GO:1900046,regulation of hemostasis,8/53,70/18870,1.8423456759766053e-11,1.2069725910892164e-08,8.830043105489686e-09,CPB2/F2/F7/HRG/KNG1/PLG/PROC/SERPINF2,8.0,,
GO:0050818,discovery_tumor_THCA,GO:0050818,regulation of coagulation,8/53,73/18870,2.6066420967419187e-11,1.2069725910892164e-08,8.830043105489686e-09,CPB2/F2/F7/HRG/KNG1/PLG/PROC/SERPINF2,8.0,,
GO:0061045,discovery_tumor_THCA,GO:0061045,negative regulation of wound healing,8/53,75/18870,3.257685805908816e-11,1.2069725910892164e-08,8.830043105489686e-09,CD109/CPB2/F2/HRG/KNG1/PLG/PROC/SERPINF2,8.0,,
GO:0030195,discovery_tumor_THCA,GO:0030195,negative regulation of blood coagulation,7/53,48/18870,6.157987254244773e-11,1.770738170708807e-08,1.2954473441509138e-08,CPB2/F2/HRG/KNG1/PLG/PROC/SERPINF2,7.0,,
GO:1900047,discovery_tumor_THCA,GO:1900047,negative regulation of hemostasis,7/53,49/18870,7.168980448213794e-11,1.770738170708807e-08,1.2954473441509138e-08,CPB2/F2/HRG/KNG1/PLG/PROC/SERPINF2,7.0,,
GO:0050819,discovery_tumor_THCA,GO:0050819,negative regulation of coagulation,7/53,52/18870,1.1093859634452594e-10,1.9517937327802945e-08,1.427905067663686e-08,CPB2/F2/HRG/KNG1/PLG/PROC/SERPINF2,7.0,,
GO:0061041,discovery_tumor_THCA,GO:0061041,regulation of wound healing,9/53,133/18870,1.1132587020367333e-10,1.9517937327802945e-08,1.427905067663686e-08,CD109/CPB2/F2/F7/HRG/KNG1/PLG/PROC/SERPINF2,9.0,,
GO:0030194,discovery_tumor_THCA,GO:0030194,positive regulation of blood coagulation,6/53,28/18870,1.3169998196898075e-10,1.9517937327802945e-08,1.427905067663686e-08,CPB2/F2/F7/HRG/PLG/SERPINF2,6.0,,
GO:1900048,discovery_tumor_THCA,GO:1900048,positive regulation of hemostasis,6/53,28/18870,1.3169998196898075e-10,1.9517937327802945e-08,1.427905067663686e-08,CPB2/F2/F7/HRG/PLG/SERPINF2,6.0,,
GO:0051918,discovery_tumor_THCA,GO:0051918,negative regulation of fibrinolysis,5/53,13/18870,1.8221766975752367e-10,2.4549689689150004e-08,1.7960210511985585e-08,CPB2/F2/HRG/PLG/SERPINF2,5.0,,
GO:0050820,discovery_tumor_THCA,GO:0050820,positive regulation of coagulation,6/53,30/18870,2.0668496987912373e-10,2.552559378007178e-08,1.8674168331183986e-08,CPB2/F2/F7/HRG/PLG/SERPINF2,6.0,,
GO:1903035,discovery_tumor_THCA,GO:1903035,negative regulation of response to wounding,8/53,97/18870,2.663051884772576e-10,3.035879148640736e-08,2.2210068350734844e-08,CD109/CPB2/F2/HRG/KNG1/PLG/PROC/SERPINF2,8.0,,
GO:0034375,discovery_tumor_THCA,GO:0034375,high-density lipoprotein particle remodeling,5/53,16/18870,6.145107460851338e-10,6.505035183558345e-08,4.758992995997653e-08,APOA4/APOC1/APOC3/APOM/LCAT,5.0,,
GO:0050817,discovery_tumor_THCA,GO:0050817,coagulation,10/53,229/18870,7.032903484575097e-10,6.948508642760196e-08,5.0834319923595444e-08,CPB2/F2/F7/HRG/KNG1/PLG/PPIA/PROC/SEMG1/SERPINF2,10.0,,
GO:1903034,discovery_tumor_THCA,GO:1903034,regulation of response to wounding,9/53,173/18870,1.1639814311815474e-09,1.0463627522813492e-07,7.655043929609985e-08,CD109/CPB2/F2/F7/HRG/KNG1/PLG/PROC/SERPINF2,9.0,,
GO:0051917,discovery_tumor_THCA,GO:0051917,regulation of fibrinolysis,5/53,18/18870,1.2002811598369053e-09,1.0463627522813492e-07,7.655043929609985e-08,CPB2/F2/HRG/PLG/SERPINF2,5.0,,
GO:0043691,discovery_tumor_THCA,GO:0043691,reverse cholesterol transport,5/53,20/18870,2.1627385848328637e-09,1.7806547681790577e-07,1.3027021885250585e-07,APOA4/APOC3/APOM/CLU/LCAT,5.0,,
GO:0051346,discovery_tumor_THCA,GO:0051346,negative regulation of hydrolase activity,9/53,218/18870,8.863096751116578e-09,6.913215465870931e-07,5.057611996482037e-07,AHSG/APOC1/APOC3/ECM1/FETUB/HRG/KNG1/SERPINA4/SERPINF2,9.0,,
GO:0034377,discovery_tumor_THCA,GO:0034377,plasma lipoprotein particle assembly,5/53,27/18870,1.1095433190543081e-08,7.561352649906575e-07,5.531780118903171e-07,APOA4/APOC1/APOC3/APOM/LCAT,5.0,,
GO:0042730,discovery_tumor_THCA,GO:0042730,fibrinolysis,5/53,27/18870,1.1095433190543081e-08,7.561352649906575e-07,5.531780118903171e-07,CPB2/F2/HRG/PLG/SERPINF2,5.0,,
GO:0007596,discovery_tumor_THCA,GO:0007596,blood coagulation,9/53,224/18870,1.1224680047094782e-08,7.561352649906575e-07,5.531780118903171e-07,CPB2/F2/F7/HRG/KNG1/PLG/PPIA/PROC/SERPINF2,9.0,,
GO:0007599,discovery_tumor_THCA,GO:0007599,hemostasis,9/53,231/18870,1.4661993810641934e-08,9.447423837987542e-07,6.911603489684755e-07,CPB2/F2/F7/HRG/KNG1/PLG/PPIA/PROC/SERPINF2,9.0,,
GO:0045861,discovery_tumor_THCA,GO:0045861,negative regulation of proteolysis,9/53,235/18870,1.7013919941848816e-08,1.0506095564091644e-06,7.686112956186088e-07,AHSG/CPB2/ECM1/F2/FETUB/HRG/KNG1/SERPINA4/SERPINF2,9.0,,
GO:0065005,discovery_tumor_THCA,GO:0065005,protein-lipid complex assembly,5/53,30/18870,1.9461575048530458e-08,1.1390546979447995e-06,8.333165273692333e-07,APOA4/APOC1/APOC3/APOM/LCAT,5.0,,
GO:0090303,discovery_tumor_THCA,GO:0090303,positive regulation of wound healing,6/53,62/18870,1.9983415753417537e-08,1.1390546979447995e-06,8.333165273692333e-07,CPB2/F2/F7/HRG/PLG/SERPINF2,6.0,,
GO:0034368,discovery_tumor_THCA,GO:0034368,protein-lipid complex remodeling,5/53,33/18870,3.2206543172928905e-08,1.7046463207957371e-06,1.2470954687261946e-06,APOA4/APOC1/APOC3/APOM/LCAT,5.0,,
GO:0034369,discovery_tumor_THCA,GO:0034369,plasma lipoprotein particle remodeling,5/53,33/18870,3.2206543172928905e-08,1.7046463207957371e-06,1.2470954687261946e-06,APOA4/APOC1/APOC3/APOM/LCAT,5.0,,
GO:0034367,discovery_tumor_THCA,GO:0034367,protein-containing complex remodeling,5/53,35/18870,4.3866097859898833e-08,2.241708863047244e-06,1.6400029326931326e-06,APOA4/APOC1/APOC3/APOM/LCAT,5.0,,
GO:0030301,discovery_tumor_THCA,GO:0030301,cholesterol transport,7/53,128/18870,6.66269836440975e-08,3.291372992018416e-06,2.407922566786681e-06,APOA4/APOC1/APOC3/APOM/CLU/LCAT/PON1,7.0,,
GO:1903036,discovery_tumor_THCA,GO:1903036,positive regulation of response to wounding,6/53,77/18870,7.46391821746782e-08,3.5682344510604224e-06,2.6104705480447726e-06,CPB2/F2/F7/HRG/PLG/SERPINF2,6.0,,
GO:0010466,discovery_tumor_THCA,GO:0010466,negative regulation of peptidase activity,7/53,137/18870,1.0634138680170464e-07,4.924935476253946e-06,3.603014092294598e-06,AHSG/ECM1/FETUB/HRG/KNG1/SERPINA4/SERPINF2,7.0,,
GO:0015918,discovery_tumor_THCA,GO:0015918,sterol transport,7/53,141/18870,1.2954630750633574e-07,5.817806900739077e-06,4.256226371021558e-06,APOA4/APOC1/APOC3/APOM/CLU/LCAT/PON1,7.0,,
GO:0052547,discovery_tumor_THCA,GO:0052547,regulation of peptidase activity,9/53,312/18870,1.925727049870754e-07,8.393904376201344e-06,6.1408633478850665e-06,AHSG/ECM1/FETUB/HRG/HSPD1/KNG1/SEMG1/SERPINA4/SERPINF2,9.0,,
GO:0097006,discovery_tumor_THCA,GO:0097006,regulation of plasma lipoprotein particle levels,6/53,91/18870,2.0365221699824566e-07,8.623216731182858e-06,6.30862506791558e-06,APOA4/APOC1/APOC3/APOM/GPLD1/LCAT,6.0,,
GO:0042060,discovery_tumor_THCA,GO:0042060,wound healing,10/53,423/18870,2.3751368283529334e-07,9.777646610052909e-06,7.153189863168191e-06,CD109/CPB2/F2/F7/HRG/KNG1/PLG/PPIA/PROC/SERPINF2,10.0,,
GO:0071827,discovery_tumor_THCA,GO:0071827,plasma lipoprotein particle organization,5/53,50/18870,2.773321651244087e-07,1.110827753282091e-05,8.126660884157638e-06,APOA4/APOC1/APOC3/APOM/LCAT,5.0,,
GO:0071825,discovery_tumor_THCA,GO:0071825,protein-lipid complex organization,5/53,53/18870,3.7324094654853194e-07,1.4556396915392745e-05,1.0649256923683874e-05,APOA4/APOC1/APOC3/APOM/LCAT,5.0,,
GO:0030203,discovery_tumor_THCA,GO:0030203,glycosaminoglycan metabolic process,6/53,112/18870,6.988495175239262e-07,2.65562816659092e-05,1.942820521051671e-05,B4GAT1/HEXB/ITIH1/ITIH2/NAGLU/PGLYRP2,6.0,,
GO:0050878,discovery_tumor_THCA,GO:0050878,regulation of body fluid levels,9/53,365/18870,7.185469768887527e-07,2.6622165493728286e-05,1.947640489987935e-05,CPB2/F2/F7/HRG/KNG1/PLG/PPIA/PROC/SERPINF2,9.0,,
GO:0043086,discovery_tumor_THCA,GO:0043086,negative regulation of catalytic activity,10/53,480/18870,7.554727302364853e-07,2.730757527342613e-05,1.9977841133339665e-05,AHSG/APOC1/APOC3/ECM1/FETUB/HRG/KNG1/PPIA/SERPINA4/SERPINF2,10.0,,
GO:0006022,discovery_tumor_THCA,GO:0006022,aminoglycan metabolic process,6/53,121/18870,1.101282680965709e-06,3.8859546028361443e-05,2.8429101789340362e-05,B4GAT1/HEXB/ITIH1/ITIH2/NAGLU/PGLYRP2,6.0,,
GO:0052548,discovery_tumor_THCA,GO:0052548,regulation of endopeptidase activity,8/53,288/18870,1.3053663788995238e-06,4.498960403556033e-05,3.291376671399044e-05,AHSG/FETUB/HRG/HSPD1/KNG1/SEMG1/SERPINA4/SERPINF2,8.0,,
GO:0010951,discovery_tumor_THCA,GO:0010951,negative regulation of endopeptidase activity,6/53,128/18870,1.531020176444508e-06,5.156754321569911e-05,3.7726095256886205e-05,AHSG/FETUB/HRG/KNG1/SERPINA4/SERPINF2,6.0,,
GO:0033344,discovery_tumor_THCA,GO:0033344,cholesterol efflux,5/53,73/18870,1.8724726538339195e-06,6.166676606626374e-05,4.511454581167104e-05,APOA4/APOC1/APOC3/APOM/PON1,5.0,,
GO:0015850,discovery_tumor_THCA,GO:0015850,organic hydroxy compound transport,8/53,308/18870,2.1539913213266297e-06,6.939598126534924e-05,5.07691318298954e-05,APOA4/APOC1/APOC3/APOM/CLU/LCAT/PON1/RBP4,8.0,,
GO:0046470,discovery_tumor_THCA,GO:0046470,phosphatidylcholine metabolic process,5/53,76/18870,2.2885176398115557e-06,7.216134345107927e-05,5.279223222857564e-05,APOA4/APOC1/GPLD1/LCAT/PON1,5.0,,
GO:0006869,discovery_tumor_THCA,GO:0006869,lipid transport,9/53,453/18870,4.24625893424595e-06,0.0001311032445948437,9.59133048744151e-05,APOA4/APOC1/APOC3/APOM/CLU/LCAT/LPA/PON1/RBP4,9.0,,
GO:0034370,discovery_tumor_THCA,GO:0034370,triglyceride-rich lipoprotein particle remodeling,3/53,12/18870,4.521178820636778e-06,0.00013400774024367412,9.803819337380803e-05,APOA4/APOC3/LCAT,3.0,,
GO:0034372,discovery_tumor_THCA,GO:0034372,very-low-density lipoprotein particle remodeling,3/53,12/18870,4.521178820636778e-06,0.00013400774024367412,9.803819337380803e-05,APOA4/APOC3/LCAT,3.0,,
GO:0010896,discovery_tumor_THCA,GO:0010896,regulation of triglyceride catabolic process,3/53,13/18870,5.865859837614791e-06,0.00016782311612943985,0.0001227770506522644,APOA4/APOC3/GPLD1,3.0,,
GO:1903510,discovery_tumor_THCA,GO:1903510,mucopolysaccharide metabolic process,5/53,92/18870,5.888530390506662e-06,0.00016782311612943985,0.0001227770506522644,B4GAT1/HEXB/ITIH1/ITIH2/NAGLU,5.0,,
GO:0033700,discovery_tumor_THCA,GO:0033700,phospholipid efflux,3/53,14/18870,7.450814576014199e-06,0.00020834164531420836,0.00015241984137625867,APOA4/APOC1/APOC3,3.0,,
GO:0051004,discovery_tumor_THCA,GO:0051004,regulation of lipoprotein lipase activity,3/53,16/18870,1.1417317613156474e-05,0.00031334193893884987,0.00022923659145323918,APOA4/APOC1/APOC3,3.0,,
GO:0010755,discovery_tumor_THCA,GO:0010755,regulation of plasminogen activation,3/53,18/18870,1.6570675565023216e-05,0.00043853109263150726,0.0003208232299243217,CLEC3B/CPB2/SERPINF2,3.0,,
GO:0034384,discovery_tumor_THCA,GO:0034384,high-density lipoprotein particle clearance,3/53,18/18870,1.6570675565023216e-05,0.00043853109263150726,0.0003208232299243217,APOC3/APOM/GPLD1,3.0,,
GO:0034381,discovery_tumor_THCA,GO:0034381,plasma lipoprotein particle clearance,4/53,55/18870,1.700885548875992e-05,0.0004422302427077579,0.00032352947651750175,APOC1/APOC3/APOM/GPLD1,4.0,,
GO:0050994,discovery_tumor_THCA,GO:0050994,regulation of lipid catabolic process,4/53,61/18870,2.5703565947540555e-05,0.0006567704264526743,0.00048048408214095776,APOA4/APOC1/APOC3/GPLD1,4.0,,
GO:0044403,discovery_tumor_THCA,GO:0044403,biological process involved in symbiotic interaction,7/53,322/18870,3.1026725269086864e-05,0.0007793492686235039,0.0005701610531161368,F2/FCN1/HRG/HSPD1/PGLYRP2/PLG/PPIA,7.0,,
GO:0046503,discovery_tumor_THCA,GO:0046503,glycerolipid catabolic process,4/53,65/18870,3.3071502264203504e-05,0.0008168661059258266,0.0005976078479320984,APOA4/APOC1/APOC3/GPLD1,4.0,,
GO:0044242,discovery_tumor_THCA,GO:0044242,cellular lipid catabolic process,6/53,223/18870,3.6773506010098855e-05,0.0008934153427371558,0.0006536102017325595,APOA4/APOC1/APOC3/GPLD1/HEXB/NAGLU,6.0,,
GO:0042157,discovery_tumor_THCA,GO:0042157,lipoprotein metabolic process,5/53,135/18870,3.789950966604166e-05,0.0009059205375011893,0.0006627588277762804,APOA4/APOC1/APOC3/APOM/LCAT,5.0,,
GO:0062012,discovery_tumor_THCA,GO:0062012,regulation of small molecule metabolic process,7/53,337/18870,4.144481108081149e-05,0.0009749398416152798,0.0007132523878569061,APOA4/APOC1/APOC3/FBP1/GPLD1/IGFBP3/MST1,7.0,,
GO:0008203,discovery_tumor_THCA,GO:0008203,cholesterol metabolic process,5/53,140/18870,4.510048613635179e-05,0.001044358132094896,0.000764037840796749,APOA4/APOC1/HMGCS1/LCAT/PON1,5.0,,
GO:0032102,discovery_tumor_THCA,GO:0032102,negative regulation of response to external stimulus,8/53,481/18870,5.441746271036533e-05,0.0012407181497963294,0.0009076920905534622,CD109/CPB2/F2/HRG/KNG1/PLG/PROC/SERPINF2,8.0,,
GO:0031639,discovery_tumor_THCA,GO:0031639,plasminogen activation,3/53,27/18870,5.834623735673248e-05,0.0012905839367563811,0.0009441732046729687,CLEC3B/CPB2/SERPINF2,3.0,,
GO:0050995,discovery_tumor_THCA,GO:0050995,negative regulation of lipid catabolic process,3/53,27/18870,5.834623735673248e-05,0.0012905839367563811,0.0009441732046729687,APOC1/APOC3/GPLD1,3.0,,
GO:0016485,discovery_tumor_THCA,GO:0016485,protein processing,6/53,245/18870,6.207924820441271e-05,0.0013455911459019302,0.0009844157115412942,BCHE/CLEC3B/CPB2/F7/NAGLU/SERPINF2,6.0,,
GO:1902652,discovery_tumor_THCA,GO:1902652,secondary alcohol metabolic process,5/53,150/18870,6.264898047721537e-05,0.0013455911459019302,0.0009844157115412942,APOA4/APOC1/HMGCS1/LCAT/PON1,5.0,,
GO:0019433,discovery_tumor_THCA,GO:0019433,triglyceride catabolic process,3/53,28/18870,6.521818551878935e-05,0.0013807621562692259,0.0010101463320955344,APOA4/APOC3/GPLD1,3.0,,
GO:0016125,discovery_tumor_THCA,GO:0016125,sterol metabolic process,5/53,154/18870,7.098244482697317e-05,0.0014816335666700598,0.0010839424488032967,APOA4/APOC1/HMGCS1/LCAT/PON1,5.0,,
GO:0032371,discovery_tumor_THCA,GO:0032371,regulation of sterol transport,4/53,80/18870,7.48896754652094e-05,0.0015203630005402784,0.0011122763623527855,APOA4/APOC1/APOC3/PON1,4.0,,
GO:0032374,discovery_tumor_THCA,GO:0032374,regulation of cholesterol transport,4/53,80/18870,7.48896754652094e-05,0.0015203630005402784,0.0011122763623527855,APOA4/APOC1/APOC3/PON1,4.0,,
GO:0006644,discovery_tumor_THCA,GO:0006644,phospholipid metabolic process,7/53,375/18870,8.122327169670683e-05,0.0016266606574935072,0.0011900422453429307,APOA4/APOC1/GPLD1/HEXB/HMGCS1/LCAT/PON1,7.0,,
GO:0006959,discovery_tumor_THCA,GO:0006959,humoral immune response,6/53,258/18870,8.259652808797571e-05,0.0016321073950184002,0.0011940270025349471,CLU/F2/FCN1/FCN2/HRG/SEMG1,6.0,,
GO:0005996,discovery_tumor_THCA,GO:0005996,monosaccharide metabolic process,6/53,261/18870,8.802309410970067e-05,0.0017164503351391632,0.0012557311209555634,FBP1/GPLD1/HEXB/IGFBP3/MST1/RBP4,6.0,,
GO:0030212,discovery_tumor_THCA,GO:0030212,hyaluronan metabolic process,3/53,34/18870,0.00011771860115923075,0.002265700869064675,0.0016575551496104944,HEXB/ITIH1/ITIH2,3.0,,
GO:0010984,discovery_tumor_THCA,GO:0010984,regulation of lipoprotein particle clearance,3/53,36/18870,0.0001399035038566621,0.00265816657327658,0.0019446775839724961,APOC1/APOC3/GPLD1,3.0,,
GO:0030100,discovery_tumor_THCA,GO:0030100,regulation of endocytosis,6/53,291/18870,0.00015954317642396178,0.0029929492083583717,0.0021895998896293224,AHSG/APOC1/APOC3/CLU/FCN1/FCN2,6.0,,
GO:0046461,discovery_tumor_THCA,GO:0046461,neutral lipid catabolic process,3/53,38/18870,0.00016464333119005134,0.003012363170662421,0.0022038028736290176,APOA4/APOC3/GPLD1,3.0,,
GO:0046464,discovery_tumor_THCA,GO:0046464,acylglycerol catabolic process,3/53,38/18870,0.00016464333119005134,0.003012363170662421,0.0022038028736290176,APOA4/APOC3/GPLD1,3.0,,
GO:0042632,discovery_tumor_THCA,GO:0042632,cholesterol homeostasis,4/53,100/18870,0.00017813761365762196,0.0032195115053731188,0.002355349705614257,APOA4/APOC3/APOM/LCAT,4.0,,
GO:0055092,discovery_tumor_THCA,GO:0055092,sterol homeostasis,4/53,101/18870,0.0001850997683616374,0.0033050344182162248,0.002417917075618092,APOA4/APOC3/APOM/LCAT,4.0,,
GO:0010906,discovery_tumor_THCA,GO:0010906,regulation of glucose metabolic process,4/53,103/18870,0.00019961048172290697,0.0035216992132541445,0.002576426017225491,FBP1/GPLD1/IGFBP3/MST1,4.0,,
GO:0006006,discovery_tumor_THCA,GO:0006006,glucose metabolic process,5/53,193/18870,0.00020478330965150335,0.003570457234159152,0.0026120967051523024,FBP1/GPLD1/IGFBP3/MST1/RBP4,5.0,,
GO:0006641,discovery_tumor_THCA,GO:0006641,triglyceride metabolic process,4/53,106/18870,0.00022289105453557266,0.0037968338255369967,0.0027777106614838456,APOA4/APOC1/APOC3/GPLD1,4.0,,
GO:0032963,discovery_tumor_THCA,GO:0032963,collagen metabolic process,4/53,106/18870,0.00022289105453557266,0.0037968338255369967,0.0027777106614838456,F2/NAGLU/PEPD/SERPINF2,4.0,,
GO:0090207,discovery_tumor_THCA,GO:0090207,regulation of triglyceride metabolic process,3/53,44/18870,0.00025542315466452713,0.004301558127418514,0.003146959919909844,APOA4/APOC3/GPLD1,3.0,,
GO:0062014,discovery_tumor_THCA,GO:0062014,negative regulation of small molecule metabolic process,4/53,115/18870,0.00030446364636164253,0.005069832852898362,0.0037090189917503465,APOC1/APOC3/FBP1/MST1,4.0,,
GO:0006953,discovery_tumor_THCA,GO:0006953,acute-phase response,3/53,48/18870,0.0003309360423379218,0.00538952983236044,0.00394290484219849,AHSG/F2/SERPINF2,3.0,,
GO:0044331,discovery_tumor_THCA,GO:0044331,cell-cell adhesion mediated by cadherin,3/53,48/18870,0.0003309360423379218,0.00538952983236044,0.00394290484219849,CDHR2/PLG/SERPINF2,3.0,,
GO:0016042,discovery_tumor_THCA,GO:0016042,lipid catabolic process,6/53,334/18870,0.0003349797369117767,0.0053960866315571,0.003947701705024371,APOA4/APOC1/APOC3/GPLD1/HEXB/NAGLU,6.0,,
GO:0051702,discovery_tumor_THCA,GO:0051702,biological process involved in interaction with symbiont,4/53,121/18870,0.00036952183349489896,0.00588850921762839,0.004307951199770752,F2/HRG/HSPD1/PLG,4.0,,
GO:0001867,discovery_tumor_THCA,GO:0001867,"complement activation, lectin pathway",2/53,11/18870,0.0004188674961110152,0.006466266971213797,0.004730630712657298,FCN1/FCN2,2.0,,
GO:0010982,discovery_tumor_THCA,GO:0010982,regulation of high-density lipoprotein particle clearance,2/53,11/18870,0.0004188674961110152,0.006466266971213797,0.004730630712657298,APOC3/GPLD1,2.0,,
GO:1903027,discovery_tumor_THCA,GO:1903027,regulation of opsonization,2/53,11/18870,0.0004188674961110152,0.006466266971213797,0.004730630712657298,FCN1/FCN2,2.0,,
GO:0019318,discovery_tumor_THCA,GO:0019318,hexose metabolic process,5/53,233/18870,0.0004869456253875467,0.007439725946642724,0.005442799719470136,FBP1/GPLD1/IGFBP3/MST1/RBP4,5.0,,
GO:0042304,discovery_tumor_THCA,GO:0042304,regulation of fatty acid biosynthetic process,3/53,55/18870,0.0004950600383394016,0.0074865201716223795,0.0054770337216926285,APOA4/APOC1/APOC3,3.0,,
GO:0034379,discovery_tumor_THCA,GO:0034379,very-low-density lipoprotein particle assembly,2/53,12/18870,0.0005017367595690904,0.007510847249306988,0.005494831072367497,APOC1/APOC3,2.0,,
GO:0006639,discovery_tumor_THCA,GO:0006639,acylglycerol metabolic process,4/53,134/18870,0.0005437127560420971,0.00805782304454388,0.005894990933930106,APOA4/APOC1/APOC3/GPLD1,4.0,,
GO:0006638,discovery_tumor_THCA,GO:0006638,neutral lipid metabolic process,4/53,135/18870,0.0005591574353207565,0.008204666526191694,0.006002419576658459,APOA4/APOC1/APOC3/GPLD1,4.0,,
GO:0034380,discovery_tumor_THCA,GO:0034380,high-density lipoprotein particle assembly,2/53,13/18870,0.000591895104974813,0.008599887701692871,0.0062915578753772695,APOM/LCAT,2.0,,
GO:0006066,discovery_tumor_THCA,GO:0006066,alcohol metabolic process,6/53,373/18870,0.0006007286124567601,0.008643493239426394,0.006323459078492213,APOA4/APOC1/HMGCS1/LCAT/PON1/RBP4,6.0,,
GO:0031638,discovery_tumor_THCA,GO:0031638,zymogen activation,3/53,59/18870,0.0006086131118332806,0.008672736843624249,0.006344853291379343,CLEC3B/CPB2/SERPINF2,3.0,,
GO:0050714,discovery_tumor_THCA,GO:0050714,positive regulation of protein secretion,4/53,144/18870,0.0007125198590209874,0.010056708867324793,0.007357347917710448,F2/GPLD1/PPIA/RBP4,4.0,,
GO:0046486,discovery_tumor_THCA,GO:0046486,glycerolipid metabolic process,6/53,390/18870,0.0007582572334796452,0.0106012945284607,0.007755759190506798,APOA4/APOC1/APOC3/GPLD1/LCAT/PON1,6.0,,
GO:0090209,discovery_tumor_THCA,GO:0090209,negative regulation of triglyceride metabolic process,2/53,15/18870,0.0007939190192496473,0.010996149406803525,0.00804462951133435,APOC3/GPLD1,2.0,,
GO:0006956,discovery_tumor_THCA,GO:0006956,complement activation,3/53,67/18870,0.0008827633014400176,0.011984417637144267,0.008767632762453723,CLU/FCN1/FCN2,3.0,,
GO:0070613,discovery_tumor_THCA,GO:0070613,regulation of protein processing,3/53,67/18870,0.0008827633014400176,0.011984417637144267,0.008767632762453723,CLEC3B/CPB2/SERPINF2,3.0,,
GO:0032368,discovery_tumor_THCA,GO:0032368,regulation of lipid transport,4/53,153/18870,0.0008935501423351784,0.011984417637144267,0.008767632762453723,APOA4/APOC1/APOC3/PON1,4.0,,
GO:0002836,discovery_tumor_THCA,GO:0002836,positive regulation of response to tumor cell,2/53,16/18870,0.0009057049766262873,0.011984417637144267,0.008767632762453723,HRG/HSPD1,2.0,,
GO:0002839,discovery_tumor_THCA,GO:0002839,positive regulation of immune response to tumor cell,2/53,16/18870,0.0009057049766262873,0.011984417637144267,0.008767632762453723,HRG/HSPD1,2.0,,
GO:0045807,discovery_tumor_THCA,GO:0045807,positive regulation of endocytosis,4/53,155/18870,0.0009377976480733841,0.012299257649953585,0.008997965323852683,AHSG/CLU/FCN1/FCN2,4.0,,
GO:0002752,discovery_tumor_THCA,GO:0002752,cell surface pattern recognition receptor signaling pathway,3/53,70/18870,0.0010027478320129663,0.013035721816168563,0.009536752234287677,FCN1/FCN2/NAGLU,3.0,,
GO:0008228,discovery_tumor_THCA,GO:0008228,opsonization,2/53,17/18870,0.0010246207918550565,0.013090413909734429,0.009576764206993722,FCN1/FCN2,2.0,,
GO:0060192,discovery_tumor_THCA,GO:0060192,negative regulation of lipase activity,2/53,17/18870,0.0010246207918550565,0.013090413909734429,0.009576764206993722,APOC1/APOC3,2.0,,
GO:1903317,discovery_tumor_THCA,GO:1903317,regulation of protein maturation,3/53,71/18870,0.0010449187074401457,0.013235636960908511,0.009683007365392262,CLEC3B/CPB2/SERPINF2,3.0,,
GO:0006801,discovery_tumor_THCA,GO:0006801,superoxide metabolic process,3/53,72/18870,0.0010881965134445358,0.013552161621216825,0.009914572391400901,APOA4/NAGLU/PON3,3.0,,
GO:0050766,discovery_tumor_THCA,GO:0050766,positive regulation of phagocytosis,3/53,72/18870,0.0010881965134445358,0.013552161621216825,0.009914572391400901,AHSG/FCN1/FCN2,3.0,,
GO:1903532,discovery_tumor_THCA,GO:1903532,positive regulation of secretion by cell,5/53,288/18870,0.001261319811652297,0.015577299673905866,0.011396135140367244,CPB2/F2/GPLD1/PPIA/RBP4,5.0,,
GO:0060191,discovery_tumor_THCA,GO:0060191,regulation of lipase activity,3/53,78/18870,0.001371726827958197,0.016800819496149155,0.012291245174397067,APOA4/APOC1/APOC3,3.0,,
GO:0006650,discovery_tumor_THCA,GO:0006650,glycerophospholipid metabolic process,5/53,298/18870,0.0014665343759338511,0.01769688616755856,0.012946795051200595,APOA4/APOC1/GPLD1/LCAT/PON1,5.0,,
GO:0055088,discovery_tumor_THCA,GO:0055088,lipid homeostasis,4/53,175/18870,0.0014687699045949412,0.01769688616755856,0.012946795051200595,APOA4/APOC3/APOM/LCAT,4.0,,
GO:0010985,discovery_tumor_THCA,GO:0010985,negative regulation of lipoprotein particle clearance,2/53,21/18870,0.001570796825415118,0.01847556266083496,0.013516463911257909,APOC1/APOC3,2.0,,
GO:0030502,discovery_tumor_THCA,GO:0030502,negative regulation of bone mineralization,2/53,21/18870,0.001570796825415118,0.01847556266083496,0.013516463911257909,AHSG/ECM1,2.0,,
GO:2000047,discovery_tumor_THCA,GO:2000047,regulation of cell-cell adhesion mediated by cadherin,2/53,21/18870,0.001570796825415118,0.01847556266083496,0.013516463911257909,PLG/SERPINF2,2.0,,
GO:0061844,discovery_tumor_THCA,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,3/53,83/18870,0.0016404255681198496,0.019142603873650528,0.014004461957425985,F2/HRG/SEMG1,3.0,,
GO:0032024,discovery_tumor_THCA,GO:0032024,positive regulation of insulin secretion,3/53,84/18870,0.001697826153124345,0.01957382677494379,0.014319938616515449,F2/GPLD1/RBP4,3.0,,
GO:0002837,discovery_tumor_THCA,GO:0002837,regulation of immune response to tumor cell,2/53,22/18870,0.0017247739512546267,0.01957382677494379,0.014319938616515449,HRG/HSPD1,2.0,,
GO:0090208,discovery_tumor_THCA,GO:0090208,positive regulation of triglyceride metabolic process,2/53,22/18870,0.0017247739512546267,0.01957382677494379,0.014319938616515449,APOA4/GPLD1,2.0,,
GO:1905952,discovery_tumor_THCA,GO:1905952,regulation of lipid localization,4/53,183/18870,0.0017302100590537355,0.01957382677494379,0.014319938616515449,APOA4/APOC1/APOC3/PON1,4.0,,
GO:0051047,discovery_tumor_THCA,GO:0051047,positive regulation of secretion,5/53,310/18870,0.0017442016438151547,0.019582627546470145,0.014326377138194655,CPB2/F2/GPLD1/PPIA/RBP4,5.0,,
GO:0002834,discovery_tumor_THCA,GO:0002834,regulation of response to tumor cell,2/53,23/18870,0.0018856468410317778,0.020854691182157423,0.015257001148960968,HRG/HSPD1,2.0,,
GO:0051131,discovery_tumor_THCA,GO:0051131,chaperone-mediated protein complex assembly,2/53,23/18870,0.0018856468410317778,0.020854691182157423,0.015257001148960968,CLU/HSPD1,2.0,,
GO:0006109,discovery_tumor_THCA,GO:0006109,regulation of carbohydrate metabolic process,4/53,188/18870,0.0019091137242378856,0.02095538163326832,0.015330664878376567,FBP1/GPLD1/IGFBP3/MST1,4.0,,
GO:0006790,discovery_tumor_THCA,GO:0006790,sulfur compound metabolic process,5/53,317/18870,0.001923030973093449,0.02095538163326832,0.015330664878376567,B4GAT1/BTD/HEXB/HMGCS1/NAGLU,5.0,,
GO:0046890,discovery_tumor_THCA,GO:0046890,regulation of lipid biosynthetic process,4/53,189/18870,0.0019463749136486806,0.021054946146185,0.01540350488711595,APOA4/APOC1/APOC3/GPLD1,4.0,,
GO:0006094,discovery_tumor_THCA,GO:0006094,gluconeogenesis,3/53,90/18870,0.002068680766907461,0.02221583258374534,0.016252793210638328,FBP1/MST1/RBP4,3.0,,
GO:0002220,discovery_tumor_THCA,GO:0002220,innate immune response activating cell surface receptor signaling pathway,3/53,91/18870,0.00213498687115899,0.022762953547177146,0.016653059275227262,FCN1/FCN2/NAGLU,3.0,,
GO:0008202,discovery_tumor_THCA,GO:0008202,steroid metabolic process,5/53,327/18870,0.0022013840028499818,0.022987724575989757,0.016817498624383444,APOA4/APOC1/HMGCS1/LCAT/PON1,5.0,,
GO:0031640,discovery_tumor_THCA,GO:0031640,killing of cells of another organism,3/53,92/18870,0.00220260248973721,0.022987724575989757,0.016817498624383444,F2/HRG/SEMG1,3.0,,
GO:0141061,discovery_tumor_THCA,GO:0141061,disruption of cell in another organism,3/53,92/18870,0.00220260248973721,0.022987724575989757,0.016817498624383444,F2/HRG/SEMG1,3.0,,
GO:0019319,discovery_tumor_THCA,GO:0019319,hexose biosynthetic process,3/53,93/18870,0.0022715366372830525,0.02354137969547891,0.017222544986393407,FBP1/MST1/RBP4,3.0,,
GO:0032967,discovery_tumor_THCA,GO:0032967,positive regulation of collagen biosynthetic process,2/53,26/18870,0.0024092561723174826,0.02462425963706558,0.018014764845640706,F2/SERPINF2,2.0,,
GO:0045717,discovery_tumor_THCA,GO:0045717,negative regulation of fatty acid biosynthetic process,2/53,26/18870,0.0024092561723174826,0.02462425963706558,0.018014764845640706,APOC1/APOC3,2.0,,
GO:0010714,discovery_tumor_THCA,GO:0010714,positive regulation of collagen metabolic process,2/53,27/18870,0.0025973289671143433,0.02636466800865381,0.01928802333185129,F2/SERPINF2,2.0,,
GO:0019216,discovery_tumor_THCA,GO:0019216,regulation of lipid metabolic process,5/53,342/18870,0.0026726770181000844,0.02669614295719581,0.01953052578017735,APOA4/APOC1/APOC3/F2/GPLD1,5.0,,
GO:0141060,discovery_tumor_THCA,GO:0141060,disruption of anatomical structure in another organism,3/53,99/18870,0.0027133227032685725,0.02669614295719581,0.01953052578017735,F2/HRG/SEMG1,3.0,,
GO:0019217,discovery_tumor_THCA,GO:0019217,regulation of fatty acid metabolic process,3/53,100/18870,0.0027917304895451953,0.02669614295719581,0.01953052578017735,APOA4/APOC1/APOC3,3.0,,
GO:0050764,discovery_tumor_THCA,GO:0050764,regulation of phagocytosis,3/53,100/18870,0.0027917304895451953,0.02669614295719581,0.01953052578017735,AHSG/FCN1/FCN2,3.0,,
GO:0001573,discovery_tumor_THCA,GO:0001573,ganglioside metabolic process,2/53,28/18870,0.0027921067195447714,0.02669614295719581,0.01953052578017735,HEXB/NAGLU,2.0,,
GO:0006027,discovery_tumor_THCA,GO:0006027,glycosaminoglycan catabolic process,2/53,28/18870,0.0027921067195447714,0.02669614295719581,0.01953052578017735,HEXB/PGLYRP2,2.0,,
GO:0051873,discovery_tumor_THCA,GO:0051873,killing by host of symbiont cells,2/53,28/18870,0.0027921067195447714,0.02669614295719581,0.01953052578017735,F2/HRG,2.0,,
GO:1902914,discovery_tumor_THCA,GO:1902914,regulation of protein polyubiquitination,2/53,28/18870,0.0027921067195447714,0.02669614295719581,0.01953052578017735,FBXO4/PPIA,2.0,,
GO:1903901,discovery_tumor_THCA,GO:1903901,negative regulation of viral life cycle,2/53,28/18870,0.0027921067195447714,0.02669614295719581,0.01953052578017735,FCN1/PPIA,2.0,,
GO:0045862,discovery_tumor_THCA,GO:0045862,positive regulation of proteolysis,5/53,350/18870,0.0029520881987200997,0.027872127645885588,0.02039085977360761,CLEC3B/CLU/GPLD1/HSPD1/SEMG1,5.0,,
GO:0046364,discovery_tumor_THCA,GO:0046364,monosaccharide biosynthetic process,3/53,102/18870,0.002952715276925801,0.027872127645885588,0.02039085977360761,FBP1/MST1/RBP4,3.0,,
GO:0002418,discovery_tumor_THCA,GO:0002418,immune response to tumor cell,2/53,29/18870,0.0029935517279101676,0.02790216138844571,0.020412832040698263,HRG/HSPD1,2.0,,
GO:0006910,discovery_tumor_THCA,GO:0006910,"phagocytosis, recognition",2/53,29/18870,0.0029935517279101676,0.02790216138844571,0.020412832040698263,FCN1/FCN2,2.0,,
GO:0015914,discovery_tumor_THCA,GO:0015914,phospholipid transport,3/53,103/18870,0.003035308420781894,0.028114544247492292,0.020568208377666784,APOA4/APOC1/APOC3,3.0,,
GO:0010955,discovery_tumor_THCA,GO:0010955,negative regulation of protein processing,2/53,30/18870,0.003201626442454422,0.02875642659222699,0.02103780054690944,CPB2/SERPINF2,2.0,,
GO:0035640,discovery_tumor_THCA,GO:0035640,exploration behavior,2/53,30/18870,0.003201626442454422,0.02875642659222699,0.02103780054690944,CHL1/NAGLU,2.0,,
GO:0070168,discovery_tumor_THCA,GO:0070168,negative regulation of biomineral tissue development,2/53,30/18870,0.003201626442454422,0.02875642659222699,0.02103780054690944,AHSG/ECM1,2.0,,
GO:0070723,discovery_tumor_THCA,GO:0070723,response to cholesterol,2/53,30/18870,0.003201626442454422,0.02875642659222699,0.02103780054690944,F7/GPLD1,2.0,,
GO:1903318,discovery_tumor_THCA,GO:1903318,negative regulation of protein maturation,2/53,30/18870,0.003201626442454422,0.02875642659222699,0.02103780054690944,CPB2/SERPINF2,2.0,,
GO:0002526,discovery_tumor_THCA,GO:0002526,acute inflammatory response,3/53,107/18870,0.0033798698532336827,0.02995826576854194,0.02191704932281994,AHSG/F2/SERPINF2,3.0,,
GO:0006664,discovery_tumor_THCA,GO:0006664,glycolipid metabolic process,3/53,107/18870,0.0033798698532336827,0.02995826576854194,0.02191704932281994,GPLD1/HEXB/NAGLU,3.0,,
GO:0032372,discovery_tumor_THCA,GO:0032372,negative regulation of sterol transport,2/53,31/18870,0.0034162934648337296,0.02995826576854194,0.02191704932281994,APOC1/APOC3,2.0,,
GO:0032375,discovery_tumor_THCA,GO:0032375,negative regulation of cholesterol transport,2/53,31/18870,0.0034162934648337296,0.02995826576854194,0.02191704932281994,APOC1/APOC3,2.0,,
GO:1903509,discovery_tumor_THCA,GO:1903509,liposaccharide metabolic process,3/53,108/18870,0.0034695958741398905,0.030246712267501866,0.022128072757672368,GPLD1/HEXB/NAGLU,3.0,,
GO:0090277,discovery_tumor_THCA,GO:0090277,positive regulation of peptide hormone secretion,3/53,109/18870,0.003560771210852829,0.030860017160724517,0.0225767580620401,F2/GPLD1/RBP4,3.0,,
GO:0042116,discovery_tumor_THCA,GO:0042116,macrophage activation,3/53,110/18870,0.0036534032258903368,0.031478741748659764,0.023029408339455614,CLU/HSPD1/NAGLU,3.0,,
GO:0002833,discovery_tumor_THCA,GO:0002833,positive regulation of response to biotic stimulus,5/53,369/18870,0.0036998832576691184,0.03169495368708458,0.023187585977482154,FCN1/FCN2/HRG/HSPD1/NAGLU,5.0,,
GO:0002793,discovery_tumor_THCA,GO:0002793,positive regulation of peptide secretion,3/53,111/18870,0.003747499189597935,0.03191835516657552,0.02335102338345961,F2/GPLD1/RBP4,3.0,,
GO:0045833,discovery_tumor_THCA,GO:0045833,negative regulation of lipid metabolic process,3/53,112/18870,0.003843066280689918,0.032545281302756905,0.023809673799161598,APOC1/APOC3/GPLD1,3.0,,
GO:0009743,discovery_tumor_THCA,GO:0009743,response to carbohydrate,4/53,230/18870,0.003945552511585006,0.03322334558050556,0.02430573616586457,CPB2/FBP1/GPLD1/NAGLU,4.0,,
GO:0006026,discovery_tumor_THCA,GO:0006026,aminoglycan catabolic process,2/53,34/18870,0.004099476655643498,0.03432443165911675,0.025111275380986047,HEXB/PGLYRP2,2.0,,
GO:0048259,discovery_tumor_THCA,GO:0048259,regulation of receptor-mediated endocytosis,3/53,115/18870,0.004138664742241379,0.034457871617987204,0.025208898193427677,APOC1/APOC3/CLU,3.0,,
GO:0072593,discovery_tumor_THCA,GO:0072593,reactive oxygen species metabolic process,4/53,234/18870,0.004194523165192899,0.034727839836960206,0.02540640317641097,APOA4/F2/NAGLU/PON3,4.0,,
GO:0002221,discovery_tumor_THCA,GO:0002221,pattern recognition receptor signaling pathway,4/53,236/18870,0.00432291130185768,0.03553641076643432,0.025997942388967507,FCN1/FCN2/HSPD1/NAGLU,4.0,,
GO:0036314,discovery_tumor_THCA,GO:0036314,response to sterol,2/53,35/18870,0.004340141935711615,0.03553641076643432,0.025997942388967507,F7/GPLD1,2.0,,
GO:0007617,discovery_tumor_THCA,GO:0007617,mating behavior,2/53,36/18870,0.004587214784644248,0.0373530346749603,0.027326959098806104,HEXB/SEMG1,2.0,,
GO:0002697,discovery_tumor_THCA,GO:0002697,regulation of immune effector process,5/53,389/18870,0.0046252277220908645,0.03745676220840799,0.02740284471529244,FCN1/FCN2/HSPD1/PGLYRP2/RBP4,5.0,,
GO:0048261,discovery_tumor_THCA,GO:0048261,negative regulation of receptor-mediated endocytosis,2/53,37/18870,0.00484065870153326,0.03898834888952332,0.028523332165785224,APOC1/APOC3,2.0,,
GO:0030282,discovery_tumor_THCA,GO:0030282,bone mineralization,3/53,123/18870,0.004993361684976439,0.04000087576829775,0.029264082705694066,AHSG/CLEC3B/ECM1,3.0,,
GO:0045926,discovery_tumor_THCA,GO:0045926,negative regulation of growth,4/53,247/18870,0.005076826592030685,0.04020663897782207,0.029414616199415256,CDHR2/FBP1/HRG/RBP4,4.0,,
GO:0032965,discovery_tumor_THCA,GO:0032965,regulation of collagen biosynthetic process,2/53,38/18870,0.005100437333218994,0.04020663897782207,0.029414616199415256,F2/SERPINF2,2.0,,
GO:0044273,discovery_tumor_THCA,GO:0044273,sulfur compound catabolic process,2/53,38/18870,0.005100437333218994,0.04020663897782207,0.029414616199415256,HEXB/NAGLU,2.0,,
GO:0009595,discovery_tumor_THCA,GO:0009595,detection of biotic stimulus,2/53,40/18870,0.005638854063986025,0.043983061699091,0.03217739438174851,CDHR2/PGLYRP2,2.0,,
GO:0030279,discovery_tumor_THCA,GO:0030279,negative regulation of ossification,2/53,40/18870,0.005638854063986025,0.043983061699091,0.03217739438174851,AHSG/ECM1,2.0,,
GO:0002758,discovery_tumor_THCA,GO:0002758,innate immune response-activating signaling pathway,4/53,255/18870,0.005677552404050611,0.044053050590591655,0.03222859727843555,FCN1/FCN2/HSPD1/NAGLU,4.0,,
GO:0009636,discovery_tumor_THCA,GO:0009636,response to toxic substance,4/53,258/18870,0.005914570403926671,0.045653090305308994,0.033399164013401705,APOA4/APOM/PON1/PON3,4.0,,
GO:0001558,discovery_tumor_THCA,GO:0001558,regulation of cell growth,5/53,417/18870,0.006183671753345504,0.046896053280613005,0.034308498386981606,CDHR2/F2/FBP1/HRG/IGFBP3,5.0,,
GO:0019730,discovery_tumor_THCA,GO:0019730,antimicrobial humoral response,3/53,133/18870,0.006201573642073011,0.046896053280613005,0.034308498386981606,F2/HRG/SEMG1,3.0,,
GO:0030168,discovery_tumor_THCA,GO:0030168,platelet activation,3/53,133/18870,0.006201573642073011,0.046896053280613005,0.034308498386981606,F2/HRG/PPIA,3.0,,
GO:0045922,discovery_tumor_THCA,GO:0045922,negative regulation of fatty acid metabolic process,2/53,42/18870,0.006202177087044635,0.046896053280613005,0.034308498386981606,APOC1/APOC3,2.0,,
GO:0010712,discovery_tumor_THCA,GO:0010712,regulation of collagen metabolic process,2/53,43/18870,0.00649308913043976,0.04811379045655862,0.03519937791764713,F2/SERPINF2,2.0,,
GO:0019098,discovery_tumor_THCA,GO:0019098,reproductive behavior,2/53,43/18870,0.00649308913043976,0.04811379045655862,0.03519937791764713,HEXB/SEMG1,2.0,,
GO:0055090,discovery_tumor_THCA,GO:0055090,acylglycerol homeostasis,2/53,43/18870,0.00649308913043976,0.04811379045655862,0.03519937791764713,APOA4/APOC3,2.0,,
GO:0070328,discovery_tumor_THCA,GO:0070328,triglyceride homeostasis,2/53,43/18870,0.00649308913043976,0.04811379045655862,0.03519937791764713,APOA4/APOC3,2.0,,
GO:0050708,discovery_tumor_THCA,GO:0050708,regulation of protein secretion,4/53,266/18870,0.006578756352180097,0.04850605429816371,0.035486352672141924,F2/GPLD1/PPIA/RBP4,4.0,,
hsa03050,discovery_tumor_others,hsa03050,Proteasome,2/3,46/8843,7.915860535487276e-05,0.0014248548963877096,0.00016664969548394265,PSMA7/PSMB1,2.0,Genetic Information Processing,"Folding, sorting and degradation"
hsa05017,discovery_tumor_others,hsa05017,Spinocerebellar ataxia,2/3,144/8843,0.000781617515289197,0.007034557637602773,0.0008227552792517863,PSMA7/PSMB1,2.0,Human Diseases,Neurodegenerative disease
hsa05012,discovery_tumor_others,hsa05012,Parkinson disease,2/3,271/8843,0.0027504531390350373,0.013006386460001509,0.0015212147906434512,PSMA7/PSMB1,2.0,Human Diseases,Neurodegenerative disease
hsa05020,discovery_tumor_others,hsa05020,Prion disease,2/3,278/8843,0.0028930884472539195,0.013006386460001509,0.0015212147906434512,PSMA7/PSMB1,2.0,Human Diseases,Neurodegenerative disease
hsa05016,discovery_tumor_others,hsa05016,Huntington disease,2/3,311/8843,0.003612885127778197,0.013006386460001509,0.0015212147906434512,PSMA7/PSMB1,2.0,Human Diseases,Neurodegenerative disease
hsa05014,discovery_tumor_others,hsa05014,Amyotrophic lateral sclerosis,2/3,371/8843,0.005120250908131772,0.01460350822224837,0.0017080126575729087,PSMA7/PSMB1,2.0,Human Diseases,Neurodegenerative disease
hsa05010,discovery_tumor_others,hsa05010,Alzheimer disease,2/3,391/8843,0.005679142086429921,0.01460350822224837,0.0017080126575729087,PSMA7/PSMB1,2.0,Human Diseases,Neurodegenerative disease
hsa05022,discovery_tumor_others,hsa05022,Pathways of neurodegeneration - multiple diseases,2/3,483/8843,0.008608361235886377,0.019368812780744347,0.002265358219970099,PSMA7/PSMB1,2.0,Human Diseases,Neurodegenerative disease
hsa05219,discovery_tumor_others,hsa05219,Bladder cancer,1/3,41/8843,0.013846475517227286,0.02769295103445457,0.003238941641456675,MMP2,1.0,Human Diseases,Cancer: specific types
R-HSA-1236978,discovery_tumor_others,R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),2/3,49/11009,5.8058287545637764e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-211733,discovery_tumor_others,R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,2/3,50/11009,6.047370943805378e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-350562,discovery_tumor_others,R-HSA-350562,Regulation of ornithine decarboxylase (ODC),2/3,51/11009,6.293820075141786e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-180534,discovery_tumor_others,R-HSA-180534,Vpu mediated degradation of CD4,2/3,52/11009,6.545175248959464e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-349425,discovery_tumor_others,R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,2/3,52/11009,6.545175248959464e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-69601,discovery_tumor_others,R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,2/3,52/11009,6.545175248959464e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-69610,discovery_tumor_others,R-HSA-69610,p53-Independent DNA Damage Response,2/3,52/11009,6.545175248959464e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-69613,discovery_tumor_others,R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,2/3,52/11009,6.545175248959464e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-75815,discovery_tumor_others,R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,2/3,52/11009,6.545175248959464e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-9762114,discovery_tumor_others,R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,2/3,52/11009,6.545175248959464e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-169911,discovery_tumor_others,R-HSA-169911,Regulation of Apoptosis,2/3,53/11009,6.801435565644868e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-180585,discovery_tumor_others,R-HSA-180585,Vif-mediated degradation of APOBEC3G,2/3,54/11009,7.062600125584445e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-9604323,discovery_tumor_others,R-HSA-9604323,Negative regulation of NOTCH4 signaling,2/3,54/11009,7.062600125584445e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-174113,discovery_tumor_others,R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,2/3,55/11009,7.328668029164625e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-4641257,discovery_tumor_others,R-HSA-4641257,Degradation of AXIN,2/3,55/11009,7.328668029164625e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-8854050,discovery_tumor_others,R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,2/3,55/11009,7.328668029164625e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-8941858,discovery_tumor_others,R-HSA-8941858,Regulation of RUNX3 expression and activity,2/3,55/11009,7.328668029164625e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-9824272,discovery_tumor_others,R-HSA-9824272,Somitogenesis,2/3,55/11009,7.328668029164625e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-450408,discovery_tumor_others,R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,2/3,56/11009,7.599638376771903e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-5362768,discovery_tumor_others,R-HSA-5362768,Hh mutants are degraded by ERAD,2/3,56/11009,7.599638376771903e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-4641258,discovery_tumor_others,R-HSA-4641258,Degradation of DVL,2/3,57/11009,7.875510268792712e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-69541,discovery_tumor_others,R-HSA-69541,Stabilization of p53,2/3,57/11009,7.875510268792712e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-449147,discovery_tumor_others,R-HSA-449147,Signaling by Interleukins,3/3,473/11009,7.883131794767094e-05,0.00037052262380592985,1.0909757049861756e-05,MMP2/PSMA7/PSMB1,3.0,,
R-HSA-351202,discovery_tumor_others,R-HSA-351202,Metabolism of polyamines,2/3,59/11009,8.441955087620697e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-5387390,discovery_tumor_others,R-HSA-5387390,Hh mutants abrogate ligand secretion,2/3,59/11009,8.441955087620697e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-5676590,discovery_tumor_others,R-HSA-5676590,NIK-->noncanonical NF-kB signaling,2/3,59/11009,8.441955087620697e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-187577,discovery_tumor_others,R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,2/3,60/11009,8.732526215200823e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-5607761,discovery_tumor_others,R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,2/3,60/11009,8.732526215200823e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-5610780,discovery_tumor_others,R-HSA-5610780,Degradation of GLI1 by the proteasome,2/3,60/11009,8.732526215200823e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-5610783,discovery_tumor_others,R-HSA-5610783,Degradation of GLI2 by the proteasome,2/3,60/11009,8.732526215200823e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-5610785,discovery_tumor_others,R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,2/3,60/11009,8.732526215200823e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-5678895,discovery_tumor_others,R-HSA-5678895,Defective CFTR causes cystic fibrosis,2/3,61/11009,9.027995288740277e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-174084,discovery_tumor_others,R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,2/3,63/11009,9.633623675242976e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-4608870,discovery_tumor_others,R-HSA-4608870,Asymmetric localization of PCP proteins,2/3,64/11009,9.943781188979159e-05,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-5358346,discovery_tumor_others,R-HSA-5358346,Hedgehog ligand biogenesis,2/3,65/11009,0.00010258833050220492,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-1234176,discovery_tumor_others,R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,2/3,66/11009,0.00010578778359353401,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-69563,discovery_tumor_others,R-HSA-69563,p53-Dependent G1 DNA Damage Response,2/3,66/11009,0.00010578778359353401,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-69580,discovery_tumor_others,R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,2/3,66/11009,0.00010578778359353401,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-1169091,discovery_tumor_others,R-HSA-1169091,Activation of NF-kappaB in B cells,2/3,67/11009,0.00010903616216764391,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-174154,discovery_tumor_others,R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,2/3,67/11009,0.00010903616216764391,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-5658442,discovery_tumor_others,R-HSA-5658442,Regulation of RAS by GAPs,2/3,68/11009,0.00011233345722839891,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-69615,discovery_tumor_others,R-HSA-69615,G1/S DNA Damage Checkpoints,2/3,68/11009,0.00011233345722839891,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-8948751,discovery_tumor_others,R-HSA-8948751,Regulation of PTEN stability and activity,2/3,69/11009,0.0001156796597796638,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-9793380,discovery_tumor_others,R-HSA-9793380,Formation of paraxial mesoderm,2/3,69/11009,0.0001156796597796638,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-68949,discovery_tumor_others,R-HSA-68949,Orc1 removal from chromatin,2/3,71/11009,0.00012251875136917948,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-174184,discovery_tumor_others,R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,2/3,72/11009,0.00012601162241515995,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-69017,discovery_tumor_others,R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,2/3,72/11009,0.00012601162241515995,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-174178,discovery_tumor_others,R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,2/3,73/11009,0.00012955336496710834,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-179419,discovery_tumor_others,R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,2/3,73/11009,0.00012955336496710834,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-8939902,discovery_tumor_others,R-HSA-8939902,Regulation of RUNX2 expression and activity,2/3,73/11009,0.00012955336496710834,0.00037052262380592985,1.0909757049861756e-05,PSMA7/PSMB1,2.0,,
R-HSA-1234174,discovery_tumor_others,R-HSA-1234174,Cellular response to hypoxia,2/3,75/11009,0.00013678342860436537,0.0003761544286620048,1.1075581263511366e-05,PSMA7/PSMB1,2.0,,
R-HSA-176409,discovery_tumor_others,R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,2/3,75/11009,0.00013678342860436537,0.0003761544286620048,1.1075581263511366e-05,PSMA7/PSMB1,2.0,,
R-HSA-176814,discovery_tumor_others,R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,2/3,76/11009,0.00014047173169740417,0.00037900863457978863,1.1159621187479973e-05,PSMA7/PSMB1,2.0,,
R-HSA-8852276,discovery_tumor_others,R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,2/3,77/11009,0.000144208870311868,0.0003818864528629098,1.1244356359599845e-05,PSMA7/PSMB1,2.0,,
R-HSA-5619084,discovery_tumor_others,R-HSA-5619084,ABC transporter disorders,2/3,78/11009,0.00014799483545162255,0.0003847865721742186,1.1329748168545268e-05,PSMA7/PSMB1,2.0,,
R-HSA-176408,discovery_tumor_others,R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,2/3,80/11009,0.00015571320932246076,0.0003930313838622328,1.1572510382399198e-05,PSMA7/PSMB1,2.0,,
R-HSA-2871837,discovery_tumor_others,R-HSA-2871837,FCERI mediated NF-kB activation,2/3,82/11009,0.00016362678134083448,0.0003930313838622328,1.1572510382399198e-05,PSMA7/PSMB1,2.0,,
R-HSA-9013694,discovery_tumor_others,R-HSA-9013694,Signaling by NOTCH4,2/3,82/11009,0.00016362678134083448,0.0003930313838622328,1.1572510382399198e-05,PSMA7/PSMB1,2.0,,
R-HSA-1168372,discovery_tumor_others,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),2/3,83/11009,0.0001676567441650084,0.0003930313838622328,1.1572510382399198e-05,PSMA7/PSMB1,2.0,,
R-HSA-195253,discovery_tumor_others,R-HSA-195253,Degradation of beta-catenin by the destruction complex,2/3,83/11009,0.0001676567441650084,0.0003930313838622328,1.1572510382399198e-05,PSMA7/PSMB1,2.0,,
R-HSA-69202,discovery_tumor_others,R-HSA-69202,Cyclin E associated events during G1/S transition,2/3,83/11009,0.0001676567441650084,0.0003930313838622328,1.1572510382399198e-05,PSMA7/PSMB1,2.0,,
R-HSA-5632684,discovery_tumor_others,R-HSA-5632684,Hedgehog 'on' state,2/3,85/11009,0.00017586297846265334,0.00039918104635173693,1.1753582520478085e-05,PSMA7/PSMB1,2.0,,
R-HSA-69656,discovery_tumor_others,R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,2/3,85/11009,0.00017586297846265334,0.00039918104635173693,1.1753582520478085e-05,PSMA7/PSMB1,2.0,,
R-HSA-174143,discovery_tumor_others,R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,2/3,87/11009,0.00018426423098512454,0.000405381308167274,1.1936144517255031e-05,PSMA7/PSMB1,2.0,,
R-HSA-453276,discovery_tumor_others,R-HSA-453276,Regulation of mitotic cell cycle,2/3,87/11009,0.00018426423098512454,0.000405381308167274,1.1936144517255031e-05,PSMA7/PSMB1,2.0,,
R-HSA-450531,discovery_tumor_others,R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,2/3,88/11009,0.0001885379665903308,0.00040849892761238337,1.2027940452333705e-05,PSMA7/PSMB1,2.0,,
R-HSA-5687128,discovery_tumor_others,R-HSA-5687128,MAPK6/MAPK4 signaling,2/3,89/11009,0.00019286042976333795,0.00041162748442025865,1.2120058429746297e-05,PSMA7/PSMB1,2.0,,
R-HSA-1236974,discovery_tumor_others,R-HSA-1236974,ER-Phagosome pathway,2/3,90/11009,0.000197231611508009,0.0004147664771418425,1.221248368470644e-05,PSMA7/PSMB1,2.0,,
R-HSA-69052,discovery_tumor_others,R-HSA-69052,Switching of origins to a post-replicative state,2/3,91/11009,0.0002016515028282096,0.0004179154333975938,1.2305202308357565e-05,PSMA7/PSMB1,2.0,,
R-HSA-4086400,discovery_tumor_others,R-HSA-4086400,PCP/CE pathway,2/3,92/11009,0.00020612009472780398,0.0004210739078010852,1.2398201186634827e-05,PSMA7/PSMB1,2.0,,
R-HSA-8878159,discovery_tumor_others,R-HSA-8878159,Transcriptional regulation by RUNX3,2/3,96/11009,0.00022448128819740781,0.00045212428467928615,1.331245593461277e-05,PSMA7/PSMB1,2.0,,
R-HSA-9759194,discovery_tumor_others,R-HSA-9759194,Nuclear events mediated by NFE2L2,2/3,97/11009,0.00022919324805193824,0.00045520325654759957,1.3403113921165982e-05,PSMA7/PSMB1,2.0,,
R-HSA-202424,discovery_tumor_others,R-HSA-202424,Downstream TCR signaling,2/3,98/11009,0.0002339538545090491,0.00045829316705197287,1.3494093987544286e-05,PSMA7/PSMB1,2.0,,
R-HSA-5607764,discovery_tumor_others,R-HSA-5607764,CLEC7A (Dectin-1) signaling,2/3,101/11009,0.00024852746353451336,0.0004769474605395363,1.404335548147328e-05,PSMA7/PSMB1,2.0,,
R-HSA-5668541,discovery_tumor_others,R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,2/3,102/11009,0.0002534825664405927,0.0004769474605395363,1.404335548147328e-05,PSMA7/PSMB1,2.0,,
R-HSA-5689603,discovery_tumor_others,R-HSA-5689603,UCH proteinases,2/3,102/11009,0.0002534825664405927,0.0004769474605395363,1.404335548147328e-05,PSMA7/PSMB1,2.0,,
R-HSA-382556,discovery_tumor_others,R-HSA-382556,ABC-family proteins mediated transport,2/3,103/11009,0.0002584862709685763,0.0004800459317987846,1.4134587612772456e-05,PSMA7/PSMB1,2.0,,
R-HSA-1236975,discovery_tumor_others,R-HSA-1236975,Antigen processing-Cross presentation,2/3,105/11009,0.0002686394489057111,0.000492505656327137,1.4501454731752284e-05,PSMA7/PSMB1,2.0,,
R-HSA-983705,discovery_tumor_others,R-HSA-983705,Signaling by the B Cell Receptor (BCR),2/3,112/11009,0.00030570520034372677,0.0005533651094829485,1.62934150749488e-05,PSMA7/PSMB1,2.0,,
R-HSA-5610787,discovery_tumor_others,R-HSA-5610787,Hedgehog 'off' state,2/3,113/11009,0.00031119442630329344,0.000556260037017137,1.6378654015962814e-05,PSMA7/PSMB1,2.0,,
R-HSA-9758941,discovery_tumor_others,R-HSA-9758941,Gastrulation,2/3,114/11009,0.00031673215492727334,0.0005591691130197542,1.6464309547876457e-05,PSMA7/PSMB1,2.0,,
R-HSA-9020702,discovery_tumor_others,R-HSA-9020702,Interleukin-1 signaling,2/3,115/11009,0.000322318377219531,0.0005620918041755235,1.6550365967626753e-05,PSMA7/PSMB1,2.0,,
R-HSA-202403,discovery_tumor_others,R-HSA-202403,TCR signaling,2/3,120/11009,0.0003509765788402434,0.0005974958425494619,1.7592810969435757e-05,PSMA7/PSMB1,2.0,,
R-HSA-69239,discovery_tumor_others,R-HSA-69239,Synthesis of DNA,2/3,120/11009,0.0003509765788402434,0.0005974958425494619,1.7592810969435757e-05,PSMA7/PSMB1,2.0,,
R-HSA-8878166,discovery_tumor_others,R-HSA-8878166,Transcriptional regulation by RUNX2,2/3,121/11009,0.0003568535742233217,0.0006003536601639412,1.7676957237068567e-05,PSMA7/PSMB1,2.0,,
R-HSA-9755511,discovery_tumor_others,R-HSA-9755511,KEAP1-NFE2L2 pathway,2/3,126/11009,0.0003869648316459492,0.0006434415223880318,1.8945646592212937e-05,PSMA7/PSMB1,2.0,,
R-HSA-8939236,discovery_tumor_others,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,2/3,129/11009,0.0004056122866444337,0.0006666960573580922,1.9630358700275073e-05,PSMA7/PSMB1,2.0,,
R-HSA-162909,discovery_tumor_others,R-HSA-162909,Host Interactions of HIV factors,2/3,130/11009,0.00041192483442460047,0.0006693778559399758,1.970932222127275e-05,PSMA7/PSMB1,2.0,,
R-HSA-69206,discovery_tumor_others,R-HSA-69206,G1/S Transition,2/3,131/11009,0.00041828573193487757,0.000672077074906601,1.978879867225914e-05,PSMA7/PSMB1,2.0,,
R-HSA-2454202,discovery_tumor_others,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,2/3,134/11009,0.0004376584328850144,0.0006953906211395229,2.0475248322105937e-05,PSMA7/PSMB1,2.0,,
R-HSA-6807070,discovery_tumor_others,R-HSA-6807070,PTEN Regulation,2/3,140/11009,0.0004777080630199738,0.0007506840990313874,2.2103322753960617e-05,PSMA7/PSMB1,2.0,,
R-HSA-68867,discovery_tumor_others,R-HSA-68867,Assembly of the pre-replicative complex,2/3,141/11009,0.0004845519630439005,0.0007531622903834541,2.217629121482382e-05,PSMA7/PSMB1,2.0,,
R-HSA-5621481,discovery_tumor_others,R-HSA-5621481,C-type lectin receptors (CLRs),2/3,143/11009,0.0004983845064134794,0.0007663331657755652,2.256409763049143e-05,PSMA7/PSMB1,2.0,,
R-HSA-3858494,discovery_tumor_others,R-HSA-3858494,Beta-catenin independent WNT signaling,2/3,146/11009,0.0005194950448301262,0.0007902956533054047,2.3269654863611475e-05,PSMA7/PSMB1,2.0,,
R-HSA-453279,discovery_tumor_others,R-HSA-453279,Mitotic G1 phase and G1/S transition,2/3,149/11009,0.0005410394353742569,0.0008059233256095702,2.372979979711653e-05,PSMA7/PSMB1,2.0,,
R-HSA-5358351,discovery_tumor_others,R-HSA-5358351,Signaling by Hedgehog,2/3,149/11009,0.0005410394353742569,0.0008059233256095702,2.372979979711653e-05,PSMA7/PSMB1,2.0,,
R-HSA-446652,discovery_tumor_others,R-HSA-446652,Interleukin-1 family signaling,2/3,153/11009,0.0005704397507006366,0.0008409575706205261,2.476135651440636e-05,PSMA7/PSMB1,2.0,,
R-HSA-69002,discovery_tumor_others,R-HSA-69002,DNA Replication Pre-Initiation,2/3,158/11009,0.0006082732908149663,0.0008875824549646956,2.6134190797635504e-05,PSMA7/PSMB1,2.0,,
R-HSA-69242,discovery_tumor_others,R-HSA-69242,S Phase,2/3,162/11009,0.0006394059379729457,0.0009235863548498105,2.719429826572869e-05,PSMA7/PSMB1,2.0,,
R-HSA-69481,discovery_tumor_others,R-HSA-69481,G2/M Checkpoints,2/3,167/11009,0.00067940307115934,0.0009715463917578562,2.8606445101445895e-05,PSMA7/PSMB1,2.0,,
R-HSA-9010553,discovery_tumor_others,R-HSA-9010553,Regulation of expression of SLITs and ROBOs,2/3,172/11009,0.0007206006261731746,0.0010202563321065738,3.0040672274024993e-05,PSMA7/PSMB1,2.0,,
R-HSA-5619115,discovery_tumor_others,R-HSA-5619115,Disorders of transmembrane transporters,2/3,176/11009,0.0007544222182246177,0.0010576703647658854,3.114230002991198e-05,PSMA7/PSMB1,2.0,,
R-HSA-109581,discovery_tumor_others,R-HSA-109581,Apoptosis,2/3,180/11009,0.0007890107848021142,0.0010954227400650713,3.225389002767968e-05,PSMA7/PSMB1,2.0,,
R-HSA-69306,discovery_tumor_others,R-HSA-69306,DNA Replication,2/3,186/11009,0.0008423304524457431,0.0011582043721128966,3.4102447467439e-05,PSMA7/PSMB1,2.0,,
R-HSA-2467813,discovery_tumor_others,R-HSA-2467813,Separation of Sister Chromatids,2/3,190/11009,0.0008788339364204383,0.0011968881229345019,3.524146110959151e-05,PSMA7/PSMB1,2.0,,
R-HSA-69275,discovery_tumor_others,R-HSA-69275,G2/M Transition,2/3,197/11009,0.0009445553705612334,0.0012742586602854376,3.7519577778003316e-05,PSMA7/PSMB1,2.0,,
R-HSA-453274,discovery_tumor_others,R-HSA-453274,Mitotic G2-G2/M phases,2/3,199/11009,0.0009637627810162212,0.0012880194176198097,3.792475281913315e-05,PSMA7/PSMB1,2.0,,
R-HSA-5357801,discovery_tumor_others,R-HSA-5357801,Programmed Cell Death,2/3,213/11009,0.0011035562715698295,0.0014611902484674595,4.302363631851187e-05,PSMA7/PSMB1,2.0,,
R-HSA-9711123,discovery_tumor_others,R-HSA-9711123,Cellular response to chemical stress,2/3,215/11009,0.0011242889947868653,0.0014749846445368964,4.342980182662928e-05,PSMA7/PSMB1,2.0,,
R-HSA-376176,discovery_tumor_others,R-HSA-376176,Signaling by ROBO receptors,2/3,219/11009,0.0011663253899549953,0.0015025633402122912,4.424183556017052e-05,PSMA7/PSMB1,2.0,,
R-HSA-5689880,discovery_tumor_others,R-HSA-5689880,Ub-specific processing proteases,2/3,219/11009,0.0011663253899549953,0.0015025633402122912,4.424183556017052e-05,PSMA7/PSMB1,2.0,,
R-HSA-162906,discovery_tumor_others,R-HSA-162906,HIV Infection,2/3,231/11009,0.0012969969835577755,0.0016542296474332317,4.870753470543192e-05,PSMA7/PSMB1,2.0,,
R-HSA-201681,discovery_tumor_others,R-HSA-201681,TCF dependent signaling in response to WNT,2/3,232/11009,0.0013081948647153477,0.0016542296474332317,4.870753470543192e-05,PSMA7/PSMB1,2.0,,
R-HSA-157118,discovery_tumor_others,R-HSA-157118,Signaling by NOTCH,2/3,235/11009,0.0013420730649492648,0.0016542296474332317,4.870753470543192e-05,PSMA7/PSMB1,2.0,,
R-HSA-68882,discovery_tumor_others,R-HSA-68882,Mitotic Anaphase,2/3,235/11009,0.0013420730649492648,0.0016542296474332317,4.870753470543192e-05,PSMA7/PSMB1,2.0,,
R-HSA-2555396,discovery_tumor_others,R-HSA-2555396,Mitotic Metaphase and Anaphase,2/3,236/11009,0.0013534606206271895,0.0016542296474332317,4.870753470543192e-05,PSMA7/PSMB1,2.0,,
R-HSA-8878171,discovery_tumor_others,R-HSA-8878171,Transcriptional regulation by RUNX1,2/3,236/11009,0.0013534606206271895,0.0016542296474332317,4.870753470543192e-05,PSMA7/PSMB1,2.0,,
R-HSA-8951664,discovery_tumor_others,R-HSA-8951664,Neddylation,2/3,246/11009,0.0014699414807303204,0.0017813697605460663,5.245107870580983e-05,PSMA7/PSMB1,2.0,,
R-HSA-1257604,discovery_tumor_others,R-HSA-1257604,PIP3 activates AKT signaling,2/3,268/11009,0.001742838481193519,0.00209433531773675,6.166611167425101e-05,PSMA7/PSMB1,2.0,,
R-HSA-5673001,discovery_tumor_others,R-HSA-5673001,RAF/MAP kinase cascade,2/3,280/11009,0.001901307593645784,0.0022657248824278927,6.671254714546611e-05,PSMA7/PSMB1,2.0,,
R-HSA-5684996,discovery_tumor_others,R-HSA-5684996,MAPK1/MAPK3 signaling,2/3,286/11009,0.00198308113818315,0.002343641345125541,6.900673817079253e-05,PSMA7/PSMB1,2.0,,
R-HSA-69620,discovery_tumor_others,R-HSA-69620,Cell Cycle Checkpoints,2/3,292/11009,0.002066544750707655,0.0024222614700917596,7.132164799681295e-05,PSMA7/PSMB1,2.0,,
R-HSA-5688426,discovery_tumor_others,R-HSA-5688426,Deubiquitination,2/3,297/11009,0.002137387383403801,0.0024849300473718987,7.316687662486268e-05,PSMA7/PSMB1,2.0,,
R-HSA-983168,discovery_tumor_others,R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,2/3,309/11009,0.00231218599309387,0.0026621527098467596,7.83850632269933e-05,PSMA7/PSMB1,2.0,,
R-HSA-9006925,discovery_tumor_others,R-HSA-9006925,Intracellular signaling by second messengers,2/3,310/11009,0.0023270565645513636,0.0026621527098467596,7.83850632269933e-05,PSMA7/PSMB1,2.0,,
R-HSA-5683057,discovery_tumor_others,R-HSA-5683057,MAPK family signaling cascades,2/3,325/11009,0.002555717749664838,0.002900536811127554,8.540410191027029e-05,PSMA7/PSMB1,2.0,,
R-HSA-195721,discovery_tumor_others,R-HSA-195721,Signaling by WNT,2/3,331/11009,0.002650119439452462,0.0029839927546590713,8.786139873858142e-05,PSMA7/PSMB1,2.0,,
R-HSA-71291,discovery_tumor_others,R-HSA-71291,Metabolism of amino acids and derivatives,2/3,376/11009,0.003411404292153133,0.0038111782326398285,0.0001122172464524057,PSMA7/PSMB1,2.0,,
R-HSA-983169,discovery_tumor_others,R-HSA-983169,Class I MHC mediated antigen processing & presentation,2/3,381/11009,0.003501773576665804,0.003881811019094651,0.00011429697516657053,PSMA7/PSMB1,2.0,,
R-HSA-68886,discovery_tumor_others,R-HSA-68886,M Phase,2/3,416/11009,0.004166559785380314,0.004583215763918346,0.0001349493047896458,PSMA7/PSMB1,2.0,,
R-HSA-5663202,discovery_tumor_others,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,2/3,433/11009,0.004509713162881101,0.004922816658717538,0.0001449485950303287,PSMA7/PSMB1,2.0,,
R-HSA-1592389,discovery_tumor_others,R-HSA-1592389,Activation of Matrix Metalloproteinases,1/3,33/11009,0.008966525522684399,0.009713735982908098,0.00028601357329136837,MMP2,1.0,,
R-HSA-3928665,discovery_tumor_others,R-HSA-3928665,EPH-ephrin mediated repulsion of cells,1/3,51/11009,0.013834688174222176,0.014874890292584748,0.0004379798393105557,MMP2,1.0,,
R-HSA-1442490,discovery_tumor_others,R-HSA-1442490,Collagen degradation,1/3,64/11009,0.01734065091832171,0.018505321502388095,0.0005448751270486004,MMP2,1.0,,
R-HSA-9009391,discovery_tumor_others,R-HSA-9009391,Extra-nuclear estrogen signaling,1/3,77/11009,0.02083829432421036,0.022073156210089494,0.0006499273083574382,MMP2,1.0,,
R-HSA-2682334,discovery_tumor_others,R-HSA-2682334,EPH-Ephrin signaling,1/3,92/11009,0.02486371198587778,0.026143461867503843,0.000769774364887857,MMP2,1.0,,
R-HSA-6785807,discovery_tumor_others,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,1/3,108/11009,0.029145314171789005,0.03042175128880166,0.0008957453452720402,MMP2,1.0,,
R-HSA-381426,discovery_tumor_others,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),1/3,125/11009,0.03368076429768507,0.03490108184470265,0.0010276358290674317,MMP2,1.0,,
R-HSA-1474228,discovery_tumor_others,R-HSA-1474228,Degradation of the extracellular matrix,1/3,140/11009,0.03767088274305308,0.03875493692270929,0.0011411096627960038,MMP2,1.0,,
GO:0014012,discovery_tumor_others,GO:0014012,peripheral nervous system axon regeneration,1/3,10/18870,0.0015890669230512744,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0060346,discovery_tumor_others,GO:0060346,bone trabecula formation,1/3,10/18870,0.0015890669230512744,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0043161,discovery_tumor_others,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,2/3,458/18870,0.0017351133062548751,0.030231027459737953,0.004508135673820571,PSMA7/PSMB1,2.0,,
GO:0071492,discovery_tumor_others,GO:0071492,cellular response to UV-A,1/3,11/18870,0.0017478809633072467,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0001553,discovery_tumor_others,GO:0001553,luteinization,1/3,12/18870,0.0019066781613090722,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0061430,discovery_tumor_others,GO:0061430,bone trabecula morphogenesis,1/3,13/18870,0.002065458517948815,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0070141,discovery_tumor_others,GO:0070141,response to UV-A,1/3,14/18870,0.0022242220341202046,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0007567,discovery_tumor_others,GO:0007567,parturition,1/3,15/18870,0.0023829687107166375,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0030728,discovery_tumor_others,GO:0030728,ovulation,1/3,15/18870,0.0023829687107166375,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0055093,discovery_tumor_others,GO:0055093,response to hyperoxia,1/3,20/18870,0.003176449531326342,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0071498,discovery_tumor_others,GO:0071498,cellular response to fluid shear stress,1/3,21/18870,0.003335095189226145,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0060343,discovery_tumor_others,GO:0060343,trabecula formation,1/3,26/18870,0.0041280709967321805,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0060740,discovery_tumor_others,GO:0060740,prostate gland epithelium morphogenesis,1/3,26/18870,0.0041280709967321805,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0036296,discovery_tumor_others,GO:0036296,response to increased oxygen levels,1/3,27/18870,0.00428661566808719,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0060512,discovery_tumor_others,GO:0060512,prostate gland morphogenesis,1/3,28/18870,0.004445143511477068,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0060325,discovery_tumor_others,GO:0060325,face morphogenesis,1/3,31/18870,0.004920626082788315,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0034405,discovery_tumor_others,GO:0034405,response to fluid shear stress,1/3,34/18870,0.005395957234567539,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0060323,discovery_tumor_others,GO:0060323,head morphogenesis,1/3,37/18870,0.005871136990928338,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0071392,discovery_tumor_others,GO:0071392,cellular response to estradiol stimulus,1/3,38/18870,0.006029496603790152,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0048246,discovery_tumor_others,GO:0048246,macrophage chemotaxis,1/3,41/18870,0.006504474537103899,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0030574,discovery_tumor_others,GO:0030574,collagen catabolic process,1/3,45/18870,0.007137543035897309,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0051602,discovery_tumor_others,GO:0051602,response to electrical stimulus,1/3,45/18870,0.007137543035897309,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0061383,discovery_tumor_others,GO:0061383,trabecula morphogenesis,1/3,47/18870,0.007453976410388474,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0010171,discovery_tumor_others,GO:0010171,body morphogenesis,1/3,49/18870,0.007770342544468289,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0035987,discovery_tumor_others,GO:0035987,endodermal cell differentiation,1/3,49/18870,0.007770342544468289,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0022602,discovery_tumor_others,GO:0022602,ovulation cycle process,1/3,50/18870,0.007928500398586835,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0030850,discovery_tumor_others,GO:0030850,prostate gland development,1/3,50/18870,0.007928500398586835,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0035094,discovery_tumor_others,GO:0035094,response to nicotine,1/3,51/18870,0.008086641445282039,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0048013,discovery_tumor_others,GO:0048013,ephrin receptor signaling pathway,1/3,51/18870,0.008086641445282039,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0031103,discovery_tumor_others,GO:0031103,axon regeneration,1/3,52/18870,0.008244765685446964,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0060324,discovery_tumor_others,GO:0060324,face development,1/3,52/18870,0.008244765685446964,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:1904707,discovery_tumor_others,GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,1/3,52/18870,0.008244765685446964,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:1904645,discovery_tumor_others,GO:1904645,response to amyloid-beta,1/3,53/18870,0.008402873119974896,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0001541,discovery_tumor_others,GO:0001541,ovarian follicle development,1/3,56/18870,0.008877094598666146,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0001706,discovery_tumor_others,GO:0001706,endoderm formation,1/3,58/18870,0.00919315823931477,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0031102,discovery_tumor_others,GO:0031102,neuron projection regeneration,1/3,58/18870,0.00919315823931477,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0007566,discovery_tumor_others,GO:0007566,embryo implantation,1/3,60/18870,0.009509154678849496,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:1905517,discovery_tumor_others,GO:1905517,macrophage migration,1/3,61/18870,0.009667127700431877,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0022617,discovery_tumor_others,GO:0022617,extracellular matrix disassembly,1/3,62/18870,0.009825083924414835,0.030231027459737953,0.004508135673820571,MMP2,1.0,,
GO:0019229,discovery_tumor_others,GO:0019229,regulation of vasoconstriction,1/3,64/18870,0.010140945983155958,0.030422837949467874,0.0045367389924645075,MMP2,1.0,,
GO:0001655,discovery_tumor_others,GO:0001655,urogenital system development,1/3,67/18870,0.0106146131116015,0.03106716032663854,0.004632822153972414,MMP2,1.0,,
GO:0043627,discovery_tumor_others,GO:0043627,response to estrogen,1/3,69/18870,0.010930307234540915,0.03110106134393119,0.004637877568831844,MMP2,1.0,,
GO:0042698,discovery_tumor_others,GO:0042698,ovulation cycle,1/3,71/18870,0.011245934195662444,0.03110106134393119,0.004637877568831844,MMP2,1.0,,
GO:0014823,discovery_tumor_others,GO:0014823,response to activity,1/3,72/18870,0.01140372249277477,0.03110106134393119,0.004637877568831844,MMP2,1.0,,
GO:0007492,discovery_tumor_others,GO:0007492,endoderm development,1/3,83/18870,0.013138285964344187,0.033633607482004835,0.005015537957842826,MMP2,1.0,,
GO:0042310,discovery_tumor_others,GO:0042310,vasoconstriction,1/3,83/18870,0.013138285964344187,0.033633607482004835,0.005015537957842826,MMP2,1.0,,
GO:0048678,discovery_tumor_others,GO:0048678,response to axon injury,1/3,84/18870,0.013295872867101766,0.033633607482004835,0.005015537957842826,MMP2,1.0,,
GO:0071230,discovery_tumor_others,GO:0071230,cellular response to amino acid stimulus,1/3,85/18870,0.013453442992801934,0.033633607482004835,0.005015537957842826,MMP2,1.0,,
GO:0034644,discovery_tumor_others,GO:0034644,cellular response to UV,1/3,90/18870,0.01424104199669518,0.03467284492525524,0.0051705119625380614,MMP2,1.0,,
GO:1904705,discovery_tumor_others,GO:1904705,regulation of vascular associated smooth muscle cell proliferation,1/3,93/18870,0.014713400131498022,0.03467284492525524,0.0051705119625380614,MMP2,1.0,,
GO:0071229,discovery_tumor_others,GO:0071229,cellular response to acid chemical,1/3,94/18870,0.014870819303868577,0.03467284492525524,0.0051705119625380614,MMP2,1.0,,
GO:1990874,discovery_tumor_others,GO:1990874,vascular associated smooth muscle cell proliferation,1/3,95/18870,0.015028221708112799,0.03467284492525524,0.0051705119625380614,MMP2,1.0,,
GO:0048661,discovery_tumor_others,GO:0048661,positive regulation of smooth muscle cell proliferation,1/3,98/18870,0.015500328321016998,0.03467284492525524,0.0051705119625380614,MMP2,1.0,,
GO:0008585,discovery_tumor_others,GO:0008585,female gonad development,1/3,101/18870,0.015972284052933716,0.03467284492525524,0.0051705119625380614,MMP2,1.0,,
GO:0042542,discovery_tumor_others,GO:0042542,response to hydrogen peroxide,1/3,101/18870,0.015972284052933716,0.03467284492525524,0.0051705119625380614,MMP2,1.0,,
GO:0046545,discovery_tumor_others,GO:0046545,development of primary female sexual characteristics,1/3,105/18870,0.016601323700076387,0.03467284492525524,0.0051705119625380614,MMP2,1.0,,
GO:0032526,discovery_tumor_others,GO:0032526,response to retinoic acid,1/3,106/18870,0.016758541713873365,0.03467284492525524,0.0051705119625380614,MMP2,1.0,,
GO:0032963,discovery_tumor_others,GO:0032963,collagen metabolic process,1/3,106/18870,0.016758541713873365,0.03467284492525524,0.0051705119625380614,MMP2,1.0,,
GO:0071347,discovery_tumor_others,GO:0071347,cellular response to interleukin-1,1/3,111/18870,0.017544380439581064,0.035683485639825895,0.005321221542781055,MMP2,1.0,,
GO:0032355,discovery_tumor_others,GO:0032355,response to estradiol,1/3,113/18870,0.01785859865300643,0.03571719730601286,0.005326248721072093,MMP2,1.0,,
GO:0046660,discovery_tumor_others,GO:0046660,female sex differentiation,1/3,120/18870,0.01895783478542179,0.03700701865443843,0.005518590501100467,MMP2,1.0,,
GO:0022612,discovery_tumor_others,GO:0022612,gland morphogenesis,1/3,122/18870,0.019271751534277848,0.03700701865443843,0.005518590501100467,MMP2,1.0,,
GO:0071482,discovery_tumor_others,GO:0071482,cellular response to light stimulus,1/3,123/18870,0.019428684793580175,0.03700701865443843,0.005518590501100467,MMP2,1.0,,
GO:0043200,discovery_tumor_others,GO:0043200,response to amino acid,1/3,126/18870,0.01989938412170056,0.03731134522818855,0.005563972534028116,MMP2,1.0,,
GO:0001704,discovery_tumor_others,GO:0001704,formation of primary germ layer,1/3,128/18870,0.02021309997455678,0.037316492260720216,0.005564740073967048,MMP2,1.0,,
GO:0070555,discovery_tumor_others,GO:0070555,response to interleukin-1,1/3,140/18870,0.022093989369852518,0.03975439269095826,0.005928286629353425,MMP2,1.0,,
GO:0001101,discovery_tumor_others,GO:0001101,response to acid chemical,1/3,141/18870,0.0222506214057252,0.03975439269095826,0.005928286629353425,MMP2,1.0,,
GO:0035296,discovery_tumor_others,GO:0035296,regulation of tube diameter,1/3,146/18870,0.023033530710692474,0.03975439269095826,0.005928286629353425,MMP2,1.0,,
GO:0097746,discovery_tumor_others,GO:0097746,blood vessel diameter maintenance,1/3,146/18870,0.023033530710692474,0.03975439269095826,0.005928286629353425,MMP2,1.0,,
GO:0035150,discovery_tumor_others,GO:0035150,regulation of tube size,1/3,147/18870,0.023190062403058986,0.03975439269095826,0.005928286629353425,MMP2,1.0,,
GO:0009411,discovery_tumor_others,GO:0009411,response to UV,1/3,152/18870,0.023972470070876106,0.040475526862446085,0.0060358241812419585,MMP2,1.0,,
GO:0034614,discovery_tumor_others,GO:0034614,cellular response to reactive oxygen species,1/3,154/18870,0.024285316117467648,0.040475526862446085,0.0060358241812419585,MMP2,1.0,,
GO:0007292,discovery_tumor_others,GO:0007292,female gamete generation,1/3,163/18870,0.025692296060551345,0.042233911332413165,0.006298039409219508,MMP2,1.0,,
GO:0048660,discovery_tumor_others,GO:0048660,regulation of smooth muscle cell proliferation,1/3,171/18870,0.026941808836465353,0.043689419734808686,0.006515088907822346,MMP2,1.0,,
GO:0048659,discovery_tumor_others,GO:0048659,smooth muscle cell proliferation,1/3,175/18870,0.0275661644112708,0.04410586305803328,0.006577190105145314,MMP2,1.0,,
GO:0071478,discovery_tumor_others,GO:0071478,cellular response to radiation,1/3,181/18870,0.028502196917799094,0.04500346881757752,0.006711043595603664,MMP2,1.0,,
GO:0048771,discovery_tumor_others,GO:0048771,tissue remodeling,1/3,184/18870,0.02896998783825422,0.04504886924872105,0.0067178138353355945,MMP2,1.0,,
GO:0007565,discovery_tumor_others,GO:0007565,female pregnancy,1/3,186/18870,0.02928176501166868,0.04504886924872105,0.0067178138353355945,MMP2,1.0,,
GO:0031099,discovery_tumor_others,GO:0031099,regeneration,1/3,191/18870,0.030060915956525158,0.045662150820038216,0.00680926810474254,MMP2,1.0,,
GO:0007369,discovery_tumor_others,GO:0007369,gastrulation,1/3,197/18870,0.030995346610842356,0.046493019916263534,0.0069331696366357895,MMP2,1.0,,
GO:0000302,discovery_tumor_others,GO:0000302,response to reactive oxygen species,1/3,205/18870,0.032240320319640525,0.04740858587327012,0.007069701402154315,MMP2,1.0,,
GO:0044703,discovery_tumor_others,GO:0044703,multi-organism reproductive process,1/3,206/18870,0.03239586701340125,0.04740858587327012,0.007069701402154315,MMP2,1.0,,
GO:0009612,discovery_tumor_others,GO:0009612,response to mechanical stimulus,1/3,213/18870,0.03348422721298572,0.048410930910340794,0.007219173907682399,MMP2,1.0,,
GO:0044706,discovery_tumor_others,GO:0044706,multi-multicellular organism process,1/3,216/18870,0.03395041735296089,0.04850059621851556,0.007232545050129513,MMP2,1.0,,
